Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,-0.15534959027359,0.00304475842268688,-0.161317316782056,-0.149381863765124,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,42346,0.501198241564394,0.0119394747037148,0.477796871145113,0.524599611983675,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42611,0.18829051568459,0.00406852195583824,0.180316212651147,0.196264818718033,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,-0.163108828530103,0.00301958689919944,-0.169027218852534,-0.157190438207672,0
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42568,0.155626976975653,0.00400918034134147,0.147768983506623,0.163484970444682,1.11263471265464e-308
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,0.152183312957983,0.00393729143436577,0.144466221746626,0.15990040416934,4.01341413082116e-307
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42721,0.226531375708074,0.00617209042874502,0.214434078467734,0.238628672948414,3.22468123124777e-281
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,-0.0953820652931082,0.00274530857361149,-0.100762870097387,-0.0900012604888297,2.15921121473931e-253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42754,0.167707565831434,0.00499342083161076,0.157920461001477,0.177494670661391,1.27833504290173e-237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42587,0.29532418207715,0.00882098037208016,0.278035060547873,0.312613303606427,4.42370684682648e-236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYY,Peptide YY,40116,0.327329548907949,0.00988662799597396,0.30795175803584,0.346707339780058,3.76068887064218e-229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,40511,0.256226768168828,0.00802424099591135,0.240499255816841,0.271954280520814,2.62885783779558e-214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,40532,-0.0728627508402378,0.00231908352287876,-0.0774081545450802,-0.0683173471353954,7.77505109917495e-208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42618,0.165720858508654,0.00551960250310857,0.154902437602561,0.176539279414747,9.64262310747034e-192
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.349960618657966,0.0117137010790862,-0.372919472772975,-0.327001764542957,5.28231836724871e-190
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,0.085533098471497,0.00297287161932313,0.0797062700976237,0.0913599268453703,1.19272141344258e-176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42663,-0.0793000046599406,0.00276002067388002,-0.0847096451807454,-0.0738903641391357,3.00370232572319e-176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,40539,-0.193376320193652,0.00675414461027697,-0.206614443629794,-0.180138196757509,3.94780739269607e-174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,0.141096943906095,0.00499990913792523,0.131297121995762,0.150896765816428,2.89252217161473e-170
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9,Complement component C9,40532,-0.143759562114841,0.00520880773669425,-0.153968825278762,-0.13355029895092,2.44296812249124e-162
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,0.0943953821689169,0.00344026233420534,0.0876524679938744,0.101138296343959,2.4679541255015e-161
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0902628600767272,0.00333671734753871,0.0837228940755514,0.0968028260779031,6.22875031210573e-157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,42370,0.211130732768275,0.00781243437608716,0.195818361391144,0.226443104145405,1.3415053595937e-156
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,0.144524913745504,0.00539034321447414,0.133959841045135,0.155089986445873,1.46825995766812e-153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,0.176155321592977,0.00670989802458553,0.16300392146479,0.189306721721165,4.13960208499228e-148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42636,-0.120149209185249,0.00457906719786358,-0.129124180893061,-0.111174237477436,4.96077904078398e-148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42636,0.155760022929115,0.00593843010925725,0.144120699914971,0.16739934594326,6.31185109915747e-148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42754,0.0732879960166766,0.00285197607326249,0.0676981229130821,0.0788778691202711,3.09564080813358e-142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,40511,0.222537956098841,0.00883349866157952,0.205224298722145,0.239851613475537,2.64464512106392e-136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42721,0.0848795949841576,0.00338377630151714,0.078247393433184,0.0915117965351312,9.13419282882413e-136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,42311,0.126375311747875,0.00514398108093495,0.116293108829243,0.136457514666508,2.41871995774874e-130
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,0.129601171133747,0.00529371526668908,0.119225489211037,0.139976853056458,1.76281215571666e-129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42600,0.249591151303045,0.0102036962698022,0.229591906614233,0.269590395991858,2.58042247839489e-129
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,0.322105423484907,0.0136180288015101,0.295414087033947,0.348796759935867,3.148402041926e-121
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.18837444280783,0.00802227989195379,0.172650774219601,0.20409811139606,1.77488709307516e-119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42636,0.0784511159576369,0.00337580651168522,0.0718345351947339,0.0850676967205399,3.67453082988307e-117
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,0.122621971607507,0.00529905557489901,0.112235822680705,0.133008120534309,3.39935230901429e-116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,0.0736765473704867,0.00318807682200743,0.0674279167993522,0.0799251779416213,2.22239884586636e-115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,0.132779482547467,0.00579629656941715,0.121418741271409,0.144140223823524,1.69383367484706e-113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42661,0.182234741493451,0.00799239248023241,0.166569652232196,0.197899830754707,6.08081618442181e-113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42569,0.165409274908552,0.00726180972267688,0.151176127852105,0.179642421964999,1.04316387403667e-112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42611,0.0910674296227207,0.00404384361754264,0.0831414961323371,0.0989933631131043,2.88684526941477e-110
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42655,0.0732880893828913,0.0033265432465958,0.0667680646195635,0.079808114146219,1.05407341383406e-105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42794,0.113255201615534,0.00516161829899496,0.103138429749504,0.123371973481564,6.78066545297948e-105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41747,0.0914343403669526,0.00416695025900524,0.0832671178593024,0.0996015628746029,9.33752665019235e-105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,-0.0464284442784157,0.00215491812060636,-0.0506520837948041,-0.0422048047620272,2.93138246586292e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FURIN,Furin,42679,0.0693542187973784,0.00322506598502591,0.0630330894667276,0.0756753481280292,6.89762480865617e-101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42689,0.245668258866162,0.0115739978753129,0.222983223030549,0.268353294701775,2.21731446680041e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.0686654962028812,0.00324091444962489,0.0623133038816164,0.0750176885241459,4.88368033373537e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,0.173032316756641,0.00817800823152547,0.157003420622851,0.189061212890431,9.58430416417596e-98
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.145555520220652,0.00689456241430127,0.132042177888621,0.159068862552682,2.3783448585129e-97
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,40033,-0.0912635068696649,0.00432180635629833,-0.0997342473280096,-0.0827927664113202,4.92220702159166e-97
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42587,0.0734731592108785,0.00349983394616672,0.0666134846763917,0.0803328337453653,2.66506408577929e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,0.0974052233322816,0.00465440876743,0.0882825821481188,0.106527864516444,9.8624227256001e-96
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MME,Neprilysin,42587,0.16801863667141,0.00804144171700519,0.15225741090608,0.18377986243674,2.00294389266309e-95
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.167706968740484,0.00805748477960284,0.151914298572463,0.183499638908506,1.01744330721714e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42794,0.0954566569044544,0.00459262161581581,0.0864551185374554,0.104458195271453,1.73738520050727e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0620995788243113,0.00298832814470146,-0.0679567019879262,-0.0562424556606964,1.94800139763669e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,0.0635236375328782,0.00306537237714618,0.0575155076736716,0.0695317673920847,6.38131616112585e-94
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,40182,0.168328160265424,0.00812814984149286,0.152396986576098,0.18425933395475,1.72063778367206e-93
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,0.062846939466332,0.00304096697769865,0.0568866441900426,0.0688072347426213,1.94357897208405e-93
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42674,0.0947477344431232,0.00462218330835125,0.0856882551587547,0.103807213727492,5.57751474854648e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.110483878916421,0.00539516157684229,0.0999093622258104,0.121058395607032,8.50842374978726e-92
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0748098279859476,0.00365753099777778,0.0676410672303032,0.0819785887415921,1.36007623769827e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,0.0667165555896984,0.00327297646851756,0.060301521711404,0.0731315894679928,5.43995440323582e-91
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,-0.106830108854747,0.0052766365004747,-0.117172316395677,-0.0964879013138166,8.81708126599258e-90
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42721,-0.0720540900879654,0.00357086948209145,-0.0790529942728646,-0.0650551859030661,3.10761805780466e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.171253978682157,0.00847823968562784,0.154636628898326,0.187871328465987,3.7285287479721e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.128631699928022,0.00638558866249729,0.116115946149528,0.141147453706517,6.61592578664166e-89
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,0.0679237165050666,0.00339176023455393,0.0612758664453409,0.0745715665647923,1.06303888060351e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,0.162877581978087,0.00817786081257072,0.146848974785449,0.178906189170726,5.22667133916861e-87
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REN,Renin,42636,0.169238546656698,0.0085134077886149,0.152552267391013,0.185924825922384,1.08222401909699e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,0.158531618753505,0.0079983292794911,0.142854893365703,0.174208344141308,3.38570663466141e-86
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,40532,-0.0992110366754681,0.00503518377805325,-0.109079996880453,-0.0893420764704838,5.26836568542183e-85
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42670,0.128429095641911,0.00655221370455618,0.115586756780981,0.141271434502841,2.26483295615115e-84
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,-0.0598652618999722,0.00307298872050279,-0.0658883197921577,-0.0538422040077868,2.23992836690541e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,40267,0.072163725862721,0.00370996062724193,0.0648922030333268,0.0794352486921151,6.80606164061284e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42794,0.0863009373424534,0.00444625159349152,0.07758628421921,0.0950155904656968,8.37576263897903e-83
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42706,0.040221639682657,0.0020778028369699,0.0361491461221959,0.044294133243118,2.27808942922065e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0797597000317776,0.00412402780850444,0.0716766055271089,0.0878427945364463,3.14373042357588e-82
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42587,0.10649898119837,0.00553754921546853,0.0956453847360515,0.117352577660688,2.47881657026562e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0461529011349449,0.00240882383400835,0.0414316064202885,0.0508741958496012,9.40867409489706e-81
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42754,0.0505605555655339,0.00264037491688087,0.0453854207284474,0.0557356904026204,1.14144431726924e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42654,-0.0377030840601877,0.00197649043636916,-0.0415770053154713,-0.0338291628049041,4.55643689056032e-80
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.28291752038039,0.0148862942985047,0.253740383555321,0.31209465720546,1.74497930296999e-79
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0587814424218594,0.00310922483988401,-0.064875523108032,-0.0526873617356867,1.75095099754394e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.062812504814379,0.00333221718931155,0.0562813591233283,0.0693436505054296,3.01332462734697e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42754,0.0574866428199386,0.00305013518524438,0.0515083778568596,0.0634649077830175,3.08568630367322e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.104103016999992,0.00552439313630963,0.0932752064528255,0.114930827547159,3.48269723056478e-78
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,40449,0.134812483948115,0.00721343551238472,0.120674150343841,0.148950817552389,8.7751206559192e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.089428249971119,0.004790747115305,0.0800383856251212,0.0988181143171168,8.86683554515305e-77
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42754,0.0642535488369229,0.00345556006100238,0.0574806511173582,0.0710264465564875,3.16326516956861e-76
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0877500023726963,0.00476247899337573,0.0784155435456799,0.0970844611997128,7.11744482417857e-75
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0940502831187548,0.00515117579767154,0.0839539785553186,0.104146587682191,1.39013764803845e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0725676656397146,0.0039825999970797,0.0647617696454384,0.0803735616339909,2.62076368542707e-73
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,-0.0606686350370309,0.0033439831432726,-0.0672228419978452,-0.0541144280762166,1.07110770251529e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42587,0.0768095276807385,0.00424376706648448,0.068491744230429,0.0851273111310481,2.34177273862496e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,0.182784208470473,0.0101074609344238,0.162973585039003,0.202594831901944,3.24538336872649e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.105940507991173,0.00587076231354324,0.0944338138566282,0.117447202125718,6.30028095758106e-72
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42711,0.0975073159698427,0.00541629595705847,0.0868913758940081,0.108123256045677,1.27337976434644e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,0.0979602883053669,0.00544831690955916,0.087281587162631,0.108638989448103,2.01089247146274e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0560286435673576,0.00312513376864065,0.049903381380822,0.0621539057538933,4.68482537312807e-71
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42663,0.0320755673629214,0.00179519424634653,0.0285569866400822,0.0355941480857606,1.37711991935611e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0482180507105779,0.00270019322812188,-0.0535104294376968,-0.042925671983459,1.65251135841866e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,-0.0452316937738924,0.00253821022728922,-0.0502065858193792,-0.0402568017284055,3.10268187915199e-70
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,40516,-0.0654595222095625,0.00368449376645789,-0.07268112999182,-0.0582379144273051,1.13475885609527e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0821859118979201,0.00464019767523216,0.0730911244544651,0.0912806993413752,3.05060993497217e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0692766621875471,0.00391729830318913,-0.0769545668617977,-0.0615987575132963,3.35017443019994e-69
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.0981770780963201,0.00557927502835634,0.0872416990407417,0.109112457151899,2.28042910281901e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,0.218255756597179,0.0124215746219923,0.193909470338075,0.242602042856284,2.36852735394168e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42621,-0.0785953929335549,0.00447360478563818,-0.0873636583134058,-0.0698271275537041,2.483427734381e-68
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0613689454587895,0.00353388470510531,0.0544425314367831,0.0682953594807959,7.93716390361253e-67
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42659,-0.0929469401941354,0.00536205102024003,-0.103456560193806,-0.0824373201944649,1.36907652813022e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.136605456362667,0.00789371717695219,0.12113377069584,0.152077142029493,2.24657049297338e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.100718340176677,0.00582809045414318,0.0892952828865563,0.112141397466798,3.41780625416502e-66
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,0.130703346591698,0.00759345419785579,0.1158201763639,0.145586516819495,1.11727018092803e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.0782535265007453,0.00454801733260761,0.0693394125288343,0.0871676404726562,1.20862163701263e-65
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.126004372836485,0.00740000333249269,0.1115003663048,0.140508379368171,3.2226319980897e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,0.0487958521628857,0.002876974312035,0.0431569825112971,0.0544347218144743,7.3091094649474e-64
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,0.0451483352844783,0.00266236721997551,0.0399300955333263,0.0503665750356303,1.05240615058792e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0654968717945721,0.00386842108571545,0.0579147664665698,0.0730789771225744,1.22832968467518e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,0.0554534972020346,0.00328177436789613,0.0490212194409582,0.061885774963111,2.09130816965695e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,0.0475535291714708,0.00281977514913158,0.0420267698791729,0.0530802884637687,4.83526758440568e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42764,-0.0925986385857106,0.00550494140446742,-0.103388323738467,-0.0818089534329544,7.41043771957274e-63
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,42326,0.0996803932706399,0.00596033713675255,0.0879981324826049,0.111362654058675,3.8487788747049e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,40283,0.0647800212608455,0.00387683355634429,0.0571814274904107,0.0723786150312803,6.37219090613888e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0631553035834991,0.00378338768987344,0.0557398637113471,0.070570743455651,8.37631711578051e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0947259377160151,0.0056784714678212,0.0835961336390856,0.105855741792945,9.80604639817114e-62
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,0.0371207632967018,0.00222866225283341,0.0327525852811483,0.0414889413122553,1.12850944718589e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,40223,0.104034289372373,0.00625770184230633,0.0917691937614528,0.116299384983294,2.55402772910847e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,-0.0613449399323017,0.00369136639128423,-0.0685800180592188,-0.0541098618053846,2.73126094462419e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,-0.0633483439421942,0.00382757890518617,-0.0708503985963591,-0.0558462892880293,6.3710140728054e-61
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,0.0597804031801377,0.00362329816302366,0.0526787387806113,0.066882067579664,1.45790533255029e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42743,0.0394616804128314,0.00240912022607046,0.0347398047697333,0.0441835560559295,9.93630938779748e-60
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0642614748158788,0.00393698646839522,0.0565449813378242,0.0719779682939335,2.49954460801273e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELE,E-selectin,42794,0.0823196012008324,0.00505649637871911,0.0724088682985429,0.0922303341031218,4.9467600830756e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,0.114276144181808,0.0070270240940462,0.100503176957478,0.128049111406139,6.70191273277428e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.149634914997152,0.00921078195258954,0.131581782370076,0.167688047624227,8.93855701656485e-59
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42754,0.0718014513756172,0.00442317907952988,0.0631320203797386,0.0804708823714958,1.05305747068133e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42611,-0.0438780908285281,0.00270964715564552,-0.0491889992535934,-0.0385671824034629,2.0116319764007e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,0.0584258970639115,0.00360883901401645,0.0513525725964393,0.0654992215313838,2.13594370196298e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42752,-0.0576786708358453,0.00356666209244096,-0.0646693285370296,-0.0506880131346611,2.80463769575354e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OCLN,Occludin,40482,0.0725311364667384,0.00449883411654819,0.0637134215983039,0.0813488513351729,7.86513239188228e-58
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42636,0.0944965990769507,0.00588055368392386,0.08297071385646,0.106022484297441,1.43761461047956e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42794,0.0971239956695921,0.00605092062124647,0.085264191251949,0.108983800087235,1.89119004040559e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42594,0.118192569369922,0.00736570646166406,0.10375578470506,0.132629354034783,2.076408204241e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,40283,0.10156936074847,0.00633452156538437,0.0891536984803165,0.113985023016623,3.23244298218124e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.130047789545458,0.00812742130778188,0.114118043782205,0.14597753530871,4.33616034339533e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.120067242069343,0.00751368807052455,0.105340413451115,0.134794070687571,7.41192433398162e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFM,Afamin,40539,0.0318323413888036,0.00199401177284202,0.0279240783140333,0.035740604463574,9.43470234954563e-57
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.078977117862854,0.00497278278126156,0.0692304636115813,0.0887237721141266,3.51510109775544e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MENT,Protein MENT,40283,-0.0367665604318505,0.00232364364652769,-0.0413209019790447,-0.0322122188846562,8.81398752495193e-56
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,40511,0.0418570306601393,0.00265135478622919,0.0366603752791301,0.0470536860411485,1.49364841442617e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,0.0562524600001203,0.0035696238464516,0.0492559972610752,0.0632489227391655,1.90455920345163e-55
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0546433834873195,0.00349241585986448,0.0477982484019851,0.0614885185726539,1.06870811748778e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.078262210952404,0.00500775578617451,0.068447009611502,0.0880774122933061,1.41805606801775e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0620110756732812,0.00396953938462458,0.054230778479417,0.0697913728671454,1.56707866248861e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0811443078419967,0.0051906009868377,0.0709707299077948,0.0913178857761986,1.62311278603377e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.162414165065257,0.0104073649356542,0.142015729791375,0.18281260033914,2.00593996989544e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,0.0820326965167462,0.00526307815970886,0.0717170633237168,0.0923483297097755,2.68591097174896e-54
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0853863604556985,0.00550891088028916,0.0745888951303317,0.0961838257810652,1.04822747548522e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,0.145966584333375,0.0094270289878272,0.127489607517234,0.164443561149517,1.29615668407521e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42721,-0.0252815654922711,0.00163636315613762,-0.0284888372783008,-0.0220742937062413,2.15989214345431e-53
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0758521226718512,0.00494964927888334,-0.0855534352584626,-0.0661508100852399,1.75731089520733e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.123962083720445,0.00810086829779576,0.108084381856765,0.139839785584125,2.08497270955332e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42613,0.0657866227337917,0.00430720606912365,0.0573444988383093,0.074228746629274,3.15010182137062e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42613,0.0475071614464304,0.00311265588915109,0.0414063559036942,0.0536079669891665,3.72024905034041e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42689,0.0847941638689299,0.00557727950398606,0.0738626960411173,0.0957256316967426,8.99560304606826e-52
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,0.127480514269531,0.00839298316719736,0.111030267261825,0.143930761277238,1.34896723384587e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0692254488132651,0.00460050809499813,0.0602084529470688,0.0782424446794615,9.48172483675937e-51
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42611,0.08305091524813,0.00552456847914798,0.072222761029,0.0938790694672601,1.15314752582353e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42613,0.0473911810828979,0.00315611535430979,0.0412051949884508,0.0535771671773451,1.49149325483253e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,40223,0.0843419279956066,0.00561228563340235,0.073341848154138,0.0953420078370752,1.51916964854831e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42749,0.041307009169427,0.00276098807100653,0.0358954725502542,0.0467185457885999,3.32243516185859e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.085533554022847,0.00571709462251943,0.0743280485627089,0.0967390594829851,4.0882608659931e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.128851639917587,0.00862177741796444,0.111952956178377,0.145750323656798,4.25795387560565e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,42475,0.0506278046978289,0.00338969496180094,0.0439840025726991,0.0572716068229588,4.90823190690863e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0905138640130445,0.00607207650060449,-0.102415133954229,-0.0786125940718597,9.10280337658344e-50
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42794,-0.024231686019005,0.00162959878389965,-0.0274256996354483,-0.0210376724025617,1.27103799248682e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42594,0.0742316178087815,0.00499665679326813,0.064438170493976,0.084025065123587,1.56971108965244e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42676,-0.0622891426935948,0.00422737552451658,-0.0705747987216473,-0.0540034866655423,9.23584234002273e-49
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42659,0.0444418077728394,0.00301831282375484,0.03852591463828,0.0503577009073989,1.0797221541653e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,40449,0.164340505688393,0.0111631527924214,0.142460726215247,0.186220285161539,1.32305182140523e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,40283,0.041777853751511,0.00284463014645547,0.0362023786644583,0.0473533288385637,2.23497479150432e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42721,0.0393161356976779,0.00268000357199329,0.034063328696571,0.0445689426987847,2.35302559516898e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0503192165778483,0.00343114966650175,0.0435941632315049,0.0570442699241917,3.01172769610734e-48
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POSTN,Periostin,40527,-0.0562617919270197,0.00386256631848145,-0.0638324219112433,-0.048691161942796,1.24548627938456e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,42188,0.0578716285665202,0.00398403271755139,0.0500629244401195,0.0656803326929209,1.95380356020149e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,40283,0.0391663109692541,0.0027064236625556,0.0338617205906451,0.0444709013478631,4.90819874451071e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,40516,0.0407038165060977,0.00281531057101177,0.0351858077869146,0.0462218252252807,5.84043389988228e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0491079259920249,0.00340764329028027,-0.0557869068409742,-0.0424289451430755,9.73101554086458e-47
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0559092290873067,0.00388841136044861,0.0482879428208274,0.063530515353786,1.56832155935285e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,0.0501659040527969,0.00349220040508721,0.0433211912588259,0.0570106168467678,1.92825213133078e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.0493024128522269,0.00343653989383079,0.0425667946603186,0.0560380310441353,2.44980619215735e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0640564762821653,0.00446462692607103,0.0553058075070661,0.0728071450572645,2.88241864611714e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0621609861451289,0.00434352044849777,0.0536476860660733,0.0706742862241845,4.06294161910929e-46
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0570889311614876,0.00401345928799067,0.0492225509570259,0.0649553113659493,1.3863059163697e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELN,Elastin,40511,0.0521172958830969,0.00367475613229147,0.0449147738638056,0.0593198179023882,2.86854095685344e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0450718146706444,0.00318366987621439,0.0388318217132642,0.0513118076280246,3.55882444543561e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,0.106705228024332,0.00754023929073258,0.0919263590144963,0.121484097034168,3.8579568607365e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0387405390461528,0.00274100149041496,0.0333681761249395,0.0441129019673662,4.95605519933878e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGRN,Agrin,42676,0.0512732439857758,0.00363603491305504,0.044146615556188,0.0583998724153637,7.75015545429919e-45
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0528399269114064,0.00375689775484905,0.0454764073119022,0.0602034465109105,1.31551646347506e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,0.0512122845476414,0.00365028047357909,0.0440577348194264,0.0583668342758565,2.1257992492353e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42676,0.0586968865708731,0.00419379185909119,0.0504770545270544,0.0669167186146919,3.3539826470705e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42651,0.0838550517264021,0.00600468894877853,0.0720858613867962,0.095624242066008,5.17430800340144e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42794,0.087036766926423,0.00624311717861471,0.0748002572563382,0.0992732765965078,7.12723431612938e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0450235212419356,0.00323004000811594,0.0386926428260284,0.0513543996578429,7.42025781323136e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42594,-0.0472386553361482,0.00338969092510958,-0.053882449549363,-0.0405948611229334,7.74316910112189e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0429157675974308,0.00308305675904072,0.036872976349711,0.0489585588451507,9.62548704336241e-44
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0424208837288682,0.00305426303702154,-0.0484072392814305,-0.036434528176306,1.47254540713493e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,40482,0.0613721487786197,0.00441651816732679,0.0527157731706592,0.0700285243865802,1.52738954277092e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42658,0.0924943058614186,0.00666388894030993,0.0794330835384112,0.105555528184426,1.67082360604437e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42721,0.0641229160341971,0.00462462374718302,0.0550586534897184,0.0731871785786758,2.0297874918541e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42636,0.0375892995155711,0.00271529772868819,0.0322673159673422,0.0429112830638,2.75790435137474e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42544,0.032026784037207,0.00231991871323557,0.0274797433592653,0.0365738247151487,4.68868796915936e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,42488,-0.0384364348232244,0.00278754407997576,-0.0439000212199768,-0.0329728484264719,5.89155638136819e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0705335833254598,0.00512325361750137,0.0604920062351571,0.0805751604157625,7.76194445222734e-43
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTR,Transthyretin,40424,0.0347880339327859,0.0025327984973432,0.0298237488779932,0.0397523189875786,1.38272966589058e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0564036547195087,0.0041122601845115,0.0483436247578661,0.0644636846811512,1.57070831179921e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42636,0.0865900924901913,0.00635905250854036,0.0741263495734522,0.0990538354069304,6.0353978361803e-42
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.0939823777265188,0.00693419645967343,0.0803913526655589,0.107573402787479,1.4199941601304e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0406941446533979,0.00301387720109062,0.0347869453392602,0.0466013439675355,2.8122387109442e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42620,0.0435381007662721,0.00322646182950298,0.0372142355804463,0.0498619659520979,3.14608893363493e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0998232040181657,0.00739979406047676,0.0853196076596312,0.1143268003767,3.72321022451138e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.0747691555124698,0.00554624571680904,0.0638985139075241,0.0856397971174155,3.79128295041906e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,-0.0366194523049762,0.00271863947816964,-0.0419479856821887,-0.0312909189277637,4.3559343282095e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42611,0.0310437759828528,0.00230811474313671,0.0265198710863048,0.0355676808794007,5.68409259682286e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42611,0.0418561127675755,0.00311381251491981,0.0357530402383327,0.0479591852968183,6.30420836326741e-41
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0587007224679735,0.0043970672016585,0.0500824707527229,0.0673189741832242,2.1468012401895e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42668,-0.0519274246854255,0.00389327162498831,-0.0595582370704026,-0.0442966123004484,2.51554284869755e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42721,0.0744719997854222,0.00561258734586737,0.0634713285875222,0.0854726709833223,6.24123539705554e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,0.051818964490137,0.00390504756358645,0.0441650712655075,0.0594728577147664,6.87709960913986e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,0.0750920191299678,0.00567328171504314,0.0639723869684832,0.0862116512914523,9.57883428367605e-40
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42587,0.108436231289983,0.00820363579507444,0.0923571051316371,0.124515357448329,1.22199329690354e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0782799392717659,0.00593178710233255,0.0666536365511941,0.0899062419923377,1.6174342850925e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0874759196753399,0.00663002566281889,0.0744810693762149,0.100470769974465,1.66921424194474e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEP,Leptin,42636,0.0875834961625286,0.00664206491434584,0.0745650489304107,0.100601943394646,1.85213084030583e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.0576881316183079,0.00438208021127796,0.0490992544042031,0.0662770088324127,2.46247423999095e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,40223,0.0777989123791076,0.00591157125224392,0.0662122327247096,0.0893855920335057,2.92750737663552e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,0.0773312052181293,0.00588196913095168,0.065802545721464,0.0888598647147945,3.10290096288299e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.0880923595906748,0.00671549949322725,0.0749299805839494,0.1012547385974,5.01531309197801e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,0.0497104502019458,0.00379244797389185,0.0422772521731177,0.0571436482307738,5.16546451188641e-39
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42611,0.0507204124598535,0.00388521348378986,0.0431053940316254,0.0583354308880817,1.0278543335678e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,0.0495798037112286,0.0038028761924412,0.0421261663740438,0.0570334410484133,1.27657960951828e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42671,0.0403602783231055,0.0031012239079243,0.0342818794635739,0.0464386771826372,1.73055702655859e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,0.0832386289609118,0.00641308848711901,0.0706689755261585,0.0958082823956651,2.72086856657393e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSN,Gelsolin,40488,-0.025378947998061,0.00195699296382772,-0.0292146542071633,-0.0215432417889587,3.46414733329698e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0491846422067428,0.00379926683183386,0.0417380792163485,0.0566312051971372,4.17304428406368e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0888864521888261,0.00688171231943713,0.0753982960427293,0.102374608334923,6.86021936225895e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,-0.0461206059721824,0.0035771901448464,-0.0531318986560814,-0.0391093132882835,8.25421609464064e-38
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,0.0805740882516204,0.00625682689177778,0.0683107075437359,0.0928374689595048,1.00031735885219e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,0.0510624699794623,0.00396570982646202,0.0432896787195967,0.0588352612393279,1.02803033101027e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,40169,0.0378437201298689,0.0029458568784663,0.0320698406480749,0.0436175996116628,1.67736568514095e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.0872927396970584,0.00679860083730007,0.0739674820559503,0.100617997338167,1.83010236115227e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42574,0.0435343707356931,0.00339369728457602,0.0368827240579241,0.0501860174134621,1.89897184844624e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,-0.0320988267003416,0.0025051156160405,-0.037008853307781,-0.0271888000929022,2.28886843984023e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,0.0715734212085573,0.0055981628291069,0.0606010220635078,0.0825458203536068,3.27355700359236e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0544800907074105,0.00427935795209016,0.0460925491213138,0.0628676322935072,6.49172399866998e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0316590402054009,0.00248805579294126,-0.0365356295595657,-0.026782450851236,7.02137288789723e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0502325033581124,0.00394898019192519,0.042492502181939,0.0579725045342858,8.28460705431268e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0649048023620761,0.00510890624522124,0.0548913461214425,0.0749182586027097,9.20832247776751e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXN,Paxillin,42311,0.0649867586077387,0.00511701632628496,0.0549574066082202,0.0750161106072572,9.71258812342321e-37
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLN,Promotilin,42594,0.112272912461066,0.0088586138072458,0.0949100293988642,0.129635795523268,1.33857836865443e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,0.160048537186438,0.0126309702317446,0.135291835532219,0.184805238840657,1.53782932497843e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42711,0.046515156274709,0.00367405379458377,0.0393140108373248,0.0537163017120932,1.57860361882171e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0371598208676286,0.00294435466051121,0.0313888857330266,0.0429307560022305,2.85761866195967e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42754,0.0447873883095192,0.00355298077170863,0.0378235459969703,0.0517512306220681,3.14027242677249e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,40527,-0.0762326562296193,0.00604926411738288,-0.0880892138996897,-0.0643760985595488,3.59849370713447e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42721,0.0476607537353143,0.00378497190584603,0.0402422087998561,0.0550792986707725,3.72228048775278e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,40511,-0.0442786716316272,0.00351675122486374,-0.0511715040323601,-0.0373858392308943,4.14159678397797e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42636,0.0875864967580828,0.00698084015184047,0.0739040500604755,0.10126894345569,6.58544114207996e-36
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.0917738061403999,0.00734225122310644,0.0773829937431113,0.106164618537689,1.19337646747125e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,-0.0938690040611521,0.00750724330900822,-0.108583200946808,-0.079154807175496,1.22378448521318e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0779333948520959,0.00623879929225519,0.0657053482392757,0.0901614414649161,1.42312928976994e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0342297263457227,0.00274347826110432,0.0288525089539582,0.0396069437374871,1.57347108411625e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,40468,0.0428508635199037,0.00343423755088958,0.0361197579201601,0.0495819691196472,1.69769525666591e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,0.0629239730496533,0.00504989022747584,0.0530261882038007,0.072821757895506,1.91701535780318e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.0374722902992772,0.00300981985177629,0.0315730433897956,0.0433715372087587,2.19286872880755e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.0771548616430146,0.00620173679484489,-0.0893102657609106,-0.0649994575251186,2.44348171383215e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,0.0559906317841008,0.00449903436151422,0.047172524435533,0.0648087391326687,2.57130418647966e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0466742123385969,0.00375720594864968,0.0393100886792435,0.0540383359979502,3.07628940301503e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,0.092767580480222,0.00747899368042947,0.0781087528665802,0.107426408093864,4.26055556091963e-35
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42594,0.068119884789466,0.00553145467439993,0.0572782336276421,0.0789615359512899,1.15794927647256e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,0.0938454448227478,0.0076433281228817,0.0788645217018997,0.108826367943596,1.81026539456801e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42588,-0.0473966470813724,0.00386714721239224,-0.0549762556176612,-0.0398170385450836,2.37627014864006e-34
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAST,Gastrin,40483,0.177500550847777,0.0146205391746345,0.148844294065493,0.206156807630061,1.04490495236803e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,40283,0.0626591244345566,0.00516218401607757,0.0525412437630445,0.0727770051060686,1.08478643319782e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0807949920435464,0.0066615517432029,0.0677383506268687,0.0938516334602241,1.20833604773827e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,0.0355114295696057,0.00293262319071122,0.0297634881158117,0.0412593710233997,1.41926887250689e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0527514608374836,0.00436088195061801,0.0442041322142723,0.0612987894606949,1.64752866146244e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,42476,0.0762528207734709,0.00631691596998952,0.0638716654722914,0.0886339760746503,2.24134185951755e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42495,-0.0417907356628231,0.00346791858191791,-0.0485878560833822,-0.034993615242264,2.86693734808553e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42794,0.0705907582573564,0.00587515033377658,0.0590754636031543,0.0821060529115585,4.35102196953631e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,42477,0.0556767154340766,0.00464009839797108,0.0465821225740532,0.0647713082940999,5.32351142562603e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,0.039365688637591,0.0032847284159233,0.0329276209423814,0.0458037563328007,6.85843094856116e-33
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.033161923691836,0.002780331222499,0.027712474495738,0.0386113728879341,1.24731746614515e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0367138691358933,0.00308599085802954,0.0306653270541555,0.0427624112176312,1.78770232503418e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0499673932679075,0.0042068291320422,0.0417220081691048,0.0582127783667102,2.40829199038619e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0431417023752638,0.00363359846108121,0.0360198493915446,0.0502635553589829,2.58323793454848e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42594,0.0679980625132744,0.00574379238009969,0.056740229448279,0.0792558955782697,3.56892502955174e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,42357,0.0646622113178695,0.00546945089858563,0.0539420875566417,0.0753823350790974,4.3433377852132e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,0.027757587673717,0.00234866686956412,0.0231542006093713,0.0323609747380627,4.83263009720756e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,-0.0542096506294028,0.00459267518854667,-0.0632112939989543,-0.0452080072598513,5.39222487233213e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,0.0690238249823556,0.00585268784109379,0.0575525568138118,0.0804950931508994,6.04371533299885e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,40283,0.0539170919561681,0.00457133371675154,0.0449572778713351,0.0628769060410011,6.45415003901902e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0385621994633459,0.00328013394928187,0.0321331369227534,0.0449912620039384,9.39694783513694e-32
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,0.0676928545378055,0.00577252757123911,0.0563787004981769,0.0790070085774342,1.41730188452184e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,0.0233670475074232,0.00199543915201643,0.019455986769471,0.0272781082453754,1.60860954109576e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,0.077598072119316,0.00664300937548933,0.0645777737433569,0.090618370495275,2.25116690085285e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,0.0421584840817412,0.0036111777054973,0.0350805757789665,0.0492363923845159,2.43473153487401e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42711,-0.0444180214854571,0.00380750752547061,-0.0518807362353795,-0.0369553067355347,2.68869080032377e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,0.0607798675032951,0.0052114052965843,0.0505655131219899,0.0709942218846003,2.8013148819261e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42679,0.046317031165591,0.00397204313367891,0.0385318266235804,0.0541022357076017,2.85690629125212e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42648,0.0375937371059225,0.0032291670705196,0.0312645696477041,0.043922904564141,3.55828623866817e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,40199,0.0546395257723816,0.00470516021042704,0.0454174117599446,0.0638616397848186,5.38507265861561e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,0.114781814455742,0.00992116518493837,0.0953363306932625,0.134227298218221,8.79331907742148e-31
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.035187774404275,0.00304843171667134,0.0292128482395992,0.0411627005689508,1.19247913022806e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,-0.0397897482611911,0.00345747092228282,-0.0465663912688655,-0.0330131052535168,1.66076171410509e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,0.0767192468159334,0.0066806620538263,0.0636251491904338,0.0898133444414329,2.20824280312213e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,0.123350049181299,0.0107464164197021,0.102287072998683,0.144413025363915,2.50209931411649e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,40483,0.0434452939176411,0.00379219763903174,0.0360125865451389,0.0508780012901433,3.20403094763147e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,42346,0.0541072727418725,0.00475510206191849,0.0447872727005122,0.0634272727832327,7.35625782876903e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,-0.0499285263768304,0.00439057629948276,-0.0585340559238166,-0.0413229968298441,7.90526545476071e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFI,Complement factor I,40539,0.0223740493003498,0.00196737621859859,0.0185179919118966,0.026230106688803,8.30789047528358e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,0.0421320757793514,0.00370917430883624,0.0348620941340324,0.0494020574246705,9.1898253716141e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,0.128607681990686,0.0113276127389069,0.106405561022428,0.150809802958943,9.74703721723043e-30
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42679,0.059560638556233,0.0052595045920524,0.0492520095558103,0.0698692675566557,1.35180780455925e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,0.0514796914888909,0.0045466246098126,0.0425683072536582,0.0603910757241236,1.46490430480798e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42495,0.0988678987378464,0.00874932409739522,0.0817192235069518,0.116016573968741,1.78651610786762e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.022309838838816,0.00197471734603897,-0.0261802848370524,-0.0184393928405796,1.83008407215724e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42711,0.0684898015795574,0.00606482898370552,0.0566027367714946,0.0803768663876202,1.92623690461233e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42636,0.0401890919024382,0.00356307144543104,0.0332054718693934,0.0471727119354831,2.24921567594062e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,40482,0.0622880203665372,0.00552228790132781,0.0514643360799347,0.0731117046531397,2.38118606934444e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0501493129902061,0.0044529804168361,-0.0588771546072049,-0.0414214713732074,2.73159302853693e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,40223,0.0677234470203235,0.00601357485427749,0.0559368403059396,0.0795100537347074,2.92684381939675e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,0.138593835373148,0.0123318365829582,0.11442343567055,0.162764235075746,3.55535334660303e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42676,0.0476125186756188,0.00423770342953564,0.039306619953729,0.0559184173975086,3.68006784953978e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,40199,0.0924071142572907,0.0082606706893174,0.0762161997062286,0.108598028808353,6.80473570104851e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,40223,0.0577595752969997,0.00517010625222594,0.0476261670426368,0.0678929835513625,7.9967752997834e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.0773443324937549,0.00692658191054598,0.0637682319490848,0.090920433038425,8.02885017538826e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42654,0.0652616098473308,0.00584859713422641,0.053798359464247,0.0767248602304145,8.70360662675736e-29
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.0427687571425529,0.00384065556193689,0.0352410722411566,0.0502964420439492,1.12176183028096e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42754,0.053297350261668,0.00480264737938756,0.0438841613980684,0.0627105391252676,1.71116394088774e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0307843701909458,0.00277449652586583,0.0253463570002488,0.0362223833816428,1.75411134927322e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,42370,0.0503240494282608,0.0045368028181391,0.0414319159047081,0.0592161829518134,1.82531565560551e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,0.0329860352863362,0.0029749871034733,0.0271550605635285,0.0388170100091438,1.90796630101177e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_E,,42594,0.0342115361367912,0.00308565070414905,0.028163660756659,0.0402594115169233,1.92218942029781e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.0752788753080495,0.00679540916122719,0.0619598733520443,0.0885978772640548,2.14432567168082e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,0.0593430709676108,0.00535927959753122,0.0488388829564496,0.069847258978772,2.25208647238559e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,0.0295645985873597,0.00267132256831356,0.0243288063534652,0.0348003908212543,2.5211196543238e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42495,0.0442725914893966,0.00400512713032883,0.0364225423139521,0.0521226406648411,2.78438351627225e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,0.0655380985003347,0.00593078207887708,0.0539137656257357,0.0771624313749338,2.88786780751794e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42663,0.0355929051652426,0.00322108718340071,0.0292795742857772,0.0419062360447079,2.9003031355127e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42618,0.0309822524026287,0.00281041890088783,0.0254738313568886,0.0364906734483689,3.86241530225827e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0318011362299114,0.0028864154849525,0.0261437618794045,0.0374585105804183,4.17814441372709e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,40449,0.11359048809651,0.0103220369427462,0.0933592956887275,0.133821680504293,5.04149628614482e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0542525681701339,0.00493569873136913,0.0445785986566505,0.0639265376836174,5.50336920500026e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.0763747800868054,0.006955530375823,0.0627419405501923,0.0900076196234184,6.57442903902587e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,40449,0.0948524855522745,0.00864217792286528,0.0779138168234585,0.11179115428109,6.93792137014622e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,40342,0.0266052381898822,0.00242596895755312,0.0218503390330781,0.0313601373466863,7.65291254172795e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,0.0306368265685851,0.00279547894230913,0.0251576878416592,0.036115965295511,7.84707478502151e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42683,0.0404446273925505,0.00369439742835694,0.0332036084329709,0.0476856463521301,8.9338313813157e-28
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42618,0.0368051131471,0.00336532106462402,0.0302090838604369,0.043401142433763,1.00858961505382e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0224979270635306,0.00205763729589856,0.0184649579635695,0.0265308961634918,1.03979248678896e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,0.0393261359204725,0.00360220147028171,0.0322658210387203,0.0463864508022247,1.24415618367574e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD248,Endosialin,40527,-0.044732280155234,0.00410258210308524,-0.0527733410772811,-0.036691219233187,1.52034839946504e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EZR,Ezrin,42711,0.0259855629949812,0.0023872621990584,0.0213065290848267,0.0306645969051357,1.76516466747782e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.114229465271581,0.0105095445135097,0.0936307580251021,0.13482817251806,2.10568955822018e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0647191612875064,0.005965961585371,0.0530258765801793,0.0764124459948336,2.6565691304759e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,0.0439939176228456,0.00406316476281859,0.0360301146877211,0.05195772055797,3.29500785905698e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,0.0253304931662511,0.00234002246153569,0.0207440491416412,0.0299169371908611,3.58684021887434e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42679,0.0481047064883616,0.00444755928405361,0.0393874902916165,0.0568219226851067,3.73771175082879e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,-0.0677364468570863,0.00626618331163075,-0.0800181661478826,-0.05545472756629,4.00216997779843e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,0.0515857297851676,0.00477389997382751,0.0422288858364657,0.0609425737338696,4.3843797814658e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,0.0691339495472085,0.0064017056924939,0.0565866063899205,0.0816812927044966,4.5045624392267e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,0.0863699025399715,0.00799999085054322,0.0706899204729068,0.102049884607036,4.89695160802176e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,40511,0.0493633916409767,0.00457819377353728,0.0403901318448437,0.0583366514371098,5.6433243308977e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,0.0606160719285952,0.00562186716141447,0.0495972122922229,0.0716349315649676,5.64877204051004e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREH,Trehalase,40527,0.0803614224254619,0.00746244606846148,0.0657350281312774,0.0949878167196464,6.52308199525232e-27
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42711,0.0484691518240209,0.00452181979576085,0.0396063850243296,0.0573319186237121,1.06179226257807e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0921947050106899,0.00859879837301906,0.0753410601995725,0.109048349821807,1.08081975767246e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42754,0.0442578650394164,0.00413228360157586,0.0361585891803277,0.052357140898505,1.16438378214357e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0883560904048368,0.00825188646229498,0.0721823929387387,0.104529787870935,1.26125288078458e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0385778686198737,0.00361415883596005,0.031494117301392,0.0456616199383554,1.71793224267681e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,0.0283912996725294,0.00266755400477947,0.0231628938231616,0.0336197055218971,2.38639157937244e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0396122102028199,0.00372986311545212,0.0323016784965337,0.046922741909106,3.2098764581145e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,0.11540698128754,0.0109037173588686,0.0940356952641572,0.136778267310922,4.67625126715687e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.0769315067029099,0.00727731576086587,0.0626679678116128,0.091195045594207,5.12807327045778e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42594,0.0501866306812797,0.00474801937822718,0.0408805126999544,0.059492748662605,5.19540883573718e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,42311,0.0673359877898613,0.00637995150335567,0.0548312828432841,0.0798406927364384,6.16412615426449e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0235700574586335,0.00223629295626795,0.0191869232643483,0.0279531916529187,7.45633568389358e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,0.0765885078497939,0.00728812439825983,0.0623037840292046,0.0908732316703832,9.92083084946095e-26
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42640,-0.0401032725197205,0.00381894311233248,-0.0475884010198921,-0.0326181440195488,1.07293647405437e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0405272517909074,0.00386287668044151,0.032956013497242,0.0480984900845728,1.24631486121467e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.0296118640001684,0.00282414515287023,0.0240765395005427,0.035147188499794,1.26984302254995e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42754,0.038397192589456,0.00367508078730728,0.0311940342463338,0.0456003509325783,1.86968724603055e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0267022426456986,0.00255627658920509,0.0216919405308566,0.0317125447605406,1.91965137948356e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.101167712625108,0.00969958101875795,0.0821565338283427,0.120178891421874,2.25981897430578e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42611,0.0605490580782582,0.00581225865393214,0.0491570311165512,0.0719410850399652,2.57727630343259e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0366686508017438,0.00352145757738478,-0.0435707076534179,-0.0297665939500696,2.70340870936918e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42613,-0.178833650972351,0.0172253397682921,-0.212595316918204,-0.145071985026499,3.72809708562086e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,0.0881302952255891,0.00848781867555591,0.0714941706214995,0.104766419829679,3.86460109901438e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,-0.0286881721165264,0.00276399978910912,-0.0341056117031802,-0.0232707325298725,3.99404779383122e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42692,0.0647904659603131,0.00624776540559043,0.0525448457653559,0.0770360861552704,4.21010407516969e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,40527,0.0290360719155775,0.00280247314506386,0.0235432245512523,0.0345289192799027,4.83139825259059e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42587,0.033292779555912,0.00321963114717832,0.0269823025074425,0.0396032566043815,5.73340772922515e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42587,0.0731301176485661,0.00707429523104481,0.0592644989957183,0.086995736301414,5.92128562926981e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,40379,-0.113604393349787,0.0109878126193991,-0.135140506083809,-0.0920682806157644,6.07091171654224e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42495,0.0711416302425453,0.00689188816214582,0.0576335294447395,0.0846497310403511,6.91989212636441e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0528364038341652,0.00513050338144221,0.0427806172065384,0.0628921904617919,8.89500913453113e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.0533746827833321,0.00518323226241887,0.0432155475489911,0.0635338180176731,8.92219847136146e-25
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,0.113061894825215,0.0109970355250177,0.0915077051961802,0.134616084454249,1.06307224746987e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAYN,Layilin,42476,0.0389791147671907,0.00379243654071731,0.0315459391473848,0.0464122903869967,1.09417991550182e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.0988200147492783,0.00962882993532357,0.0799475080760441,0.117692521422512,1.27679826756814e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0291099381118741,0.00284024843044479,0.0235430511882023,0.0346768250355458,1.47011134389307e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0289906295380369,0.00283020861386084,0.0234434206548697,0.0345378384212041,1.56016615159914e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,0.0316247435162711,0.00308639891969133,0.0255754016336761,0.0376740853988661,1.56952239318799e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.0433342479315311,0.00423288217329714,0.0350377988718687,0.0516306969911935,1.65479500419723e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.0909454689165797,0.00888574853054013,0.0735294017967211,0.108361536036438,1.70418621264791e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.0643453552405525,0.0062910591633353,0.0520148792804153,0.0766758312006897,1.8330922843032e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,0.0297559474962812,0.00291221332977226,0.0240480093699276,0.0354638856226348,2.11247246175437e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0506065407448097,0.00495305366734882,0.040898555556806,0.0603145259328134,2.13443161558884e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,40515,0.0574290816841642,0.00562722346224974,0.0463997236981547,0.0684584396701737,2.38608500381023e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.107474518792462,0.0105549484012937,0.0867868199259261,0.128162217658997,2.91269281831162e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42754,-0.00891614570754814,0.000876694359460595,-0.0106344666520909,-0.00719782476300537,3.29042778150593e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,0.058677363714668,0.0057711820995807,0.0473658467994898,0.0699888806298462,3.39655566016916e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,0.0459486644109995,0.00452408294806624,0.0370814618327896,0.0548158669892093,3.79580860820224e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,0.063304905131817,0.00623521192874954,0.0510838897514679,0.0755259205121661,3.93658801652295e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,0.0826106611587562,0.00814072347719746,0.0666548431434492,0.0985664791740632,4.13987576698538e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0401013638298897,0.0039528416577231,0.0323537941807524,0.047848933479027,4.25899808389539e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0281550810375618,0.00277869429252458,0.0227088402242136,0.03360132185091,4.83363980025248e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0410427253999366,0.00405113592867188,0.0331024989797397,0.0489829518201334,4.89890959049223e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42636,0.0379237855705146,0.00374679105465652,0.0305800751033878,0.0452674960376414,5.39743561143546e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,42370,0.0476837904644543,0.00471453332433753,0.0384433051487528,0.0569242757801559,5.844506293497e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,0.0687132506465245,0.00680853615733515,0.0553685197781476,0.0820579815149014,7.26877294965187e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,40511,0.032728810795217,0.00324388754241507,0.0263707912120835,0.0390868303783506,7.7631985123772e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39872,0.0246994140435197,0.00245350646607087,0.0198905413700207,0.0295082867170186,9.86417344369939e-24
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,0.0341495542742406,0.00339661696170834,0.0274921850292922,0.0408069235191889,1.0779601167706e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,0.0449673167744787,0.00447374859276075,0.0361987695326676,0.0537358640162898,1.14394570381459e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,0.0270963281498345,0.00270712712034746,0.0217903589939535,0.0324022973057155,1.74225161856891e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42571,0.0309435841230888,0.0030955205445013,0.0248763638558662,0.0370108043903113,1.91287996320069e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0816676689169122,0.00818336204870515,0.0656282793014501,0.0977070585323743,2.35294871955771e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0341569776514583,0.00343519117450529,-0.0408899523534886,-0.0274240029494279,3.24554875005779e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,-0.0281266412945833,0.00283437098119129,-0.0336820084177182,-0.0225712741714484,3.96521886209111e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0592682608960838,0.00597729104225044,0.047552770453273,0.0709837513388947,4.42890039678525e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,0.0898534422807093,0.00908018020444959,0.0720562890799881,0.107650595481431,5.21866197202174e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,0.0842711827165646,0.0085160848361349,0.0675796564377402,0.100962708995389,5.22000953856556e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,42437,0.0422222578616692,0.00427131657749631,0.0338504773697764,0.050594038353562,5.80308454480024e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,0.0901699369818157,0.00912820526703074,0.0722786546584355,0.108061219305196,6.19355542910848e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0344109134802563,0.00348601946184271,0.0275783153350446,0.041243511625468,6.64503153912961e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,40539,0.0312564410136836,0.00316775141607894,0.0250476482381689,0.0374652337891983,7.14775495154792e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,0.0393630302829328,0.00399067644449121,0.03154130445173,0.0471847561141356,7.17397629344369e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0370676019619972,0.0037623296876385,-0.0444417681497686,-0.0296934357742257,7.99873841091297e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0232878340529532,0.00236614307778451,0.0186501936204956,0.0279254744854109,8.86854452977852e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,0.0853444932086964,0.00868081101552703,0.0683301036182634,0.102358882799129,9.83855543419479e-23
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42721,-0.0464840187946451,0.00473474343782551,-0.0557641159327831,-0.0372039216565071,1.12541137500944e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPN,Asporin,40511,-0.0278397485014333,0.00283528843514547,-0.0333969138343184,-0.0222825831685482,1.14853951547954e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,0.0317430886034033,0.00324881993580338,0.0253754015292287,0.0381107756775779,1.78642178323583e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,40283,-0.0513209683732953,0.00525166191139777,-0.061614225719635,-0.0410277110269557,1.82359443926722e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0520501985262642,0.00534242861129788,0.0415790384481203,0.062521358604408,2.34936496554094e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,0.040540876197152,0.00417529954547999,0.0323572890880112,0.0487244633062928,3.36026422203624e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,42136,0.0889795108881178,0.00917437104911399,0.0709977436318544,0.106961278144381,3.63276637011658e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0292478656951459,0.00302431012837796,0.0233202178435251,0.0351755135467668,4.89619399688943e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,0.072790931845808,0.00753064771967518,0.0580308623152447,0.0875510013763714,4.95440756728975e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.0816445468925396,0.00846050308575656,0.0650619608444568,0.0982271329406225,5.79032746143558e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0561239185482078,0.00581927462893847,0.0447181402754884,0.0675296968209272,6.11209550902975e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42646,0.044296479192947,0.00459417564689637,0.0352918949250301,0.0533010634608638,6.26445597068863e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42721,0.0386193910170021,0.00401662931174308,0.0307467975659856,0.0464919844680185,8.12490657614735e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0560898891881391,0.00583580728358052,0.0446517069123213,0.067528071463957,8.4143933541401e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,40527,0.110445307963952,0.0114969603887986,0.0879112656019068,0.132979350325997,9.08618954006675e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,0.0386359510786146,0.00402458413585844,0.030747766172332,0.0465241359848971,9.38845361745134e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,40346,0.0269974136230743,0.00281221497025905,0.0214854722813666,0.032509354964782,9.69575167538925e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,42317,0.0476529724155829,0.00496575257813923,0.03792009736243,0.0573858474687358,9.76383679658032e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42575,0.0503917341018339,0.00525181381148182,0.0400981790313296,0.0606852891723383,9.84755317579489e-22
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42721,0.0618789280106805,0.00646562998665887,0.0492062932368291,0.0745515627845319,1.24635512369264e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0432810619497157,0.00454202966994452,0.0343786837966245,0.052183440102807,1.92080786811992e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42590,0.0874046569194003,0.00918012462703771,0.0694116126504064,0.105397701188394,2.00337711021475e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42556,0.0792709142882913,0.00832593862653529,0.0629520745802821,0.0955897539963005,2.0064102952754e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0309268986413542,0.00325595564630401,0.0245452255745983,0.03730857170811,2.48366039015864e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0188270215346737,0.00198371857485157,0.0149389331279646,0.0227151099413828,2.68639064606611e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0494518453309858,0.00521243991425983,0.0392354630990365,0.059668227562935,2.84768344326234e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,42311,0.0588005632832282,0.00620892621666259,0.0466310678985695,0.0709700586678869,3.26066263557176e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,0.0399136328361347,0.00421565155687482,0.03165095578466,0.0481763098876093,3.3238779295505e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,0.0342472682987634,0.00362141510260155,0.0271492946976643,0.0413452418998624,3.69967330438551e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,40511,0.0868827540958997,0.00918519929662109,0.0688797634745224,0.104885744717277,3.72173526496496e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0309046404383652,0.00327001576968389,0.0244954095297848,0.0373138713469456,4.03688781537794e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.068122088628913,0.00721442715023715,0.0539818114144482,0.0822623658433778,4.24580018763956e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.0453912343325141,0.00481124757716713,0.0359611890812666,0.0548212795837617,4.56275108455322e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42587,0.0506552411995893,0.00537043322504818,0.0401291920784949,0.0611812903206837,4.66547626998627e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42594,0.0891430678296335,0.0094516505841819,0.0706178326846369,0.10766830297463,4.69896669673473e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.029387050674231,0.00311976795390093,0.0232723054845851,0.0355017958638768,5.40817600077875e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0381156223939571,0.00405381057527375,0.0301701536664206,0.0460610911214937,6.17539736351355e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,42346,0.0599155639719993,0.00639170187997555,0.0473878282872473,0.0724432996567514,8.11202162483017e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.0345311159403614,0.00368834363115713,0.0273019624232935,0.0417602694574294,9.03243574174103e-21
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,40511,0.0638851106952713,0.00682996591398693,0.0504983775038569,0.0772718438866857,1.00571551029114e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,-0.0227533251507134,0.00243414941195687,-0.0275242579981489,-0.017982392303278,1.03618470108799e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,40451,0.0926217017537405,0.0099152650688606,0.0731877822187737,0.112055621288707,1.13000603526624e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0409513129570444,0.00439801164685682,0.032331210129205,0.0495714157848838,1.46687048093343e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42754,0.0856025734526402,0.00919754192123989,0.06757539128701,0.10362975561827,1.51230237745833e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0413926564810537,0.00445419578429834,0.032662432743829,0.0501228802182785,1.78046198934719e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42594,0.0309081162798815,0.00332847879102775,0.0243842978494671,0.0374319347102958,1.84583862720834e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0540750121732069,0.00582525824075181,0.0426575060213333,0.0654925183250804,1.9049281674859e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42495,0.0497322426931241,0.00536099858810543,0.0392246854604374,0.0602397999258107,2.0148819633883e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.0592237431009492,0.00638665055911067,0.0467059080050923,0.0717415781968061,2.13707135439676e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42611,-0.0240102322667046,0.00259197550085245,-0.0290905042483754,-0.0189299602850338,2.27958251493702e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,40223,0.0374005842027809,0.00403708973716815,0.0294878883179314,0.0453132800876305,2.3286206402519e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,0.0294178933605117,0.00317587278643527,0.0231931826990985,0.0356426040219248,2.35136872882205e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.0748912343170214,0.00808546221850733,0.059043728368747,0.0907387402652957,2.35908531216881e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,0.0626034177748642,0.00676332961423,0.0493472917309734,0.075859543818755,2.4311853199009e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0260953539723593,0.00281923241424037,0.0205696584404482,0.0316210495042705,2.43373249020507e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,0.0558366657145391,0.00603399393586601,0.0440100376002417,0.0676632938288364,2.49981976830982e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.0782299465793609,0.00845583888287885,0.0616565023689184,0.0948033907898035,2.61916812610653e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0610575191512127,0.00660046570511624,0.0481206063691849,0.0739944319332405,2.63402003644782e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,40483,0.0357381010716543,0.00386391122204038,0.0281648350764552,0.0433113670668535,2.66748137650517e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.0787406218693117,0.00851942227402703,0.0620425542122188,0.0954386895264047,2.76509467280458e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,0.028821249065,0.00312226364573849,0.0227016123193526,0.0349408858106475,3.16158620782821e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0215274396263134,0.00233488423467195,0.0169510665263564,0.0261038127262704,3.41060900683747e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,-0.0220055289591281,0.00238814787034205,-0.0266862987849985,-0.0173247591332577,3.58785936866442e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.0681083265740186,0.00740731135566403,0.0535899963169171,0.0826266568311201,4.44033092564439e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42563,0.0336134070636239,0.00365728818667384,0.0264451222177432,0.0407816919095046,4.46734492496984e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,42336,0.0366480644409685,0.00399162613151583,0.0288244772231974,0.0444716516587395,4.89120925319248e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,-0.0315622434499743,0.00345301226592515,-0.0383301474911876,-0.024794339408761,7.09777947284836e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0557770430030473,0.00611515339986981,0.0437913423393025,0.0677627436667922,8.48026361404571e-20
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0587951478362115,0.006466714341544,0.0461203877267852,0.0714699079456377,1.13482496612103e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.0626682935304214,0.0068988326242169,0.0491465815869563,0.0761900054738866,1.22597017475216e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.0735417176586574,0.0081141542506185,0.0576379753274451,0.0894454599898696,1.43618068282683e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0485956431189886,0.00536634790199584,0.0380776012310768,0.0591136850069004,1.58662696744956e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.0628777963207046,0.00694448806228557,0.0492665997186249,0.0764889929227843,1.5989765692951e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,0.0520157858288636,0.00574975976026999,0.0407462566987345,0.0632853149589928,1.67999630984038e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0316215419173145,0.00349896358902975,0.0247635732828162,0.0384795105518128,1.81943793702102e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0194597829904879,0.00215483325966855,-0.0236832561794383,-0.0152363098015376,1.93932407896547e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0352037808534715,0.00390420370607763,0.0275515415895594,0.0428560201173837,2.19918736670996e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.0716943789616245,0.00795207161924676,0.0561083185879008,0.0872804393353481,2.2695515691852e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,40539,-0.0250567151898888,0.00278664500676237,-0.0305185394031431,-0.0195948909766346,2.81919255805054e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42594,0.0748417576344963,0.00832690137774042,0.0585210309341251,0.0911624843348675,2.85214499451146e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0446367605053895,0.00496815500256013,0.0348991767003716,0.0543743443104073,2.9473229295036e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,42333,0.0455888799536915,0.00507817687233612,0.0356356532839127,0.0555421066234703,3.14477912011281e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0473972712712428,0.00528332389830219,-0.0577525861119151,-0.0370419564305705,3.32026474269832e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.047825925141361,0.00533732650770879,0.0373647651862518,0.0582870850964703,3.73365367227187e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,40430,0.0386165354129497,0.00431165545499353,0.0301656907211624,0.0470673801047371,3.88500057349603e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,42346,0.0362714215528197,0.00405314908277628,0.0283272493505782,0.0442155937550612,4.06440338035848e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0369154381238175,0.00413994697971879,-0.0450297342040663,-0.0288011420435686,5.40871959787649e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,0.0313633845962131,0.0035182119454612,0.0244676891831091,0.038259080009317,5.64569383340453e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,42255,0.0617620615016432,0.00693096408962469,0.0481773718859788,0.0753467511173076,5.71882521387644e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0264895797848471,0.00297219831300848,0.0206640710913505,0.0323150884783438,5.75432772332887e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,0.0755953922872732,0.008486433480734,0.0589619826650346,0.0922288019095119,5.88116251366652e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.0975670411471903,0.0109536414884895,0.0760979038297509,0.11903617846463,6.03561801185371e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,0.0733598659343103,0.00824430569306945,0.0572010267758942,0.0895187050927264,6.38853288529941e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42587,0.0627467745282014,0.00706722090455536,0.0488950215552729,0.0765985275011299,7.62464265049155e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42538,0.0639741584335921,0.0072084811582891,0.0498455353633455,0.0781027815038387,7.88560487340947e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42711,0.0204921629764845,0.00231174793395095,0.0159611370259407,0.0250231889270284,8.64646355075019e-19
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42594,0.0804785930709217,0.00910084922867873,0.0626409285827114,0.098316257559132,1.0472164557591e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASN,Vasorin,42449,-0.0244916864180474,0.00277110844068166,-0.0299230589617835,-0.0190603138743114,1.0938057152929e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,0.0599513384743958,0.00678947774737372,0.0466439620895433,0.0732587148592483,1.17413373426687e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.0357322066271322,0.00405475908163778,0.0277848788271222,0.0436795344271423,1.40376595378856e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0399018870268402,0.00453107323168654,0.0310209834927346,0.0487827905609458,1.45064538340408e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.068780278682552,0.00782532496931425,0.0534426417426961,0.0841179156224079,1.71957430920726e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.0908774690255256,0.0103491139346591,0.0705932057135938,0.111161732337457,1.81180206734033e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,0.0560707663144824,0.00638818068977913,0.0435499321625153,0.0685916004664495,1.92417694269299e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0255374756300537,0.00291154059292546,-0.0312440951921876,-0.0198308560679198,1.9770068949311e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42677,0.038034011267132,0.00434220907394602,0.0295232814821978,0.0465447410520663,2.19966580993728e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42754,0.0820101901245318,0.00936537293556191,0.0636540591708305,0.100366321078233,2.24516225835261e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,0.0599257965239672,0.00684520903274647,0.0465091868197841,0.0733424062281503,2.35359593770953e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.0855758618246766,0.00977577058448075,0.0664153514790943,0.104736372170259,2.35436997428711e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0309285994526686,0.00354013208057526,0.0239899405747411,0.0378672583305961,2.68540685224243e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.0634939684076687,0.0072794847582054,0.0492261782815861,0.0777617585337513,3.11656835886036e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0429435890670367,0.00493525090609639,0.0332704972910878,0.0526166808429856,3.66415172359497e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42676,0.0400000322048497,0.00459839434793553,0.0309871792828961,0.0490128851268034,3.74217329971285e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,42439,0.0417867302864377,0.00480676872221658,0.0323654635908932,0.0512079969819821,3.93050956380916e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.018955782707261,0.00218342528737801,0.0146762691440001,0.0232352962705219,4.4451741824986e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0333107092158314,0.00383869454648436,0.0257868679047221,0.0408345505269408,4.50331996555293e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0375025288254639,0.00432361721439383,0.029028239085252,0.0459768185656758,4.65213221277973e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,0.0419062758701747,0.00484652717290347,0.0324070826112839,0.0514054691290655,5.8994534734911e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,42346,0.0647019896583323,0.00749706945278084,0.0500077335308819,0.0793962457857827,6.81580676450865e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0396435561420685,0.00459689521741444,0.0306336415159362,0.0486534707682008,7.34386792754182e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0388098494148965,0.00450446704055122,-0.0476386048143768,-0.0299810940154161,7.71084244872788e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0166863361247669,0.00193722384653894,0.0128893773855506,0.0204832948639832,7.85920828468916e-18
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.0737721627630559,0.00859786988787497,0.0569203377828209,0.0906239877432908,1.05292015654833e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42711,0.0244977275052084,0.00285533452689372,0.0189012718324967,0.0300941831779201,1.05453207888753e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,0.0727174677537132,0.00848131310056284,0.05609409407661,0.0893408414308164,1.11209299784381e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,-0.0259888229157365,0.00304153402725201,-0.0319502296091504,-0.0200274162223225,1.42647804679589e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,40116,0.0669663877438999,0.00784108032849876,0.0515978703000424,0.0823349051877575,1.51427460765938e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42594,0.0723757646366209,0.0084772336491343,0.0557603866843177,0.0889911425889241,1.51590032929606e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,40199,0.0804486896944806,0.00945196046179231,0.0619228471893676,0.0989745321995935,1.9426371321e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42566,0.039627489060836,0.0046606149030497,0.0304926838508585,0.0487622942708134,2.04842401996159e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42581,-0.0533520908029009,0.00627578259054693,-0.0656526246803729,-0.041051556925429,2.07231561432794e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,42488,0.0301964202618167,0.00355730978289719,0.0232240930873382,0.0371687474362952,2.31219676313783e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0566226584098645,0.00666976001562722,0.0435499287792352,0.0696953880404939,2.34025609583531e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.0610283873794049,0.00718942840225183,0.0469371077109913,0.0751196670478185,2.35274912239223e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,0.0246344864198443,0.00290831944497648,0.0189341803076904,0.0303347925319982,2.69706582540723e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,0.0489674420090314,0.00578345624279043,0.0376318677731622,0.0603030162449006,2.7880580744026e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.0710180285999477,0.00839599157917988,0.0545618851047551,0.0874741720951403,3.04626654926372e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,40462,0.0621366416425875,0.00734951403845163,0.0477315941272223,0.0765416891579527,3.14702436461326e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.035888664191006,0.0042463271035945,0.0275658630679608,0.0442114653140512,3.17058555141582e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0329490120303058,0.00390408188245836,0.0252970115406874,0.0406010125199242,3.50706311756465e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELL,L-selectin,40539,-0.0203347690149243,0.00241117072684859,-0.0250606636395476,-0.0156088743903011,3.75817190243421e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,0.0397901135283249,0.0047237481467842,0.0305315671606279,0.0490486598960219,4.02127621133544e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0242098488482364,0.00287682115726546,0.0185712793799961,0.0298484183164767,4.30076828443e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,40283,0.0278618527051736,0.0033118655360028,0.0213705962546082,0.0343531091557391,4.49644196199115e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42754,0.0486768942920239,0.00578961832028756,0.0373292423842603,0.0600245461997875,4.59842568302542e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,-0.0340405100256931,0.00404977353862308,-0.0419780661613944,-0.0261029538899919,4.68279982037718e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42794,-0.0235254419980458,0.00279946220576747,-0.02901238792135,-0.0180384960747415,4.7581134774058e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,-0.033465615759416,0.00398370561453756,-0.0412736787639097,-0.0256575527549224,4.89254582837628e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0381582977897659,0.00454909167499812,0.0292420781067696,0.0470745174727622,5.43423280654458e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42495,-0.0216779618472218,0.00258529049424028,-0.0267451312159328,-0.0166107924785108,5.57375045164407e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42794,0.0463028684488481,0.0055242982904617,0.0354752437995432,0.057130493098153,5.72641124204423e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,-0.0201925768736059,0.00241116038273129,-0.0249184512237593,-0.0154667025234526,6.08414484854058e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,40451,0.0178274258941978,0.00213035163959752,0.0136519366805867,0.0220029151078089,6.53520216038462e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,-0.0246280549944031,0.00294572494123184,-0.0304016758792175,-0.0188544341095887,6.84653030035226e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.0818971604512571,0.00980762224789662,0.0626742208453797,0.101120100057135,7.46055494955975e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0815647189677274,0.00976878485771273,0.0624179006466104,0.100711537288844,7.6724350255887e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.050846874475883,0.00609177940957895,0.0389069868331082,0.0627867621186577,7.71117728629712e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDK,Midkine,42638,0.0427032272910642,0.00512566562655658,0.0326569226630133,0.0527495319191151,8.76839872693039e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.063987627190199,0.00768066270036475,0.0489335282974841,0.0790417260829139,8.79002004259245e-17
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,40483,0.0240511041178122,0.00289201471772682,0.0183827552710677,0.0297194529645568,1.01084622028448e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.115653955811901,0.0139123343713097,0.0883857804441336,0.142922131179668,1.03980889496557e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42594,-0.0367732637204105,0.00443831840572995,-0.0454723677956412,-0.0280741596451798,1.28813881683719e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42638,-0.0178210094368571,0.00215137084155383,-0.0220376962863027,-0.0136043225874116,1.30777044472447e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.036004435288834,0.0043524135189282,0.0274737047917347,0.0445351657859333,1.46144265602754e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42594,0.0666288080041888,0.00805931123616263,0.0508325579813101,0.0824250580270676,1.4982932489042e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.03715047587358,0.00449750152708809,0.0283353728804873,0.0459655788666726,1.61625845018571e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,0.0524499695273739,0.00635370856607674,0.0399967007378634,0.0649032383168843,1.68766205841035e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,0.0416683105889656,0.0050577660026059,0.031755089223858,0.0515815319540732,1.90464418377546e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,0.0286442139427731,0.00347647869901333,0.021830315692707,0.0354581121928393,1.92631698133252e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42721,0.0326208009839053,0.00396262597505793,0.0248540540727918,0.0403875478950188,2.00667454825994e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,40482,0.0858752805393956,0.0104323271144925,0.0654279193949902,0.106322641683801,2.04940015193961e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42754,0.0286065670201978,0.00347866926523086,0.0217883752603453,0.0354247587800503,2.15646846126758e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0221820410085457,0.00269885855854573,0.016892278233796,0.0274718037832953,2.27467041856825e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0423920227118728,0.00516540771931495,0.0322678235820155,0.0525162218417301,2.48012186477579e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.0658536136307966,0.00803061136748027,0.0501136153505352,0.0815936119110579,2.66345637107883e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42581,0.0349094564071543,0.00426540805504365,0.0265492566192687,0.0432696561950398,2.98440082859445e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,42339,0.031665964137777,0.00387169113876535,0.0240774495057969,0.0392544787697571,3.12730109019178e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39956,0.0189717848736576,0.0023195378612747,0.0144254906655592,0.023518079081756,3.1808380751035e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42594,0.0314987266215485,0.0038536090732854,0.0239456528379091,0.0390518004051879,3.25422221269864e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42636,-0.0424088155308719,0.00519436739108738,-0.0525897756174032,-0.0322278554443406,3.51676139229537e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0425178440272151,0.005222718629729,0.0322813155129463,0.052754372541484,4.26332309936108e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,0.0436771368201546,0.00536479811982317,0.0331621325053011,0.054192141135008,4.33319801236261e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,0.0538680266952044,0.00661884035128137,0.0408950996066929,0.0668409537837159,4.34430528745551e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,0.04652182273702,0.00571982461543414,0.0353109664907691,0.0577326789832709,4.54495448287196e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,0.0473978935215456,0.00583006937926227,0.0359709575381915,0.0588248295048996,4.74583141419173e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42636,0.0202549909517057,0.00249697447101781,0.0153609209885108,0.0251490609149007,5.41689554708649e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.0768277052869782,0.00947149163369475,0.0582635816849365,0.0953918288890199,5.44172048242877e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,40283,0.0415394914216164,0.00512139422871027,0.0315015587333443,0.0515774241098886,5.55043106391847e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,0.0634090876716668,0.00782843723715819,0.0480653506868367,0.0787528246564968,5.98684647237878e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0390960154117374,0.00483066949828189,0.0296279031951049,0.0485641276283699,6.40401734975787e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.0602707039006351,0.00749120451326562,0.0455879430546345,0.0749534647466357,9.46693255184628e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,0.0975740798554785,0.0121350268931482,0.073789427144908,0.121358732566049,9.84911219814292e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,40136,0.0325412890507497,0.00404733212208904,0.0246085180914552,0.0404740600100442,9.89438959296036e-16
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0399646162855088,0.00497271969969846,0.0302180856740998,0.0497111468969178,1.01859713174212e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.0903994292517658,0.0112578952377088,0.0683339545858564,0.112464903917675,1.07417130099642e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42636,0.0441551416163646,0.0055023991010025,0.0333704393783997,0.0549398438543295,1.10161977105404e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,40257,0.0404789724059512,0.00504662398317692,0.0305875893989244,0.0503703554129779,1.15462162808512e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0523764166646574,0.00653363089821317,0.0395705001041596,0.0651823332251552,1.19778445170315e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,40539,-0.0245692026204982,0.00306944473579585,-0.0305853143026581,-0.0185530909383383,1.31691556204641e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0349380138611643,0.00436601301300626,0.026380628355672,0.0434953993666566,1.32215467679851e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,0.0679642392690207,0.00849216133752723,0.0513196030474674,0.0846088754905741,1.33150401844453e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,40302,0.10389858965616,0.0129846348150242,0.0784487054187129,0.129348473893608,1.34958025923872e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,0.0242055058043459,0.0030265432479069,0.0182734810384484,0.0301375305702434,1.36973288570242e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42711,0.0287606840496547,0.0036097957792247,0.0216854843223743,0.0358358837769351,1.74953222984157e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNST,Consortin,42636,0.086529644998678,0.0108846763364348,0.0651956793792658,0.10786361061809,2.01842808025426e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,0.0328319794688451,0.00413385774917532,0.0247296182804615,0.0409343406572287,2.14205924110571e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,42357,0.0462679243540583,0.00582988739769967,0.0348413450545669,0.0576945036535496,2.25023327370318e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,0.075620709158392,0.00953144262600683,0.0569390816114186,0.0943023367053654,2.29147367891846e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,-0.0223906664122592,0.00282816017654987,-0.0279338603582969,-0.0168474724662214,2.62037356129043e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.0905193774661176,0.0114345856906532,0.0681075895124373,0.112931165419798,2.67676087315053e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0350162714855239,0.00442451733748146,0.0263442175040602,0.0436883254669875,2.72839488162135e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,42475,0.0403773589390507,0.00511137433045918,0.0303590652513507,0.0503956526267507,3.01927258100696e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42754,0.0388670511778791,0.00493025658146513,0.0292037482782075,0.0485303540775508,3.42882095710617e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0279448569001002,0.00354805096782374,0.0209906770031657,0.0348990367970347,3.63621853788527e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,0.0404495618076156,0.00513616787712429,0.030382672768452,0.0505164508467792,3.65345380702887e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,40494,0.0372321909694407,0.00473164625565321,0.0279581643083605,0.046506217630521,3.90815574638186e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0408654764792779,0.00520223521830882,0.0306690954513926,0.0510618575071632,4.28688300279586e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,42346,0.0513077025280274,0.00654252870550905,0.0384843462652296,0.0641310587908251,4.76785606309038e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42611,0.0196742806654102,0.00251031486555923,0.0147540635289141,0.0245944978019062,4.94581787089455e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0267489037328314,0.0034187705953154,0.0200481133660132,0.0334496940996496,5.49346609628117e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,40527,0.0327286352063043,0.00418461551872889,0.0245267887895957,0.0409304816230129,5.69680668571955e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.0516043956108858,0.00661697232558326,0.0386351298527426,0.064573661369029,6.71945989321825e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42534,0.0547416432889053,0.00702481607583427,0.0409730037802701,0.0685102827975405,7.0480135213586e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42636,-0.0244340594840822,0.00313643014686312,-0.0305814625719339,-0.0182866563962305,7.1676504778782e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42613,0.028885825559192,0.00371168480959527,0.0216109233323853,0.0361607277859988,7.63479184852003e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42495,0.0322591296542976,0.00414510526735619,0.0241347233302795,0.0403835359783158,7.63589644107189e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,40223,0.0238819276655929,0.00306802340836871,0.0178686017851903,0.0298952535459956,7.64640732767692e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,40269,-0.0165153282430707,0.00212421293261449,-0.0206787855909951,-0.0123518708951463,8.22619326975517e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,42311,0.0272143559823965,0.00350778008274435,0.0203391070202175,0.0340896049445754,9.24305443903782e-15
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0187003654670626,0.00241533100202452,-0.0234344142310306,-0.0139663167030945,1.04518806053689e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0524419572544715,0.00677397854521546,0.0391649593058492,0.0657189552030938,1.05143076205832e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COCH,Cochlin,40511,0.036522270558293,0.00472583861080425,0.0272596268811166,0.0457849142354693,1.18288177580327e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42594,0.0273739196009646,0.00354427026948668,0.0204271498727707,0.0343206893291585,1.21257302337462e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.0412209502930588,0.00534496638623395,0.0307448161760403,0.0516970844100773,1.3253295173254e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0448625345443023,0.00582674368268301,0.0334421169262436,0.056282952162361,1.48307812974513e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FST,Follistatin,42654,-0.0380042436118665,0.00494169364787325,-0.0476899631616981,-0.0283185240620349,1.56673619423864e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,-0.0378355412117248,0.00492660498848362,-0.0474916869891527,-0.0281793954342969,1.70537603019977e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,40451,0.0278295624782655,0.00362651975446712,0.0207215837595099,0.034937541197021,1.80615661269337e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.042375621310733,0.0055245107244707,0.0315475802907704,0.0532036623306956,1.83380921856666e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.029765744551327,0.00388603043136717,0.0221491249058473,0.0373823641968066,1.99183988456052e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42679,0.0436704108153256,0.00571064176830116,0.0324775529494553,0.0548632686811959,2.1928027215289e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0209391073912696,0.00274001560259753,-0.0263095379723607,-0.0155686768101784,2.3117405966086e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42587,0.0420940310433085,0.0055100187599637,0.0312943942737797,0.0528936678128374,2.32761673277043e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,0.0641796595884976,0.0084106336930591,0.0476948175501018,0.0806645016268935,2.49081312730071e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,0.0315005914419371,0.00413220154899798,0.023401476405901,0.0395997064779731,2.63827184345522e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,0.0365057734184381,0.00478917683501865,0.0271189868218016,0.0458925600150747,2.65712804710659e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42600,0.0232529275672376,0.00305173922760132,0.017271518681139,0.0292343364533362,2.71576187433061e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42711,0.0456405367385454,0.00599100296786955,0.0338981709215211,0.0573829025555697,2.74349410624114e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,40511,0.0568532858534217,0.00746865065878,0.0422147305622129,0.0714918411446305,2.90752684082901e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.0116783698031872,0.00153603115923653,-0.0146889908752909,-0.00866774873108364,3.12356209420442e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42587,0.0775939749102642,0.0102138735508203,0.0575747827506565,0.0976131670698719,3.23348536347681e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39870,0.0947613990093606,0.012486886600462,0.0702871012724552,0.119235696746266,3.49596660893185e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,-0.0457783067177093,0.00604208631135695,-0.0576207958879689,-0.0339358175474496,3.78034994037323e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,0.0520094890699504,0.00686540466054558,0.038553295935281,0.0654656822046197,3.80918093516397e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,0.0308504108896069,0.00407218693062374,0.0228689245055844,0.0388318972736294,3.85078838721248e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42587,0.0247168985560907,0.00326458061480929,0.0183183205510645,0.0311154765611169,3.9385161560755e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0472276299348561,0.00623769276757639,0.0350017521104064,0.0594535077593058,3.9921293379342e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42495,0.0454327323522389,0.0060024769144797,0.0336678775998587,0.0571975871046191,4.00831692800135e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,40539,0.0275871767593536,0.00364788497551525,0.0204373222073437,0.0347370313113635,4.25863294548108e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42644,-0.0210455377995517,0.00278581526411144,-0.0265057357172102,-0.0155853398818933,4.47458123785588e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,40223,0.0553072409407371,0.00732229286891659,0.0409555469176606,0.0696589349638136,4.58027274222841e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0255769799252256,0.00338709714023646,0.0189382695303621,0.032215690320089,4.65050899276506e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,40499,0.033468331987106,0.00443230810340788,0.0247810081044265,0.0421556558697854,4.65194177117178e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0314099416776789,0.00417245999725572,-0.0395879632723001,-0.0232319200830577,5.48458843352875e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.0249583386655999,0.00332105183307514,-0.0314676002584271,-0.0184490770727726,6.12388926961055e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42592,0.0422775402783232,0.00563309982721262,0.0312366646169865,0.0533184159396599,6.52006324836672e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42611,0.0335034954996997,0.00446647580924158,0.0247492029135862,0.0422577880858132,6.72568774837284e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0301440533966142,0.00401884251458553,0.0222671220680266,0.0380209847252019,6.82495422548137e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.0476698243209628,0.0063624499435077,0.0351994224316877,0.0601402262102379,7.26792772331695e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0251150739806936,0.00335537630382889,0.0185385364251889,0.0316916115361982,7.59366757673833e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42636,0.0316465849302195,0.0042363212955302,0.0233433951909803,0.0399497746694587,8.49451062059905e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42711,0.043049637153306,0.00576456058626759,0.0317510984042215,0.0543481759023905,8.64184644280917e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42642,0.0513317666325596,0.00687707968369312,0.037852690452521,0.0648108428125981,8.89666138928709e-14
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,0.040957723644095,0.00551333994089403,0.0301515773599427,0.0517638699282473,1.1766644418165e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGRN,Neugrin,40483,0.0173416570067306,0.00233608642400215,0.0127629276156864,0.0219203863977748,1.22379193810185e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,0.0366444574094662,0.00493940862876389,0.026963216497089,0.0463256983218435,1.26895547502655e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0350844041825405,0.00473222274042337,0.0258092476113107,0.0443595607537703,1.31402582483492e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,0.0274035737445194,0.0036984885614128,0.0201545361641503,0.0346526113248885,1.36169856800778e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,0.0422602093071883,0.00570543554758367,0.0310775556339243,0.0534428629804523,1.37047980729968e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,40470,0.0242004510002469,0.00327423833972597,0.017782943854384,0.0306179581461098,1.55838594734023e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.0299844971281308,0.00406214607095482,0.0220226908290594,0.0379463034272023,1.66066686554e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,40223,0.0502936076090313,0.00681953488784121,0.0369273192288626,0.0636598959892001,1.76223478264185e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,0.101099214911076,0.013720849372927,0.0742063501401395,0.127992079682013,1.82944184433049e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0530374766461252,0.0071983858307035,0.0389286404179464,0.0671463128743041,1.83458380280915e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0588114306762315,0.00799526727374165,0.0431407068196979,0.0744821545327652,2.03008751931097e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,0.0242417536433497,0.00329625479319478,0.017781094248688,0.0307024130380115,2.05416440528288e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,0.024398957113271,0.00331839796132854,0.0178948971090671,0.030903017117475,2.05831579041821e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,40054,0.0537559188090511,0.00733010684082705,0.03938890940103,0.0681229282170721,2.400496002691e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,40451,0.0292293068638965,0.00398673210041868,0.0214153119470759,0.0370433017807171,2.42934147830542e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42594,0.0600399542291682,0.00819674321309454,0.0439743375315029,0.0761055709268335,2.52817518607539e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0356941951497479,0.00488052765974267,0.0261283609366523,0.0452600293628435,2.77700191935372e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.0560465686700069,0.00767732140170071,0.0409990187226735,0.0710941186173402,3.03390053523444e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,0.0193795457763182,0.0026562482516572,0.0141732992030701,0.0245857923495664,3.13247836315275e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,0.0415299899418249,0.00569205097147477,0.0303735700377343,0.0526864098459154,3.16527761163229e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,0.0291979583278692,0.00400363120431953,0.0213508411674029,0.0370450754883354,3.20779658524433e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0237912320415183,0.00326394871026458,0.0173938925693997,0.0301885715136369,3.29255734532164e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,40342,0.0799255447900593,0.0109680655505597,0.0584281363109622,0.101422953269156,3.38064378436278e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.0690125603033711,0.00948094605750121,0.0504299060306688,0.0875952145760735,3.54966653026945e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,40451,0.0348613148568114,0.00479017438743144,0.0254725730574458,0.044250056656177,3.62235328883376e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42618,0.0295350264706258,0.00405911323646247,0.0215791645271594,0.0374908884140923,3.62340728190803e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,42261,0.0530896148049926,0.00729746363337597,0.0387865860835756,0.0673926435264095,3.6596284687319e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.0784253644560096,0.0107835645864839,0.0572895778665012,0.0995611510455179,3.75759286435903e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,0.0570733975231839,0.00788134170167075,0.0416259677879092,0.0725208272584586,4.72852559432923e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,0.0897103325989578,0.012391795776547,0.0654224128769256,0.11399825232099,4.74745052601384e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,40451,0.0603753357111264,0.00834152258903519,0.0440259514366175,0.0767247199856354,4.85249622429487e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZN,Kazrin,40449,0.0758500054230191,0.0104878515438844,0.0552938163970056,0.0964061944490326,5.06156436461148e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42636,0.0872368984451352,0.0120690951280558,0.063581471994146,0.110892324896124,5.16144195337554e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.04242027055794,0.00586938645578889,0.0309162731045938,0.0539242680112862,5.18972356613417e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0200511208192688,0.00277388653609335,0.0146143032085258,0.0254879384300117,5.20691599502303e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,0.0600525367026838,0.00831103876911349,0.0437629007152214,0.0763421726901462,5.25761542312179e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,40116,0.0353951363423664,0.00490182442882035,0.0257875604618785,0.0450027122228542,5.51165010658065e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0276501481073838,0.00383082887706762,0.0201417235083313,0.0351585727064364,5.57326858045392e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,0.0555251713470922,0.00769579878757433,0.0404414057234466,0.0706089369707379,5.74015846506406e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0411616780268544,0.0057063962413253,0.0299771413938568,0.052346214659852,5.81866995213444e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0464774423066767,0.00644481256649509,0.0338456096763463,0.059109274937007,5.88436834787546e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,0.0223370823574869,0.00309875835625734,0.0162635159792225,0.0284106487357513,5.96186924676962e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,0.05606805526498,0.00779683757921842,0.0407862536097119,0.0713498569202481,6.84614608669726e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0549030454299444,0.00764485312209112,0.0399191333106458,0.069886957549243,7.3193035668899e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0310840903598271,0.0043301517320048,0.0225969929650977,0.0395711877545565,7.4244291064196e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0551373499313249,0.00768111809736524,0.0400823584604891,0.0701923414021608,7.51229108108366e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0596849242492787,0.00831687511947006,0.0433838490151173,0.07598599948344,7.60924574396039e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0455076155390202,0.00634624614503092,0.0330689730947596,0.0579462579832808,7.8461704769946e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NBN,Nibrin,42370,0.0385025720736977,0.00537212088767557,0.0279732151338535,0.0490319290135418,8.06759864809176e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,-0.0215489158078045,0.00300695009544104,-0.0274425379948689,-0.01565529362074,8.09798943884983e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,0.0531577189409092,0.00742551631215377,0.0386037069690878,0.0677117309127306,8.64319418012106e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,40283,0.0241048063705505,0.00336912857553275,0.0175013143625063,0.0307082983785947,8.92036738121026e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.0224396455478342,0.00313715192345996,0.0162908277778526,0.0285884633178157,8.9344305719973e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,40451,0.0292216072958556,0.00408497871149916,0.0212150490213173,0.037228165570394,8.98901958438789e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0770452336928958,0.0107744012965012,0.0559274071517534,0.0981630602340381,9.08022505453051e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0465739834551898,0.00652035502181202,0.0337940876124382,0.0593538792979413,9.608488411269e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.048695593801725,0.00681856550802674,0.0353312054059925,0.0620599821974574,9.7078500831398e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,40449,0.0501898705805983,0.00702705104325229,0.0364168505358238,0.0639628906253728,9.73882218800662e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,0.0748454508147786,0.0104863726141344,0.0542921604910751,0.095398741138482,9.99753814279168e-13
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,0.071003103932084,0.00995102759616875,0.0514990898435932,0.0905071180205747,1.01565726104617e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42594,0.0422785839472144,0.00592768468553893,0.0306603219635581,0.0538968459308707,1.03699059864558e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,42346,0.0696159905381007,0.00976255170891302,0.0504813891886312,0.0887505918875702,1.0490911474864e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,0.0433471921116325,0.00608324348588863,0.0314240348792908,0.0552703493439742,1.10038678058103e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,0.063479320937695,0.00892013778586779,0.0459958508773942,0.0809627909979959,1.17492318985608e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,42509,0.0379037889204196,0.00533163050945864,0.0274537931218807,0.0483537847189586,1.22640285885749e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,0.037697667246021,0.00532437282262973,0.0272618965136667,0.0481334379783753,1.51073155281795e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0232484488078261,0.00328372112151493,0.0168123554096568,0.0296845422059953,1.52812310904265e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0520579781702604,0.00735815035022744,0.0376360034838146,0.0664799528567061,1.56991818137064e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0360718910996503,0.00510486124717129,0.0260663630551946,0.0460774191441061,1.67274292112113e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,40527,0.0199608162754914,0.00282452526705893,0.0144247467520559,0.0254968857989269,1.67656215366684e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0272058737372611,0.00384978880574675,0.0196602876779974,0.0347514597965247,1.67858845068758e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,40440,0.0206482484734214,0.00292315653954231,0.0149188616559185,0.0263776352909243,1.7172270389518e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,40283,0.0507138396851157,0.00718076819377638,0.036639534025314,0.0647881453449174,1.73382161250183e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42611,-0.0203443113713579,0.00288611480596531,-0.0260010963910499,-0.0146875263516659,1.88975410488388e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.0654003123769858,0.00929678609644005,0.0471786116279632,0.0836220131260083,2.09528687603452e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,0.0247204090309422,0.00351453961790332,0.0178319113798517,0.0316089066820327,2.10877705409036e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42760,0.0201306123442564,0.00286458166326278,0.0145160322842614,0.0257451924042514,2.20434790736882e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,40483,0.0497281175396073,0.00707599684232515,0.03585916372865,0.0635970713505646,2.22034586678811e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0470464715394024,0.00669708540764225,0.0339201841404236,0.0601727589383812,2.24441933777211e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.0779621306265018,0.0111092407411663,0.0561880187738159,0.0997362424791877,2.36369213438313e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,0.046941618822557,0.0066911114794815,0.0338270403227733,0.0600561973223407,2.39965250694351e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42711,0.0264392095314529,0.00376925309486195,0.0190514734655235,0.0338269455973823,2.41848355778363e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,-0.0371137264459,0.00529770195930535,-0.0474972222861385,-0.0267302306056616,2.57621256632935e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0236947624207172,0.00338465301625794,0.0170608425088516,0.0303286823325827,2.66919129991151e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,40449,0.0493017942933836,0.00705131807857929,0.0354812108593682,0.063122377727399,2.86635625862628e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNC,Tenascin,42689,-0.0339735214129049,0.00486324848210825,-0.0435054884378371,-0.0244415543879727,2.96581166857141e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0245091438928719,0.00350885738627212,0.0176317834157786,0.0313865043699653,2.98387782032026e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,-0.0298667010401602,0.00428288874248659,-0.0382611629754339,-0.0214722391048865,3.26591598762294e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,0.0577969401294143,0.00829161114569243,0.0415453822838572,0.0740484979749715,3.33306024586167e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,0.0549175056434952,0.00788514683417928,0.0394626178485038,0.0703723934384866,3.47449948641028e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,42311,0.0469705988076894,0.00675248708252367,0.033735724125943,0.0602054734894358,3.66558012753394e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42711,0.0408777306587541,0.0058796106785838,0.0293536937287299,0.0524017675887784,3.75460268925251e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,42476,-0.0348270391715924,0.00501550133675045,-0.0446574217916233,-0.0249966565515616,3.99213147516766e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0400914253635821,0.00577639937845807,0.0287696825818042,0.0514131681453599,4.08940406137233e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0678912765056427,0.00978235529362902,0.0487178601301298,0.0870646928811556,4.09593457840751e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.0622488155986172,0.00897184780765362,0.0446639938956161,0.0798336373016183,4.19322909612371e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0224994693325698,0.00325413819806322,0.0161213584643659,0.0288775802007737,4.9621785487782e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.040746511383296,0.00589737289890436,0.0291876605014435,0.0523053622651486,5.14021582538038e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,-0.0263912987646832,0.00382714828098593,-0.0338925093954156,-0.0188900881339508,5.59867937173387e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,0.039340792973299,0.00570571543581016,0.0281575907191111,0.0505239952274869,5.6268395952621e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0255927003105274,0.00371319703848087,0.0183148341151049,0.0328705665059499,5.78979897237616e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGN,Mimecan,42611,0.0306784193275632,0.00445649992442319,0.0219436794756938,0.0394131591794327,6.07939052782833e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RETN,Resistin,42598,0.0299771201053236,0.00435581254407885,0.0214397275189291,0.0385145126917182,6.15997420062196e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,40532,0.0197378707486149,0.00287085920117562,0.0141109867143107,0.0253647547829191,6.51321804905164e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.044622605021733,0.0065057496176015,0.031871335771234,0.0573738742722319,7.30956866121191e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0217602586635845,0.00317376704825954,0.0155396752489958,0.0279808420781732,7.37412831905681e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,-0.0203071483742025,0.00296338245925292,-0.0261153779943382,-0.0144989187540668,7.56363122289939e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.0619072386445953,0.00904300775882294,0.0441829434373024,0.0796315338518883,7.9955444083124e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42669,0.0205537373626694,0.00300800804354063,0.0146580415973298,0.026449433128009,8.6725856395939e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.027466030099964,0.00402452198508386,0.0195779670091996,0.0353540931907284,9.26559676312032e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0194390129957655,0.00285316778373369,0.0138468041396475,0.0250312218518836,9.95890248660683e-12
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.0652438083951736,0.00958235760927093,0.0464623874810026,0.0840252293093446,1.0262230397112e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0182086616653938,0.00267620864698686,-0.023454030613488,-0.0129632927172995,1.06150090932336e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0236292257274923,0.00348279339809477,0.0168029506672265,0.030455500787758,1.21270933134672e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0260458509274341,0.00384558306682181,0.0185085081164634,0.0335831937384049,1.31582692652668e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42587,0.0203469785024351,0.00300500616302653,0.0144571664229031,0.0262367905819671,1.33201462312276e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.022854607434228,0.00337845633933012,0.0162328330091409,0.029476381859315,1.40368009582679e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,40223,0.0207786457328137,0.00307699977321447,0.0147477261773133,0.0268095652883141,1.5221340811137e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.0451322955254661,0.00668521575911078,0.0320292726376089,0.0582353184133232,1.52944266499995e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0285971772931695,0.00423926444411497,0.0202882189827042,0.0369061356036349,1.59776564039529e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB2,Calretinin,42311,0.0217421267222727,0.00322736442845235,0.0154164924425061,0.0280677610020393,1.68662110004672e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.0539231150264023,0.00800500284537641,0.0382333094494645,0.06961292060334,1.70512898404793e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0268695301446027,0.00398994618831328,0.0190492356155086,0.0346898246736967,1.71361628054878e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.020310127033045,0.00301737735321793,0.0143960674207379,0.0262241866453522,1.7542475005257e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42721,0.0327974912121586,0.00487635488455004,0.0232398356384405,0.0423551467858766,1.81619647611633e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0437259115978051,0.00650209801312154,0.0309817994920869,0.0564700237035233,1.84410281172792e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,0.0115333292734206,0.00171675684469585,0.00816848585781674,0.0148981726890245,1.92929316658852e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,42370,0.0504702750620229,0.00751549675698234,0.0357399014183375,0.0652006487057083,1.95116846805081e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,40527,-0.0337786287201652,0.00503150161954465,-0.0436403718944727,-0.0239168855458577,1.99183018578e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,0.0344215629101609,0.00512965676495105,0.0243674356508568,0.044475690169465,2.02023418457788e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,40451,0.0413803258549965,0.00617746445601098,0.029272495521215,0.0534881561887781,2.20465423413872e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42494,0.0468967176412858,0.00700637625816485,0.0331642201752827,0.0606292151072889,2.26733404633718e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0221649383976439,0.00331345960961471,-0.0286593192324887,-0.015670557562799,2.32905903338112e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,0.0416945631611927,0.00623243246114866,0.0294789955373413,0.053910130785044,2.33829162809782e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42611,0.0496249019189946,0.00742558018935155,0.0350707647478655,0.0641790390901236,2.43400382327032e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELP,P-selectin,42689,0.037444548840179,0.00561609972257246,0.026436993383937,0.048452104296421,2.70578773723848e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,-0.0193475991282824,0.00290205572587021,-0.025035628350988,-0.0136595699055767,2.71555696427773e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42587,-0.0198111362054728,0.00297316535190095,-0.0256385402951986,-0.0139837321157469,2.78187737336142e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0220774191316618,0.00331592308511352,0.0155782098848393,0.0285766283784843,2.88320930297862e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0465678336868567,0.00700119220997917,0.0328454969552975,0.0602901704184159,3.04076588694341e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.0684288355443207,0.0103047986792072,0.0482314301330745,0.0886262409555668,3.24653261422517e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0163399304405465,0.00246078892271065,0.0115167841520336,0.0211630767290593,3.25524347148741e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0299010082124634,0.00451140636581024,-0.0387433646894514,-0.0210586517354753,3.53539116305693e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,-0.0224890712228967,0.00339331588029221,-0.0291399703482695,-0.015838172097524,3.54653154103678e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,0.0367348221732597,0.00554279992330059,0.0258709343235906,0.0475987100229289,3.57007379003171e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42654,0.0206928609144831,0.00312454640893636,0.0145687499529678,0.0268169718759984,3.66144456771105e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42754,0.040547078271962,0.00613285188543843,0.0285266885765027,0.0525674679674213,3.94802676475431e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.0724016855509855,0.0109498361171017,0.0509400067614662,0.0938633643405049,3.95989102752705e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.0732169613508104,0.0111128743895498,0.0514357275472927,0.094998195154328,4.60950434825688e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42587,0.0620050647533195,0.00941145804666226,0.0435586069818615,0.0804515225247776,4.61665750633814e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0395864478490856,0.00600810114670674,0.0278105696015404,0.0513623260966308,4.63162239716022e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0353753085280667,0.00537294844757901,0.0248443295708118,0.0459062874853215,4.74966812891368e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42587,0.0920925365205525,0.013991781764701,0.0646686442617386,0.119516428779366,4.81760840047613e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,0.0159612913861298,0.00242577125155171,0.0112067797330884,0.0207158030391711,4.883170430772e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,-0.0165884640157414,0.00252469906882729,-0.0215368741906429,-0.0116400538408399,5.19819573763881e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,0.030409633487992,0.00462918409703808,0.0213364326577974,0.0394828343181867,5.24684380313909e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,0.0313924181583883,0.00478812708681523,0.0220076890682305,0.0407771472485462,5.71756819025585e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,0.0252039617860336,0.00385119176894236,0.0176556259189066,0.0327522976531606,6.19314028832654e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,42130,0.016442656727151,0.00251902107444583,0.0115053754212371,0.0213799380330648,6.9418494597126e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42613,0.025542267856847,0.0039193652151813,0.0178603120350917,0.0332242236786024,7.43193272709909e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,42311,0.0343995877477062,0.00529164687646746,0.02402795986983,0.0447712156255824,8.28222986112066e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,0.0308345863264883,0.00474599655340123,0.0215324330818219,0.0401367395711547,8.5387517225452e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,0.0344147913036372,0.00530346651008119,0.0240199969438781,0.0448095856633964,8.99490912651955e-11
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,0.0155117147907749,0.0024013135668377,0.0108051401997731,0.0202182893817768,1.09342694662737e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,0.0313082068812161,0.00486119303570526,0.0217802685312338,0.0408361452311984,1.23970502539439e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0452318695190658,0.00702463650653991,0.0314635819662475,0.059000157071884,1.24317355738616e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42676,0.0280125466837811,0.00435201790087767,0.0194825915980609,0.0365425017695014,1.26247773129598e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.0276005171349911,0.0042886606709572,0.019194742219915,0.0360062920500672,1.27046787865241e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,0.0270205909028624,0.0042025061281899,0.0187836788916101,0.0352575029141146,1.32180782750574e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0310774748073642,0.00484219309950802,0.0215867763323285,0.0405681732824,1.43554814288226e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.0505436939174216,0.00788406776341003,0.035090921101138,0.0659964667337053,1.49545737654672e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42636,0.0304386192841356,0.00475817697304301,0.0211125924169713,0.0397646461512999,1.63581925083629e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,40418,0.0295133527370937,0.00461357258646889,0.0204707504676146,0.0385559550065727,1.64686325836906e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.049772337891616,0.00779368146627406,0.0344967222177189,0.0650479535655132,1.7669086650936e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42580,0.0185898732848058,0.00291222812473098,0.0128819061603331,0.0242978404092786,1.78928876950203e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0339507104684038,0.00531991823115234,0.0235236707353452,0.0443777502014624,1.819758969223e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,40482,0.042115453178823,0.00660037318322775,0.0291787217396966,0.0550521846179494,1.83100388489795e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,0.0647385850526293,0.0101505860293475,0.0448434364351081,0.0846337336701505,1.85530512236525e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.054624837082936,0.00856766298081595,0.0378322176405368,0.0714174565253353,1.89379669564242e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSG,Basigin,42746,0.0139279984229578,0.00218523807598764,0.00964493179402207,0.0182110650518936,1.9052608489797e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42562,0.0487444440514328,0.00765122435850667,0.0337480443087597,0.0637408437941059,1.9420309449814e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,0.0389465361347808,0.00611818944399195,0.0269548848245566,0.050938187445005,2.00665085390983e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0315896026162248,0.00496594079934828,0.0218563586495022,0.0413228465829475,2.07878697740771e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2,Brorin,42456,0.0262876687628602,0.00413458288336188,0.0181838863114709,0.0343914512142495,2.110993618409e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.0453226955532378,0.00713222110322113,0.0313435421909243,0.0593018489155512,2.15676900212323e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,0.0443676635030241,0.00698428725028044,0.0306784604924745,0.0580568665135738,2.18650809628558e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,0.024666439389831,0.00388549383029159,0.0170508714824595,0.0322820072972025,2.2466931795241e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,0.0479804083541684,0.00756322595011723,0.0331564854919386,0.0628043312163982,2.31193826714401e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0729428413936565,0.0115252738166627,0.0503533047129977,0.0955323780743154,2.54792815044361e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0173700168146342,0.00274617806790382,0.0119875078015427,0.0227525258277257,2.60954496509211e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,42292,0.0299323827393386,0.00473679826018087,0.0206482581493841,0.0392165073292931,2.71583066258788e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,40182,0.0288390375431681,0.00458228604125592,0.0198577569023065,0.0378203181840297,3.22021221620839e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,42346,0.0599895295053702,0.00953510656427118,0.0413007206393987,0.0786783383713417,3.24510063766598e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.0361728050523358,0.00575747287152747,0.024888158224142,0.0474574518805297,3.4298773506171e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TF,Serotransferrin,40539,0.0135324622434753,0.00215504793741853,0.00930856828613496,0.0177563562008156,3.52248376365692e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0330802771526215,0.00526936157232771,0.0227523284708592,0.0434082258343838,3.54069774956752e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.0661091091026617,0.0105372701711234,0.0454560595672598,0.0867621586380636,3.65193075201447e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42711,0.0825887518808761,0.0131685950919184,0.056778305500716,0.108399198261036,3.68132406450278e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42572,0.028052590550428,0.00447423653744235,0.019283086937041,0.036822094163815,3.72611597788429e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42689,0.0626404230435349,0.00999440776426609,0.0430513838255733,0.0822294622614964,3.77937643053418e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0296434038160093,0.00473645153222081,-0.038926848819162,-0.0203599588128565,4.00262281434962e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.0490443999697338,0.0078408037833498,0.0336764245543682,0.0644123753850994,4.09810403243054e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,0.0453119432261182,0.00724913181145995,0.0311036448756567,0.0595202415765797,4.234349429765e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0167487620048781,0.002682301201569,0.0114914516498028,0.0220060723599533,4.39018162436164e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,0.0182988658879867,0.00293079611630813,0.0125545055000228,0.0240432262759507,4.40336103525292e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0278230409288439,0.00445723725127676,0.0190868559163415,0.0365592259413463,4.44428143010218e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.0392305653658969,0.00628851747019007,0.0269050711243244,0.0515560596074695,4.55492548029115e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,40166,0.0282035539722447,0.00452306090526765,0.0193383545979201,0.0370687533465693,4.668933534631e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,0.0333597975017137,0.00535816938724585,0.0228577855027119,0.0438618095007156,4.95989732535807e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.021604534708045,0.00347125489854129,0.0148008751069041,0.0284081943091859,5.02385547190935e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0421636891047986,0.00677914513934687,0.0288765646316788,0.0554508135779185,5.16595744424187e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0377669326127894,0.00607465218293367,0.0258606143342394,0.0496732508913394,5.24147548538214e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,42370,0.0706062820277039,0.011361301461211,0.0483381311637304,0.0928744328916774,5.29963807858005e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0342674179538983,0.00551442890666429,0.0234591372968363,0.0450756986109603,5.31177784080154e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,42311,0.0446203117332167,0.00718462860405282,0.0305384396692732,0.0587021837971602,5.44027578288206e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,40482,0.0343165293441552,0.00553238083239512,0.0234730629126607,0.0451599957756496,5.73899805533978e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,42357,-0.0146594668092768,0.0023641163239221,-0.0192931348041641,-0.0100257988143895,5.78484269170001e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.020742982643439,0.00334688154466161,-0.0273028704709758,-0.0141830948159023,5.92827951168143e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42679,0.0196342475092716,0.00317001439671112,0.0134210192917178,0.0258474757268254,6.04596432695922e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,0.0430290883680218,0.00695145232049504,0.0294042418198515,0.056653934916192,6.19417000606425e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,40483,0.0466052056865842,0.00753201923033752,0.0318424479951227,0.0613679633780457,6.31993367851018e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,0.0450168018047052,0.00727626088698169,0.0307553304662211,0.0592782731431893,6.32158479609042e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,0.032753439195336,0.00529543420431729,0.0223743881548741,0.0431324902357979,6.37977537264876e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,0.0511392054333251,0.00828062756518575,0.034909175405561,0.0673692354610892,6.8108335928705e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0352037985898572,0.00570612475574092,0.024019794068605,0.0463878031111094,7.09182472592721e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.0167143553174659,0.00270968183155661,-0.0220253317073169,-0.011403378927615,7.13533608825306e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,40479,0.0192347744141229,0.0031224961031082,0.0131146820520309,0.025354866776215,7.51920984060754e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0419753062643608,0.00681566824741645,0.0286165964994246,0.0553340160292971,7.5870869971532e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.0635270866888559,0.0103155584668602,0.0433085920938099,0.0837455812839019,7.60537900163351e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,-0.0367610281026498,0.0059762240206654,-0.048474427183154,-0.0250476290221456,7.90594117400139e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0301376069199277,0.00489898624221323,0.0205355938851898,0.0397396199546656,7.91936945954778e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,0.0272340368992864,0.0044343658572368,0.0185426798191022,0.0359253939794705,8.40082316132607e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,0.0491953282583634,0.00801171405137703,0.0334923687176644,0.0648982877990624,8.46061042931256e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,0.0485231889513313,0.00790307020753045,0.0330331713445716,0.064013206558091,8.49572138450822e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42495,-0.0212313921926255,0.00346070582944875,-0.028014375618345,-0.0144484087669059,8.75810927418244e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.0439527459859235,0.00716508860601579,0.0299091723181326,0.0579963196537145,8.8455693654953e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,40482,-0.0298946926871932,0.00487963715193879,-0.0394587815049933,-0.0203306038693932,9.2874337520008e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,0.017562036519714,0.00286870373857281,0.0119393771921113,0.0231846958473167,9.50722449100182e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,0.0604968286192016,0.00988843777924082,0.0411154905718896,0.0798781666665136,9.79278401566104e-10
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,40449,0.0414557264280096,0.00678051143157185,0.0281659240221288,0.0547455288338904,1.00414638542579e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0356510376932322,0.00583735169348754,0.0242098283739966,0.0470922470124678,1.04122119555648e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0321486651505252,0.0052659636124127,0.0218273764701963,0.0424699538308541,1.05639893299333e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,40532,0.0499512953428449,0.00818730838007408,0.0339041709178997,0.0659984197677901,1.0880208776506e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0398349339213155,0.00653023924601395,0.0270356649991282,0.0526342028435029,1.08994542359111e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,-0.0235236909189233,0.00386186203633696,-0.0310929405101437,-0.0159544413277029,1.1513447352593e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42779,0.0217191273279177,0.00357319706516863,0.0147156610801871,0.0287225935756482,1.24679279045009e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42562,0.0219633254236328,0.00361397036967139,0.0148799434990769,0.0290467073481888,1.25515361716679e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,0.0466065079218052,0.00766842700168898,0.0315763909984948,0.0616366248451156,1.25945423497429e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,0.0401504694785345,0.00662105134063867,0.0271732088508828,0.0531277301061863,1.37116080463524e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0249986797097128,0.00412303878975857,0.016917523681786,0.0330798357376396,1.37713940797679e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,0.0330767456860959,0.00545604809606313,0.0223828914178122,0.0437705999543796,1.37734886496082e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.0129920589066266,0.00214490414207277,-0.0171960710250893,-0.00878804678816398,1.42927638219925e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,40449,0.0342577579950093,0.00566061677779272,0.0231629491105356,0.045352566879483,1.47660496058208e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42585,0.0531083873295745,0.00879331602230064,0.0358734879258653,0.0703432867332838,1.58557831350362e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,0.0177289737972528,0.00293715633783758,0.0119721473750911,0.0234858002194144,1.62050759401511e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,42311,0.0524325198626907,0.00870020845224344,0.0353801112962936,0.0694849284290879,1.71953917820386e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,40451,0.0197246854273788,0.00327409194768092,0.0133074652099242,0.0261419056448334,1.74963186791961e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.062578424405933,0.0103889502780201,0.0422160818610136,0.0829407669508525,1.75094780894588e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0347810874286321,0.00577506138687977,0.0234619671103477,0.0461002077469164,1.76125441385007e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0114802947126914,0.0019074412550909,0.00774170985271321,0.0152188795726695,1.80429260627081e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,40116,0.0399364698934031,0.00663668962048424,0.026928558237254,0.0529443815495522,1.82782622603796e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42677,-0.0253130412015607,0.00421175501139077,-0.0335680810238866,-0.0170580013792348,1.90199974526769e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,0.0290142798950065,0.00482719523831763,0.0195529772279039,0.038475582562109,1.90579453817164e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.0603088987934322,0.0100485630878205,0.0406137151413041,0.0800040824455603,2.00249890003063e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,40223,0.0286891929034653,0.0047869849318583,0.019306702437023,0.0380716833699075,2.12229659002814e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,0.0392800786280588,0.006567700928026,0.0264073848091278,0.0521527724469898,2.28776146958716e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.01707645014994,0.002855789720514,0.0114791022977326,0.0226737980021475,2.2935771834913e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0176679823394486,0.00295573379687337,0.0118747440975768,0.0234612205813204,2.3229489905192e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,40199,0.0263862393394615,0.00441382719001544,0.0177351380470312,0.0350373406318917,2.32778894333027e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,0.0213976891217665,0.00358151950983153,0.0143779108824966,0.0284174673610363,2.36796521479844e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI3,Elafin,42446,0.0341506580300926,0.00571991015607187,0.0229396341241918,0.0453616819359935,2.4259456929377e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0171761091850378,0.00287734996260665,0.0115365032583288,0.0228157151117468,2.45500403169654e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42563,0.0229109045637486,0.00384082070861879,0.0153828959748558,0.0304389131526414,2.50650441998547e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,0.0333211854689635,0.00559649060621494,0.0223520638807822,0.0442903070571448,2.68425903923337e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0294377767302583,0.00494651561199397,0.0197426061307501,0.0391329473297665,2.74253561736266e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.0432314821781716,0.00728702861478117,0.0289489060932005,0.0575140582631427,3.05369171490193e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0405947775512317,0.00684850610977296,0.0271717055760768,0.0540178495263867,3.15046702358773e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42624,0.0328356656267035,0.00553966385769539,0.0219779244656205,0.0436934067877865,3.15364529907964e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,40283,0.0187161078716291,0.00315743358662291,0.0125275380418482,0.02490467770141,3.1648248345107e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,42476,0.0374666628854183,0.00632258956935429,0.0250743873294839,0.0498589384413527,3.18400380880597e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,-0.0172480558794689,0.00291467050130069,-0.0229608100620183,-0.0115353016969196,3.3619354826473e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0178476823382227,0.00301830824499388,0.0119317981780347,0.0237635664984107,3.43806700632652e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,0.0315167728991907,0.00533175089257344,0.0210665411497468,0.0419670046486346,3.49923182185882e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42590,0.0180117408737159,0.0030481077413305,0.0120374497007081,0.0239860320467236,3.52220340753771e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,0.0577085129791431,0.0097675009403368,0.038564211136083,0.0768528148222032,3.56073326071751e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42642,0.0557370980438727,0.00944516959252691,0.03722456564252,0.0742496304452255,3.69727141384661e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42543,0.0194296166050699,0.00329711950923048,0.0129672623669781,0.0258919708431616,3.8861225799905e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0202919710923444,0.00344380104376427,0.0135421210465664,0.0270418211381224,3.89873155771733e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42587,0.0456413118366364,0.00774740660485697,0.0304563948911167,0.060826228782156,3.92670094871036e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42754,0.0291160432510482,0.00495258164192945,0.0194089832328664,0.0388231032692299,4.22553622207398e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0179812399273686,0.00306488398929046,0.0119740673083593,0.0239884125463779,4.56567536136134e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0255053980414323,0.0043560651785626,0.0169675102914496,0.034043285791415,4.87674498458711e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0253933932628236,0.00433742805460203,0.0168920342758036,0.0338947522498436,4.91823279929883e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,40182,0.0763338466873537,0.0130616957140352,0.0507329230878446,0.101934770286863,5.23788193229788e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0124932530804477,0.00213832312458712,0.00830213975625692,0.0166843664046384,5.26033114403186e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.0175606052459618,0.00300559085610787,0.0116696471679904,0.0234515633239333,5.28013560856146e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.0604109147353208,0.0103445657177093,0.0401355659286106,0.080686263542031,5.36863450586966e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42587,0.0526449763717441,0.00902187009391795,0.0349621109876649,0.0703278417558233,5.49479567502392e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,0.0441908243053451,0.00757515885992847,0.0293435129398853,0.0590381356708049,5.57167310536707e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,0.0168278584814215,0.00288512146796708,0.0111730204042061,0.022482696558637,5.60521080925972e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.016401791734351,0.00281297184570155,0.0108883669167759,0.021915216551926,5.67253925389495e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42587,0.034797575993765,0.00596884670911385,0.0230986364439019,0.0464965155436282,5.6749976358439e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0311008929896761,0.00533471244042112,0.0206448566064507,0.0415569293729015,5.67563032163099e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0255247214153388,0.00438205970274764,0.0169358843979534,0.0341135584327242,5.85102798550537e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.035076242523352,0.00602301917013226,0.0232711249498928,0.0468813600968112,5.89022752211798e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,0.033707323749028,0.00578732358386536,0.0223641695246518,0.0450504779734041,5.89041471446149e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0207040328648516,0.00355728049546705,0.0137317630937362,0.0276763026359671,6.04232021201832e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.0186717266542397,0.00321142328487152,0.0123773370158915,0.0249661162925879,6.2328550824254e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0185709981235313,0.00319648511548125,-0.0248361089498746,-0.012305887297188,6.41580970482716e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.0385645072236128,0.00663774681598964,0.0255545234642731,0.0515744909829524,6.4207023841996e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPSE,Heparanase,40408,0.0548459387569569,0.00944024349400305,0.0363430615087109,0.0733488160052028,6.42481059972108e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.0453904344577106,0.00781689837230871,0.0300693136479855,0.0607115552674357,6.51689173984638e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,40483,0.0327565577288876,0.00564312570997683,0.021696031337333,0.0438170841204421,6.62237944258464e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.0489863000712231,0.00844268270730221,0.0324386419649108,0.0655339581775354,6.72500955985461e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,0.0408042605507912,0.00704290097689694,0.0270001746360732,0.0546083464655092,7.04111520859862e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0175042544732012,0.00302195380749553,0.0115812250105099,0.0234272839358924,7.09507737863076e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42705,-0.0161348650675344,0.00279138331349592,-0.0216059763619864,-0.0106637537730823,7.62413768172742e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0352436536231669,0.00609761656320589,0.0232923251592834,0.0471949820870505,7.64345730659183e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,40283,0.0392749101867192,0.0067997289307846,0.0259474414823813,0.052602378891057,7.85759423679111e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42611,0.0158264908407843,0.00274792370881118,0.0104405603715144,0.0212124213100542,8.6245818399236e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42636,-0.0208019388613489,0.00361344273226909,-0.0278842866165963,-0.0137195911061015,8.75857048659643e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,42357,0.0286396540100415,0.00498700119820541,0.0188651316615589,0.0384141763585241,9.51475703248086e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,40511,0.0312949653541504,0.00545321194900699,0.0206066699340967,0.0419832607742042,9.77900063666055e-09
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.0444428781575451,0.00776055294131309,0.0292321943925714,0.0596535619225187,1.04602006410658e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42495,0.054830473903282,0.00958530763332772,0.0360432709419596,0.0736176768646043,1.08650005294104e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0201410171375174,0.0035246838757153,0.0132326367411154,0.0270493975339194,1.13032880759304e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0328082417240457,0.00574347347019963,0.0215510337224544,0.044065449725637,1.1437335445008e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,0.0231340666040843,0.00405004096826594,0.0151959863062831,0.0310721469018856,1.14512480386996e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRN,Progranulin,42552,0.0140872426001868,0.00246836956959998,0.00924923824377089,0.0189252469566028,1.17356030395585e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2,Complement C2,42663,0.0131473409234954,0.00230528834761261,0.0086289757621747,0.0176657060848161,1.20104516506184e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,-0.0206495547992854,0.00362878601876032,-0.0277619753960557,-0.0135371342025152,1.2930347286309e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42721,0.0125662558333394,0.00221035883580303,0.00823395251516546,0.0168985591515133,1.33386684655612e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.024259997838916,0.00427002730274777,0.0158907443255303,0.0326292513523016,1.3632727041792e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0322490483614483,0.00569396197904372,0.0210888828825226,0.043409213840374,1.51158461369226e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,42357,0.0324472972374784,0.00572953314996951,0.0212174122635382,0.0436771822114187,1.51714280434997e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,0.036781754502676,0.00649894284016717,0.0240438265359484,0.0495196824694037,1.54762301122945e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42636,0.059401365874638,0.010498775863166,0.0388237651828327,0.0799789665664434,1.56334121965897e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0172677845496051,0.00305352587068925,0.0112828738430542,0.023252695256156,1.5902546380722e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,0.0133964353454549,0.002370514089755,0.00875022772953508,0.0180426429613747,1.62505366107011e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,0.0365967102444874,0.00647830453248077,0.0238992333608251,0.0492941871281497,1.645563073848e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,42134,0.0344724844627297,0.00610245645745972,0.0225116698061087,0.0464332991193508,1.64831083023947e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,40511,0.0365314414733227,0.00647530008973169,0.0238398532974486,0.0492230296491969,1.7246168483332e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.0539006834604959,0.00955904882106503,0.0351649477712084,0.0726364191497833,1.74792207736092e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,40483,0.0353241644718617,0.00626943323930321,0.0230360753228274,0.0476122536208961,1.79930230000765e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,42346,0.0219999178202206,0.00390781640868086,0.0143405976592061,0.0296592379812351,1.84193602664728e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.0587754102439732,0.0104556280490312,0.038282379267872,0.0792684412200743,1.93158504233991e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0376601956516655,0.00670592866174209,0.024516575474651,0.05080381582868,1.99450785957608e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42711,-0.0172638009305949,0.00307476168225256,-0.0232903338278099,-0.0112372680333799,2.00805261306723e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42689,0.0174170836159309,0.00310295427498574,0.0113352932369589,0.023498873994903,2.02690621492994e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,-0.0142362741614189,0.0025368289098511,-0.019208458824727,-0.00926408949811071,2.04132233799869e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42594,0.0268525477021552,0.00479222047861185,0.017459795564076,0.0362452998402344,2.1437689888375e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0376107642179467,0.00672006124057999,0.0244394441864099,0.0507820842494834,2.23624290673103e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.053501229007469,0.00956152448099068,0.0347606410247273,0.0722418169902108,2.2437567804457e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0356834347427967,0.00638428973403705,0.0231702268640841,0.0481966426215094,2.33350652264701e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLGN,Calmegin,40182,0.0262705625544526,0.00470208380032682,0.017054478305812,0.0354866468030932,2.36519608077873e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,40483,0.0600698006583047,0.0107549250919827,0.0389901474780186,0.0811494538385908,2.38654568510488e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0357434910360378,0.00640405119827427,0.0231915506874203,0.0482954313846554,2.43339400663135e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,-0.0225688260597174,0.00404633799246441,-0.0304996485249477,-0.0146380035944872,2.48671238792219e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,40223,-0.0240222526504965,0.00431266731004431,-0.0324750805781833,-0.0155694247228096,2.60468440426091e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,0.0271143704743749,0.00487450960996296,0.0175603316388475,0.0366684093099023,2.72188141339224e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0327327272592378,0.0058869583004009,-0.0442711655280235,-0.021194288990452,2.7455331136476e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0293242686047339,0.00527808484795404,0.018979222302744,0.0396693149067238,2.81464833256347e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,-0.0212489779898831,0.00382495084180549,-0.0287458816398219,-0.0137520743399444,2.82310725885843e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.0187855750721467,0.00338157353209539,0.0121576909492397,0.0254134591950537,2.82550839062641e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,40532,0.0151298285741,0.00272462748532672,0.00978955870285963,0.0204700984453404,2.87148155494656e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,42475,0.0296137562606164,0.00534035419108494,0.01914666204609,0.0400808504751429,2.9908868619954e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,0.0460144101464951,0.00831523732675722,0.029716544986051,0.0623122753069393,3.19346406525441e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42638,0.0136627463259893,0.00247013960136256,0.00882127270731865,0.0185042199446599,3.24053467577843e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0224116345777834,0.00405431137636785,0.0144651842801024,0.0303580848754644,3.31359311257633e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,40539,0.0231433592255517,0.00419356481651836,0.0149239721851757,0.0313627462659277,3.48860577780153e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0335608886981223,0.00608429812473902,0.0216356643736339,0.0454861130226108,3.53222076184925e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,0.0492086882417673,0.00892104794885038,0.0317234342620205,0.066693942221514,3.54582506674711e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0237837249938524,0.00431444967160221,0.015327403637512,0.0322400463501927,3.6164416324189e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0208816161075998,0.0037916943379174,0.0134498952052817,0.0283133370099179,3.71281797110734e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0290293479166633,0.00527268127698584,0.018694892613771,0.0393638032195555,3.76120817162238e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,-0.0147477664323932,0.00267978373910458,-0.0200001425610382,-0.00949539030374827,3.7943895547932e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,-0.0366845749470694,0.00667067076309725,-0.04975908964274,-0.0236100602513987,3.88106678783895e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42721,0.0601043939358202,0.0109329670307384,0.0386757785555729,0.0815330093160674,3.92110452791604e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OPTC,Opticin,42587,-0.0256489392491112,0.00466969725714552,-0.0348015458731164,-0.016496332625106,4.03204508279413e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.0119624515397129,0.00217798784101745,0.00769359537131874,0.0162313077081071,4.05049912009079e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.0479970497976028,0.00875693919511394,-0.0651606506200261,-0.0308334489751794,4.30466375411881e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0241335418994838,0.00440651271519753,0.0154967769776966,0.032770306821271,4.42612445620474e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0217542944731898,0.00398827066701136,0.0139372839658475,0.029571304980532,4.99633485399816e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,40116,0.0217406522250826,0.00398872583779568,0.013922749583003,0.0295585548671621,5.13129050931507e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0270047485633384,0.00495711192449349,0.0172888091913311,0.0367206879353456,5.21200726445316e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0296325698667717,0.0054400182127307,0.0189701341698195,0.0402950055637239,5.22777469432278e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,0.0694033445129302,0.0127586476146696,0.0443963951881778,0.0944102938376826,5.43011021186858e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0166006313050758,0.00305562543946343,0.0106116054437274,0.0225896571664241,5.66315936217926e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42654,0.030535123403598,0.00562222590533223,0.0195155606291468,0.0415546861780491,5.69660487494388e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0820912137979729,0.0151641899454181,0.0523694015049534,0.111813026090992,6.28720969885872e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42636,-0.0204683831750817,0.00378288597051191,-0.0278828396772851,-0.0130539266728784,6.38243153726494e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,40466,0.0357907256647195,0.00661845951079459,0.0228185450235621,0.0487629063058769,6.51381805161277e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,40136,0.0295848136857681,0.0054753058062643,0.0188532143054901,0.0403164130660461,6.67916337431915e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42587,0.0248295963962494,0.00459741728467318,0.01581865851829,0.0338405342742089,6.74882628776768e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,0.0264633883578377,0.00490343201618247,0.01685266160612,0.0360741151095553,6.89516802708594e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,0.0148323775400271,0.00275245013028646,0.0094375752846656,0.0202271797953885,7.21192521552329e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,42216,0.0413313966999306,0.00767772876759851,0.0262830483154375,0.0563797450844237,7.44074402479786e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,0.041593265258761,0.00772899551012361,0.0264444340589187,0.0567420964586033,7.53979348878328e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.0615074064101803,0.0114317989658974,0.0391010804370213,0.0839137323833392,7.55775218267796e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,40483,0.0360329849307336,0.00671665004682043,0.0228683508389655,0.0491976190225017,8.26743763248367e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0233929842712822,0.00436147817638935,0.0148444870455591,0.0319414814970053,8.29628981416282e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0249405318804878,0.00465451097003446,0.0158176903792203,0.0340633733817553,8.56390056663273e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0291081275831273,0.00544803772485839,0.0184299736424049,0.0397862815238497,9.30133512345253e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.0472075658513721,0.00883691468206665,0.0298872130745215,0.0645279186282228,9.3673622543051e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,0.0404703655491892,0.00757755512439358,0.0256183575053778,0.0553223735930006,9.40657862653631e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,40199,0.0241578939625681,0.00452482200533656,0.0152892428321084,0.0330265450930277,9.5335426547995e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0189699889570872,0.00355449917624129,0.0120031705716543,0.0259368073425201,9.64319152974212e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.032353151518471,0.00606689746015101,0.0204620324965751,0.044244270540367,9.83461157153892e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0221150669218442,0.00414770511828832,0.0139855648899991,0.0302445689536893,9.90689199951906e-08
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42794,-0.0161659876034634,0.00303387246989324,-0.0221123776444541,-0.0102195975624727,1.00607301555629e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.0193921162090018,0.00364114954670516,0.0122554630974597,0.0265287693205439,1.02149146802971e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,42476,0.042880253114533,0.0080585325270568,0.0270855293615017,0.0586749768675643,1.04817947839214e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,42214,0.0444618748544736,0.00835952631927021,0.0280772032687039,0.0608465464402432,1.06236529299982e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.0780557976629118,0.0146761898134156,0.0492904656286172,0.106821129697206,1.06611862087354e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.020121416802416,0.00378354035765399,0.0127056777014141,0.0275371559034178,1.06900383599888e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,40223,0.0486891440432783,0.00917083326214319,0.0307143108494777,0.066663977237079,1.12289378613907e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,0.0291790612125785,0.00550083602852027,0.0183974225966787,0.0399606998284782,1.1520789199835e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.019553002413656,0.00368969103227322,0.0123212079904005,0.0267847968369115,1.18455015366236e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42754,0.032846718848386,0.00621519872601703,0.0206649293453926,0.0450285083513794,1.2772072567756e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0275531678426774,0.00521454574806923,0.0173326581764617,0.0377736775088931,1.28820205659624e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,40269,0.0313212318009536,0.00593135575088324,0.0196957745292225,0.0429466890726848,1.31186419564264e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0212025684255611,0.00402052316096987,0.0133223430300601,0.029082793821062,1.36257669498141e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,40199,0.0237580351779312,0.00451433691589796,0.0149099348227712,0.0326061355330912,1.44549818812982e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,40449,0.0188663538929472,0.00360223699075138,0.0118059693910745,0.0259267383948199,1.65794030588297e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,40283,0.0388138079949508,0.00742156021727144,0.0242675499690987,0.0533600660208028,1.72717731483361e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,-0.0317024607048713,0.00606642266793407,-0.0435926491340221,-0.0198122722757206,1.75896021297669e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0454271775039781,0.00872262471686413,0.0283308330589244,0.0625235219490317,1.93744444710124e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0423120021517223,0.00812771396934333,0.0263816827718094,0.0582423215316353,1.96553354184043e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0345520647338366,0.0066374502925534,0.021542662160432,0.0475614673072413,1.96799631847227e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,0.019887052488744,0.00382552569932819,0.0123890221180608,0.0273850828594273,2.0389754700859e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0179499053303973,0.00345939123081178,0.0111694985180062,0.0247303121427883,2.14806652309287e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.030393336318764,0.00586354622622715,0.0189007857153588,0.0418858869221692,2.2159563455229e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.0349905376633776,0.00675989704726224,0.0217411394507436,0.0482399358760116,2.30350537798247e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.0163805420086951,0.00316746583273072,0.0101723089765429,0.0225887750408473,2.35522608058364e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42594,0.0354860690592377,0.00686388601926021,0.0220328524614877,0.0489392856569878,2.3750496365363e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42689,0.025892813578886,0.00501568263369204,0.0160620756168496,0.0357235515409224,2.47307192058915e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,0.0414322392678789,0.00803002717202621,0.0256933860107075,0.0571710925250503,2.50954223390432e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,40449,0.0304542786168287,0.00590316432217948,0.018884076545357,0.0420244806883005,2.52530462035534e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,0.029758792493488,0.00577242552455008,0.0184448384653698,0.0410727465216061,2.57460064979973e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42611,0.0240799970312525,0.00467483064269868,0.0149173289715631,0.0332426650909419,2.6279013332308e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42676,-0.0333046304458395,0.00647601276253438,-0.0459976154604069,-0.0206116454312722,2.74514732615288e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.012209473160071,0.00237480631243594,0.00755485278769659,0.0168640935324455,2.76704266752242e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,0.0350745240665844,0.00683061112551021,0.0216865262605844,0.0484625218725844,2.86992588199664e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42597,0.0241161047270829,0.00470901489234063,0.0148864355380952,0.0333457739160705,3.0770589045724e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,42370,0.0248833089452539,0.00486565345245975,0.0153466281784328,0.034419989712075,3.19710055520285e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0344982557552676,0.00674697524701214,0.0212741842711238,0.0477223272394114,3.22032878738349e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42771,0.0158879679996718,0.0031077522015185,0.00979677368469554,0.0219791623146481,3.22475224407055e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.053328464020736,0.0104644544901499,0.0328181332200422,0.0738387948214299,3.52333080325801e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42638,0.0174029569296105,0.00341724060005586,0.010705165353501,0.02410074850572,3.57790427952455e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.0368728748283974,0.00724236919984637,0.0226778311966985,0.0510679184600963,3.61558238380561e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,0.0354415523751357,0.00696230767582014,0.0217954293305282,0.0490876754197432,3.62997194858359e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0262732988013564,0.0051671295863349,0.01614572481214,0.0364008727905728,3.74131453926943e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0197115723187635,0.00387725794347617,0.0121121467495502,0.0273109978879768,3.74844522209985e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,0.0143187619840113,0.00281673989941267,0.00879795178116242,0.0198395721868601,3.75607451574114e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,0.0450580374020381,0.00888337770393378,0.0276466171023279,0.0624694577017483,3.99704888883677e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42611,0.0196932921362531,0.00388420212195097,0.0120802559772292,0.027306328295277,4.0290654046032e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,40451,0.021515831549056,0.00424745643409258,0.0131908169382345,0.0298408461598774,4.13610197602741e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,0.0139321625254098,0.00275038811449618,0.00854140182099729,0.0193229232298223,4.13681394597191e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,0.0299276325195879,0.00591555147347184,0.0183331516315831,0.0415221134075927,4.26819311690208e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,0.046014040953189,0.00910744168990185,0.0281634552409814,0.0638646266653966,4.42246309087927e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.0472282081192503,0.00935122886976625,0.0288997995345084,0.0655566167039921,4.46534416673751e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.0473860923442797,0.00938465967306174,0.0289921593850787,0.0657800253034807,4.50319607655983e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,0.0268772968700439,0.00533004374795613,0.0164304111240498,0.0373241826160379,4.66486860508415e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,0.0336008407775498,0.00666423923929104,0.0205389318685394,0.0466627496865602,4.67901772504747e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,0.0175535946920297,0.00348244568662582,0.0107280011462431,0.0243791882378163,4.70275004082594e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,42292,0.0450740497815969,0.00894652356983504,0.0275388635847202,0.0626092359784736,4.76281769193385e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42676,0.0463086650981628,0.00919736596808881,0.0282818278007087,0.0643355023956169,4.84037962896869e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.0424206595872367,0.00842479623108942,0.0259080589743014,0.0589332602001719,4.84681732898954e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42495,0.0180283047362418,0.00359159692913201,0.0109887747551431,0.0250678347173406,5.24545229363385e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,-0.0177103066108837,0.00352898761117167,-0.0246271223287802,-0.0107934908929872,5.28815930716543e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.040000317769868,0.00797680761708012,-0.055634860699345,-0.0243657748403909,5.38276826253701e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42587,0.0167272195375656,0.00333712894219326,0.0101864468108669,0.0232679922642644,5.44254117415691e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,42261,0.0155335971322062,0.00309978915248994,0.0094580103933259,0.0216091838710865,5.48052561547237e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.0381908840436418,0.00765713058227468,0.0231829081023835,0.0531988599849002,6.18910257167639e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,40223,0.0263302500219875,0.00528243854824383,0.0159766704674296,0.0366838295765454,6.30701085873507e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0263952994285377,0.00530647888376868,0.0159946008163511,0.0367959980407243,6.64943776533296e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,0.0426460254578049,0.00858277253085977,0.0258237912973198,0.0594682596182901,6.81969957534401e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0377191026557965,0.0076108124944607,0.0228019101666536,0.0526362951449395,7.28385572353443e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,0.0451737631034091,0.00911736037475545,0.0273037367688884,0.0630437894379298,7.349071702394e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,0.0162394880233785,0.00327937315457788,0.00981191664040587,0.0226670594063512,7.43442060268603e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,0.0171758197122393,0.00348029084056596,0.01035444966473,0.0239971897597485,8.12441392504101e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.027228435151343,0.00552271555303164,0.016403912667401,0.038052957635285,8.31031310992771e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42636,-0.0350375575652747,0.00710736794811954,-0.048967998743589,-0.0211071163869604,8.33166249721954e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0343171989887051,0.00696740564788055,0.0206610839188592,0.047973314058551,8.5425088020899e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.052869314375924,0.0107507933036975,0.0317977595006769,0.0739408692511711,8.87914786338669e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,40483,0.0230268201299156,0.00468428392418392,0.0138456236385151,0.032208016621316,8.9682005760579e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42681,0.0360986637276477,0.00734423942171771,0.021703954461081,0.0504933729942144,8.97184355677796e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,42346,0.0273408049042971,0.00557922373922944,0.0164055263754074,0.0382760834331868,9.67482447544218e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,42346,0.0212026691739792,0.00432729739028047,0.0127211662890295,0.0296841720589289,9.71023045029553e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42721,0.0146631612967557,0.00299306501455494,0.00879675386822804,0.0205295687252834,9.74178669104381e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,-0.0159307076340601,0.00325388730757299,-0.0223083267569031,-0.00955308851121701,9.92081325834546e-07
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,0.0123547902378209,0.00253242760434236,0.00739123213330989,0.017318348342332,1.08042934199824e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,0.0225139471237812,0.00461789180047496,0.0134628791948503,0.0315650150527121,1.09871586325891e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,-0.00871566443394975,0.00178906205619105,-0.0122222260640842,-0.00520910280381529,1.11940923512032e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",40539,0.0082376225951377,0.00169319188963509,0.00491896649145293,0.0115562786988225,1.15911048849166e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,42311,0.0223597697873527,0.00459731977981799,0.0133490230189094,0.031370516555796,1.1657607630774e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,40014,0.0396845107096506,0.00816283917368006,0.0236853459292377,0.0556836754900636,1.18074125445612e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,0.0571637467093137,0.0117589833341234,0.0341161393744319,0.0802113540441955,1.1819838324006e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,-0.0295450138208033,0.00607849239752877,-0.0414588589199597,-0.0176311687216469,1.1861645022709e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.0169560045188356,0.00349023074754779,0.0101151522536419,0.0237968567840293,1.19851886568731e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42592,0.0323045386188463,0.00666663385394644,0.0192379362651113,0.0453711409725813,1.27576096311467e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42461,0.028555821630213,0.00589325412386131,0.0170050435474448,0.0401065997129811,1.27715066480173e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,-0.014869176846861,0.00307292062344212,-0.0208921012688075,-0.00884625242491444,1.32374284727686e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,0.0189351394471475,0.00391374901344038,0.0112641913808043,0.0266060875134906,1.32814316537401e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42664,0.0209064382032114,0.00432242745886014,0.0124344803838455,0.0293783960225773,1.33448719352013e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,40199,0.0131264220976025,0.00271408312700119,0.00780681916868016,0.0184460250265248,1.33995289606403e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,40302,0.0266656212714266,0.005517888589239,0.0158505596365182,0.037480682906335,1.36580286431449e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPART,Spartin,40283,0.0373885707928741,0.00773758943225048,0.0222228955056632,0.0525542460800851,1.36931271593298e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,-0.0290555595311847,0.00601946583793103,-0.0408537125735295,-0.0172574064888398,1.40199097841638e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42594,0.0324775169904582,0.006729656642778,0.0192873899706134,0.0456676440103031,1.40817720283923e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,42357,0.0688828295121549,0.0142879192420545,0.0408785077977281,0.0968871512265817,1.44397981409124e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,42311,0.0222359432959013,0.00462004983801538,0.0131806456133911,0.0312912409784114,1.50396370245721e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42654,0.0414294663621342,0.00861607043616824,0.0245419683072445,0.058316964417024,1.53793451359074e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,40199,0.0277092456659111,0.00576446322696721,0.0164108977410554,0.0390075935907668,1.55310302412119e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.015875284463865,0.00330441978030105,0.00939862169447495,0.0223519472332551,1.57320437185905e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0198612872859467,0.00413509487369949,0.0117565013334957,0.0279660732383977,1.58239939298136e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,0.0161097120559939,0.00335754301778551,0.00952892774113434,0.0226904963708536,1.61929819692337e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,40116,0.0282576588430742,0.00588955513281248,0.0167141307827617,0.0398011869033866,1.62437583963447e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0221771921327162,0.00462803885714881,0.0131062359727045,0.0312481482927278,1.66949109624504e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0154346468821735,0.00322262819132624,0.00911829562717404,0.0217509981371729,1.69408098928949e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,40283,0.0262260883369219,0.00548400632805496,0.0154774359339342,0.0369747407399096,1.7554339551845e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.0406731546223841,0.00852124441796019,0.0239715155631822,0.0573747936815861,1.83686360178604e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42587,0.0262448070614934,0.00552238615314206,0.0154209302013349,0.0370686839216518,2.03065639418211e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,0.0292074626096298,0.00614667189162013,0.0171599857020544,0.0412549395172053,2.04148651531035e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42611,-0.0114934718481799,0.00242049076230915,-0.0162376337423059,-0.00674930995405401,2.0714676664906e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,0.0293394000465289,0.00617878955817099,0.0172289725125138,0.041449827580544,2.07195257752946e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,0.0297993277149532,0.00627571569526629,0.0174989249522312,0.0420997304776751,2.07685050836025e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,0.028312311647591,0.00597085172308244,0.0166094422703494,0.0400151810248326,2.14098819756635e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,40182,0.0385823522302765,0.00814055460885359,0.0226268651969235,0.0545378392636296,2.16908993133306e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,42370,0.0373511733690889,0.00788528910434922,0.0218960067245644,0.0528063400136134,2.19365624209647e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0396138145631713,0.00836400299153258,0.0232203686997674,0.0560072604265751,2.19966907963193e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0269313835838169,0.005690068059182,0.0157788501878202,0.0380839169798136,2.23428382901781e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0265836166851253,0.00561942710730503,0.0155695395548074,0.0375976938154431,2.26568460012318e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LXN,Latexin,42461,-0.0321954320603835,0.00681139431693353,-0.0455457649215732,-0.0188450991991938,2.30540396808317e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0258438183247169,0.00546972345197795,0.0151231603588401,0.0365644762905936,2.33088777663839e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42636,0.016679082640481,0.00353325194396664,0.00975390883030635,0.0236042564506556,2.37518303651579e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,40182,0.0199588296497507,0.00423158654410429,0.0116649200233063,0.0282527392761951,2.42735642631167e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,40223,0.0138569704450609,0.00293868007239666,0.00809715750316344,0.0196167833869583,2.44226317079976e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,40516,0.0169931244332052,0.00360774138711284,0.00992195131446403,0.0240642975519464,2.504356683157e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,40267,0.0484216141618199,0.0103003938402671,0.0282328422348965,0.0686103860887433,2.62080689142509e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,-0.0126139305890004,0.00268338629137802,-0.0178733677201013,-0.00735449345789946,2.62259650013198e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,0.0171409209275056,0.00364754581026501,0.00999173113938619,0.024290110715625,2.64250946915436e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.028821240308488,0.00613715495774799,0.016792416591302,0.0408500640256741,2.68176349868868e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,0.0309256099402502,0.00659092468825799,0.0180073975512645,0.0438438223292359,2.72982293939206e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0185504923131512,0.00395754819403111,0.0107936978528503,0.0263072867734522,2.8008585334887e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,40527,0.039138801640685,0.00835133600235265,0.0227701830760738,0.0555074202052962,2.81110081833081e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,0.0204692300481225,0.00437367455035675,0.0118968279294232,0.0290416321668217,2.90183946374185e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.029599382521703,0.00632777168471337,0.0171969500196648,0.0420018150237412,2.93014910909409e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCT,Secretin,40182,0.0236611950709506,0.00505805126086105,0.013747414599663,0.0335749755422383,2.93246589006175e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,0.0230867123059944,0.00493698854254827,0.0134102147625998,0.032763209849389,2.95520958613353e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.0425076578045697,0.00909748211742365,0.0246765928544194,0.0603387227547201,3.01038828238423e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,40483,0.0329620568513713,0.00705458192267636,0.0191350762829257,0.046789037419817,3.01093701976061e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,0.0294270889042269,0.00630257632663465,0.0170740393040229,0.0417801385044308,3.06155240926406e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,40449,0.03558525138771,0.00763527714634666,0.0206201081808706,0.0505503945945495,3.188519435341e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0152230258600154,0.00327054895442835,-0.021633301810695,-0.00881274990933585,3.27738820469826e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0255136008395911,0.00548309076691212,0.0147667429364433,0.0362604587427388,3.30729628428769e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0201774782057426,0.00433852537403261,0.0116739684726387,0.0286809879388466,3.3455750828296e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,40449,0.0145289154181665,0.00313617993736287,0.00838200274093523,0.0206758280953977,3.65012669146445e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,-0.0073626470993781,0.00158986885144697,-0.0104787900482142,-0.00424650415054205,3.67987286505847e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42546,0.0261397317750239,0.00564544623444361,0.0150746571555145,0.0372048063945334,3.68698628148618e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,0.0276207672674753,0.00597213465825582,0.0159153833372939,0.0393261511976567,3.78190322076234e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,0.0110907270920574,0.00240327554351023,0.00638030702677733,0.0158011471573374,3.9700185805107e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0176809401782579,0.00383283788767953,0.010168577918406,0.0251933024381098,4.01245107889829e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,40283,0.0536382924419702,0.0116418811739896,0.0308202053409506,0.0764563795429899,4.12367515225659e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPARC,SPARC,42679,0.0323562666951551,0.00703218345843708,0.0185731871166185,0.0461393462736918,4.23954283808832e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,0.0174359259301093,0.00379660702809517,0.00999457615504273,0.0248772757051758,4.4194538796158e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,40483,0.0328500316512174,0.00715561837436161,0.0188250196374686,0.0468750436649661,4.46312863928585e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,0.0167710275374769,0.00365358367508663,0.00961000353430708,0.0239320515406467,4.46642013081324e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,0.0277476683265863,0.00604578765683516,0.0158979245191894,0.0395974121339833,4.48157584549372e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0237284560591477,0.0051708119921032,-0.03386324756367,-0.0135936645546255,4.50357821762449e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,-0.0283410873247857,0.00617697230504134,-0.0404479530426667,-0.0162342216069046,4.51214437420956e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,0.0288718764878243,0.00630303856789945,0.0165179208947414,0.0412258320809073,4.67723826721154e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,0.0201923628079831,0.00440838970677765,0.0115519189826989,0.0288328066332673,4.6898188550814e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0281187061284856,0.00614536791610183,0.016073785012926,0.0401636272440451,4.79134171995021e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DMD,Dystrophin,40223,0.0238186344317379,0.00520950590153973,0.01360800286472,0.0340292659987557,4.88002193337038e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0176425203787795,0.00386212414254168,0.0100727570593978,0.0252122836981612,4.9749486941258e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,-0.0125769145922397,0.00276022286021574,-0.0179869513982625,-0.00716687778621684,5.24761689223638e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,0.0237623332645968,0.00522114506002541,0.013528888946947,0.0339957775822466,5.39080928474233e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42554,0.0382950881071394,0.00842842459581771,0.0217753758993367,0.0548148003149421,5.5795665235649e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,-0.0117409043842957,0.00258941216365343,-0.0168161522250564,-0.006665656543535,5.84154560453392e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42594,0.030545202692344,0.00674345984663227,0.0173280213929447,0.0437623839917432,5.96045873798816e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,0.0269754132136349,0.00595924920061636,0.0152952847804269,0.038655541646843,6.05419063810566e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0284117281047412,0.00628410585282084,0.0160948806332123,0.04072857557627,6.20254014109713e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,0.0162294765316439,0.00359412636251601,0.00918498886111254,0.0232739642021753,6.37929397511198e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0121939550766065,0.00270377387418263,-0.0174933518700044,-0.00689455828320855,6.54856443660716e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,40182,0.0222824423975757,0.00494388329609735,0.0125924311372249,0.0319724536579265,6.6407513583508e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,0.0120934962702388,0.00268592137615579,0.00682909037297347,0.0173579021675042,6.77086711125981e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,0.0448390901328067,0.00997090880823605,0.0252961088686641,0.0643820713969494,6.95049438784028e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.0495294232819274,0.0110163691997922,0.0279373396503347,0.07112150691352,6.98403931906295e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,0.0147984139847734,0.00329165179578741,0.00834677646503003,0.0212500515045167,7.00189154405209e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,40511,0.0136080208957382,0.00302757637442911,0.00767397120185711,0.0195420705896192,7.03628233823733e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,40199,0.0192398902477704,0.00428532154862,0.0108406600124752,0.0276391204830656,7.20423976210041e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,0.0190080360058293,0.00423878693893758,0.0107000136055117,0.027316058406147,7.38987313512874e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,0.029703366193051,0.006624949178344,0.0167184658034968,0.0426882665826052,7.40273209405313e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,40451,0.0182980989716767,0.00408283805855104,0.0102957363769167,0.0263004615664368,7.47781501809021e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,0.0132970678687317,0.00296783168683984,0.0074801177625256,0.0191140179749378,7.51312927191147e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGMN,Legumain,42676,0.0160922792272571,0.0035918781582716,0.00905219803704474,0.0231323604174694,7.51919271517331e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.0413088395371885,0.00923601762954041,0.0232062449832893,0.0594114340910877,7.80537678876418e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,0.0279336999779974,0.00624631364018761,0.0156909252432297,0.0401764747127651,7.82372233451097e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,40527,0.0199170876591925,0.00445575725542237,0.0111838034385647,0.0286503718798204,7.89911803605268e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.0104523897320629,0.00234403206464316,0.00585808688536231,0.0150466925787635,8.29486453650451e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,0.0386828812757938,0.00867874310292163,0.0216725447940674,0.0556932177575202,8.38382206177763e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42679,0.0155089894537841,0.00348087143353022,0.00868648144406489,0.0223314974635034,8.43756971862978e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0218263191020315,0.00489842966387381,0.0122253969608388,0.0314272412432241,8.44161099025178e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,40532,-0.0262648158447866,0.00589961471881432,-0.0378280606936627,-0.0147015709959106,8.59052626922048e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,0.0389561471111887,0.008754495539374,0.0217973358540156,0.0561149583683617,8.6774950464683e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0104604657010925,0.00235192807781824,0.00585068666856879,0.0150702447336163,8.7656717739285e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,0.0162638474937296,0.00365841107452932,0.00909336178765218,0.0234343331998071,8.84817555752856e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,0.0235488433045158,0.00529892902910577,0.0131629424074685,0.0339347442015631,8.89742097416703e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,0.0113905726461583,0.00256481223783739,0.00636354065999698,0.0164176046323195,9.03507901665042e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,0.0580830326430893,0.0130846218758382,0.0324371737664465,0.0837288915197321,9.10827509215033e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,39042,0.0495014433610828,0.0111587849670339,0.0276302248256964,0.0713726618964693,9.25994511163361e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0303428822192731,0.00684064890175684,0.0169352103718297,0.0437505540667165,9.26677581007756e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0155712040861021,0.00351087625608557,0.00868988662417435,0.0224525215480298,9.27476738563326e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,40511,0.0239291516037036,0.00539618799711603,0.0133526231293561,0.034505680078051,9.3175940026059e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0127327978705573,0.00287151851825739,0.00710462157477284,0.0183609741663418,9.32994667898579e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,40223,0.0101565960206655,0.00229311127524469,0.00566209792118588,0.0146510941201451,9.550442829545e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,40250,0.029344906190033,0.00662634780988089,0.0163572644826664,0.0423325478973995,9.57935709735697e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42495,-0.0188606101986625,0.00426411157528047,-0.0272182688862123,-0.0105029515111128,9.80652375816829e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.0375289051050038,0.00848696442807603,0.0208944548259748,0.0541633553840329,9.8600227617128e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0104786031734486,0.00237125420409606,0.0058309449334203,0.0151262614134768,9.99264150692842e-06
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7,Complement component C7,40251,0.0146696288719907,0.0033353277438521,0.00813238649404058,0.0212068712499408,1.1014428643915e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0295409896710504,0.00672037646823173,0.0163690517933162,0.0427129275487846,1.11245828605893e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.014489391960854,0.00329714789733625,0.00802698208207491,0.020951801839633,1.11884305866596e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,40223,0.0134280631909789,0.00306021839343779,0.00743003513984079,0.0194260912421169,1.15491207664384e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42611,-0.0139653155665586,0.00318351329572824,-0.0202050016261859,-0.00772562950693125,1.15927876935349e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0181997796225794,0.00415952138386692,0.0100471177102003,0.0263524415349586,1.222702002529e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0255508309801177,0.00584082838094976,0.0141028073534561,0.0369988546067792,1.22635736170438e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0125724858962879,0.00287410182768833,0.00693924631401877,0.018205725478557,1.22853677230498e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.0531523722003904,0.0121517049109078,0.0293350305750111,0.0769697138257696,1.22902530188508e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,40283,0.024903071474811,0.00570154717130433,0.0137280390190545,0.0360781039305675,1.26658848733326e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,0.0314071510964925,0.00720213552820738,0.0172909654612061,0.045523336731779,1.30534290053154e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.0167581361294015,0.00384352516243,0.00922482681103875,0.0242914454477643,1.31157531731324e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,40532,0.0321493036173658,0.00737584821481999,0.0176926411163186,0.0466059661184129,1.31974154282765e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0191993222193574,0.00440859050935946,0.0105584848210129,0.027840159617702,1.34086199662668e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,0.0343884614686965,0.00790716373177629,0.018890420554415,0.049886502382978,1.37761153353128e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0183062594936077,0.00421096961167537,0.010052759054724,0.0265597599324914,1.39072869063186e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,0.0298509841733009,0.00687297572474708,0.0163799517527966,0.0433220165938052,1.4165567657697e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,0.0399334407369136,0.00922451938741075,0.0218533827375885,0.0580134987362387,1.50856839183219e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42636,0.0168721544803114,0.003901086579756,0.00922602478398968,0.0245182841766332,1.53639613386551e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0229658905421757,0.00531529083299733,0.012547920509501,0.0333838605748505,1.56854751482262e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,0.0128428561877605,0.00297280255260116,0.00701616318466224,0.0186695491908588,1.57274666963358e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42679,0.0250464668164145,0.00580262113669282,0.0136733293884966,0.0364196042443325,1.59721517532574e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,40471,0.0366582546131179,0.00849823851654385,0.0200017071206919,0.0533148021055438,1.61962836842709e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0208698061959631,0.00483944748853452,0.0113844891184354,0.0303551232734907,1.62837477169732e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42594,0.0155554883845075,0.00360827798133133,0.00848326354109811,0.0226277132279169,1.63637447461288e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,0.0351613730484974,0.00817367755311029,0.0191409650444013,0.0511817810525936,1.70889852999093e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,40449,0.0157347271647626,0.00366899806871986,0.00854349095007167,0.0229259633794535,1.81333257465903e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,40483,0.0586384053268021,0.0136781089986545,0.0318293116894392,0.085447498964165,1.82585082636369e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,40483,-0.0161808004175516,0.00377439719270552,-0.0235786189152544,-0.00878298191984874,1.82614966118754e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.0390276490025642,0.00910465609273052,0.0211825230608124,0.056872774944316,1.82972571048408e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0308053821319741,0.00718856183720269,0.0167158009310568,0.0448949633328913,1.8376129385538e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,0.0150426660300239,0.00351044185619592,0.00816219999187988,0.0219231320681679,1.83907643341068e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42587,-0.00658631885942487,0.00153963663207149,-0.00960400665828499,-0.00356863106056476,1.90025304681144e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,0.0133882245770258,0.00313491913006114,0.00724378308210602,0.0195326660719457,1.96513777244118e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,42261,-0.038308150860311,0.00898758955613668,-0.0559238263903389,-0.0206924753302831,2.03717611357286e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,42311,0.0309865232254753,0.00728271782721647,0.016712396284131,0.0452606501668195,2.10686274629542e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,0.0185377798921922,0.0043637294999199,0.00998487007234918,0.0270906897120352,2.17005885244122e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,0.0232300376702356,0.00547441548946344,0.0125001833108872,0.0339598920295839,2.21688544613262e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,42347,0.0184286230863874,0.00434813747020503,0.00990627364478554,0.0269509725279892,2.26775093529233e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSPN,Persephin,42594,0.0396281214713283,0.00935575851532612,0.0212908347812891,0.0579654081613675,2.29369479377727e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,42370,0.0203644462714603,0.00482332188226136,0.010910735382228,0.0298181571606925,2.4368321026509e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.0469987164154104,0.0111322549013946,0.0251794968086771,0.0688179360221438,2.43894185443721e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,0.0375296374887263,0.00889188367181406,0.0201015454919707,0.0549577294854818,2.45193531367403e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0161226629693874,0.00382297032998173,0.00862964112262318,0.0236156848161516,2.4919388909333e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,0.0290488876383952,0.00691074776875883,0.0155038220116279,0.0425939532651626,2.64954850451592e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,40302,0.0128050658696845,0.00304645824623865,0.00683400770705677,0.0187761240323123,2.65153695385457e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42676,0.0328029328668737,0.00780527461923731,0.0175045946131685,0.0481012711205788,2.65493505064199e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,0.0318836953750151,0.00759676855312652,0.0169940290108871,0.0467733617391431,2.72536232008971e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42604,0.038656817161579,0.00921594966625127,0.0205935558157266,0.0567200785074315,2.75164439476267e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.048466654901644,0.011586681446639,0.0257567592662315,0.0711765505370565,2.89567667636669e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,42292,0.0256347090373639,0.00613077332540558,0.0136183933195689,0.0376510247551588,2.91710048658486e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,0.0185929034678683,0.00445545863396075,0.00986020454530527,0.0273256023904314,3.02838616552487e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42495,0.0183675974613009,0.00441164675206251,0.00972076982725835,0.0270144250953434,3.15472804788813e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42771,-0.0197846321066644,0.00476128798016589,-0.0291167565477896,-0.0104525076655393,3.26835696440091e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,0.00976304365953986,0.00235118410559452,0.00515472281257459,0.0143713645065051,3.31069793124295e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.0222924715962468,0.00536952682685883,0.0117681990156035,0.0328167441768901,3.32498497568036e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,0.0124419497350817,0.00299786587450737,0.00656613262104728,0.0183177668491162,3.34584636354845e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0235549986932341,0.00567962936623215,0.0124229251354191,0.0346870722510491,3.38985658049604e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.0449501727077782,0.010840696116258,0.0237024083199126,0.0661979370956438,3.40170871785948e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42636,0.027912292647365,0.00673951879117494,0.0147028358166622,0.0411217494780679,3.47021151936084e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,0.0230709853306415,0.00557847727143562,0.0121371698786277,0.0340048007826553,3.55996877526845e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0285445459438998,0.00690274845589583,0.0150151589703439,0.0420739329174556,3.56740515192639e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,0.0120792759138453,0.00293047464993593,0.00633554559997088,0.0178230062277197,3.77963647781999e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,0.0229942307244862,0.0055787145406057,0.012059950224899,0.0339285112240733,3.78633929995648e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,42311,0.0297174639596193,0.00722013601691744,0.0155659973664612,0.0438689305527775,3.8800563468515e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,0.0279229879836876,0.00678844453507335,0.0146176366949438,0.0412283392724313,3.92354050088286e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C3,Complement C3,39989,0.0196382916641805,0.00477797691622368,0.0102734569083821,0.0290031264199789,3.98294117559148e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.0484709873424318,0.0118171615950574,0.0253093506161192,0.0716326240687443,4.12931234666172e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEXN,Nexilin,40532,0.0286121154488403,0.00697848627657508,0.0149342823467532,0.0422899485509275,4.15949022337983e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,0.0467800226874303,0.0114201628936543,0.0243965034158678,0.0691635419589928,4.22799140445087e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,0.0464709550638835,0.0113845126131459,0.0241573103421176,0.0687845997856495,4.49192181758459e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,42357,0.0182444212227595,0.0044710224044224,0.00948121731009162,0.0270076251354274,4.51859727913229e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.0340227224300353,0.00834270777476935,0.0176710151914873,0.0503744296685832,4.56592115699717e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,0.00761907985874186,0.0018702598509172,0.00395337055094416,0.0112847891665396,4.65652056155275e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0149414467599872,0.00366857806668346,0.00775103374928766,0.0221318597706868,4.67170935948316e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,0.009016971368815,0.00221815913742451,0.00466937945946296,0.0133645632781671,4.82901482828523e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,42311,0.0148702011621082,0.00365840619389211,0.00769972502207962,0.0220406773021367,4.83816977867459e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,0.0163478252302371,0.00402288234140884,0.00846297584107574,0.0242326746193984,4.8626951827836e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,42357,0.0317944879330972,0.00783532758652886,0.0164372458635007,0.0471517300026938,4.98151540520178e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0141047441336298,0.00347737467619271,0.00728908976829211,0.0209203984989676,5.02252192468758e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,40483,0.0378226069617229,0.00933500164443845,0.0195260037386235,0.0561192101848223,5.11877779995539e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42611,0.0210502337573663,0.00519680771283789,0.010864490640204,0.0312359768745285,5.13720301852392e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0191424772113108,0.00472730788752878,0.00987695375175437,0.0284080006708672,5.16579541745156e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,0.0197685001603629,0.00488304574390579,0.0101977305023075,0.0293392698184182,5.1916660143035e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42679,0.0230314561195704,0.00569466904712724,0.011869904787201,0.0341930074519398,5.27517465415017e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0175540432497979,0.0043452109477383,0.00903742979223083,0.026070656707365,5.37865101435114e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,0.0199188235476909,0.00493606681123764,0.0102441325976651,0.0295935144977167,5.48783804581696e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.0334084512653379,0.0082817372481156,0.0171762462590313,0.0496406562716444,5.51996673102648e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,-0.0256703676072439,0.0063642877966746,-0.0381443716887261,-0.0131963635257617,5.53258772187303e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,0.00936401843612068,0.00232511030637381,0.00480680223562802,0.0139212346366133,5.67168714075846e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0231976251119361,0.00576615456033464,0.0118959621736802,0.034499288050192,5.78247308041269e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,40449,0.0413579516351047,0.0102900517566546,0.0211894501920616,0.0615264530781478,5.87722472567819e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,0.0190494875106126,0.00475157423234665,0.00973640201521313,0.028362573006012,6.12863048004704e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,42292,0.0147846673653786,0.00369093568081512,0.00755043343098099,0.0220189012997763,6.21838099633582e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.0353020103827014,0.00881657541277936,0.0180215225736539,0.052582498191749,6.26030503067531e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0213082509453776,0.00532729064392695,0.0108667612832808,0.0317497406074744,6.38020594680068e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.01962015143783,0.00490925155054427,-0.0292422844768968,-0.00999801839876326,6.46847581073816e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,0.03416763158245,0.00856407584007069,0.0173820429359114,0.0509532202289885,6.65974062026199e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,0.0357855036722895,0.00898196640103666,0.0181808495262576,0.0533901578183213,6.80805077878455e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42636,-0.0189149561148128,0.00474896757360348,-0.0282229325590756,-0.00960697967054996,6.84202856439013e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,40436,0.0353379441370856,0.00887203833368417,0.0179487490030646,0.0527271392711065,6.84596300762385e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,40483,0.0335347074454834,0.00841980321231785,0.0170318931493404,0.0500375217416263,6.85246140617187e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0165343097100907,0.00415408310617276,0.00839230682199213,0.0246763125981893,6.9273518007524e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42679,0.0247803820376941,0.00622723062306405,0.0125750100164886,0.0369857540588997,6.94631629045682e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42679,0.00878923195190438,0.00221167967836118,0.00445433978231647,0.0131241241214923,7.10412760179925e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.032046217405855,0.00806435437812688,0.0162400828247263,0.0478523519869837,7.11831820138394e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0229620756573209,0.00578069461263753,0.0116319142165514,0.0342922370980905,7.15811348227338e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42618,0.00974262442874793,0.00245562170664364,0.0049296058837264,0.0145556429737695,7.30148683696765e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,-0.0193895799416316,0.00488823891639492,-0.0289705282177657,-0.00980863166549755,7.32913363193507e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.11863871681832,0.0299132291452526,0.0600087876936246,0.177268645943015,7.34389322733109e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,0.0223281658571715,0.00563456782686775,0.0112844129165107,0.0333719187978323,7.45702479913335e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,40451,0.0280829426512561,0.00709581322388711,0.0141751487324374,0.0419907365700748,7.61468539607012e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00841188925986683,0.00212707205601414,-0.0125809504896545,-0.00424282803007911,7.71163209480807e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,40482,0.0103264710493586,0.00261140130055787,0.00520812450026522,0.0154448175984521,7.72022131578057e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,40283,0.0427441783669105,0.0108280023221856,0.0215212938154266,0.0639670629183943,7.94396649418264e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTD,Biotinidase,40539,0.00820270133805536,0.00208136234920766,0.00412323113360835,0.0122821715425024,8.16208140333465e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42563,0.0258078113406313,0.00655016825644069,0.0129694815580076,0.038646141123255,8.18881212704341e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,0.0206375785508485,0.0052403956127748,0.0103664031498099,0.0309087539518871,8.25283394052101e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0180818502653016,0.00459457166314407,0.0090764898055392,0.0270872107250639,8.34496997536085e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,42434,0.0298021148664929,0.00757950508912948,0.0149462848917991,0.0446579448411867,8.46943780013389e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,42357,0.0269358298094698,0.00685368334828191,0.0135026104468373,0.0403690491721024,8.53360850054592e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.035162789086199,0.00895888702478155,0.0176033705176271,0.0527222076547708,8.72801754376961e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.0386206501076945,0.00986026926397819,0.0192945223502973,0.0579467778650918,9.01875911450579e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0303226201993331,0.00774311331858637,0.0151461180949038,0.0454991223037624,9.05331668634336e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,0.0256274820497006,0.0065447485164011,0.0127997749575545,0.0384551891418468,9.05754543710313e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,40532,0.00948664762446147,0.00242566293191176,0.00473234827791442,0.0142409469710085,9.24696556809833e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,0.0165046911515121,0.00423394854766255,0.00820615199809346,0.0248032303049307,9.73909561260814e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,42311,0.0194156817320675,0.00498122144157379,0.00965248770658293,0.0291788757575522,9.7563379944385e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,40463,0.0386344414936985,0.00991207822169551,0.0192067681791753,0.0580621148082217,9.76675868726055e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,0.0108332977832619,0.00278077268285938,0.00538298332485752,0.0162836122416663,9.84453000841852e-05
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.0175555962609765,0.00452098825647598,-0.0264167332436695,-0.00869445927828363,0.000103611257535709
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.037995222464511,0.00978640048076963,0.0188138775222026,0.0571765674068195,0.000103997804556286
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,42370,0.0332003287463092,0.00855674205978813,0.0164291143091244,0.0499715431834939,0.000104956356881336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,0.036239986578974,0.0093467689799809,0.0179203193782115,0.0545596537797366,0.000106133516752615
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,0.0112598610289745,0.00290875605601508,0.0055586991591849,0.016961022898764,0.000108990160790325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.0117768961490749,0.00304911436936451,0.00580063198512047,0.0177531603130293,0.00011280832159471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.0347801113088182,0.00901246641075476,0.0171156771437389,0.0524445454738975,0.000114432134583169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,42141,-0.0125531912717274,0.00325320485816904,-0.0189294727937388,-0.0061769097497161,0.000114537662027005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,0.033810732924565,0.00876659428252602,0.016628208130814,0.050993257718316,0.000115535622724105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0283310024939284,0.00734683736143785,0.0139312012655102,0.0427308037223466,0.00011579281981169
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,0.028930471777929,0.00750298867108201,0.0142246139826083,0.0436363295732498,0.000115875757076204
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0219608270139534,0.00569702574647228,0.0107946565508678,0.0331269974770391,0.000116380990371621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42794,0.00979627431001698,0.00254739651810928,0.00480337713452279,0.0147891714855112,0.000120804898758091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,40532,0.0353386918359287,0.0091904801569891,0.01732535072823,0.0533520329436273,0.000121141984006842
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,0.0233531610524416,0.00607578279995573,0.0114446267645284,0.0352616953403548,0.000121781279676666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42594,-0.0167369394945541,0.00435472179014237,-0.0252721942032331,-0.00820168478587506,0.000121901554878146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0185444535373254,0.004830988783971,0.00907571552074225,0.0280131915539086,0.000124293375031304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42597,0.0395740751755263,0.0103160370976143,0.0193546424642023,0.0597935078868502,0.000125540594910773
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAX,Protein max,42311,0.0403111489794385,0.0105310331885668,0.0196703239298476,0.0609519740290295,0.000129871350539653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,0.0450882327556633,0.0117920023678753,0.0219759081146276,0.0682005573966989,0.00013223304527398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,0.00837647689123686,0.00219196612369439,0.00408022328879586,0.0126727304936779,0.000133402504690943
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,-0.0105913478401507,0.00277406647630037,-0.0160285181336994,-0.00515417754660193,0.000135267621681342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,0.0266916025126208,0.00699472285350066,0.0129819457197595,0.0404012593054821,0.000136258740533686
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0264508313159743,0.00693394582690213,0.0128602974952462,0.0400413651367025,0.000137094366611273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,0.0316800197074989,0.00832118603435513,0.0153704950801629,0.047989544334835,0.000141333453493606
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.0249164425727672,0.00656171790448441,-0.0377774096655566,-0.0120554754799777,0.000146956302988236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,0.0173429605627391,0.00460038941973753,0.00832619730005356,0.0263597238254247,0.00016416581011152
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.0343044090981076,0.009106575847369,0.0164555204372643,0.0521532977589508,0.000166086994237384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,0.0173747620196797,0.00461500426574865,0.00832935365881236,0.0264201703805471,0.000167357552507442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.021604087285507,0.00574473007266607,-0.0328637582279325,-0.0103444163430815,0.00017017296338885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.0321105714334516,0.0085664876770377,0.0153202555864577,0.0489008872804455,0.000178858403447939
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,0.0166306899612021,0.00444043957516836,0.00792742839387216,0.0253339515285321,0.000180960973199517
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,40451,-0.0437193481551863,0.0116752841715024,-0.066602905131331,-0.0208357911790416,0.000181576997214947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,40283,0.0216672203199578,0.00579092067639923,0.0103170157942153,0.0330174248457003,0.000183785898278312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0259221046951107,0.00693189799045032,0.0123355846338281,0.0395086247563933,0.000185300079081751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0260699987020649,0.0069779780874624,0.0123931616506386,0.0397468357534912,0.000187893710402043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,42311,0.0193662768990994,0.00518914766328151,0.00919554747906768,0.0295370063191312,0.000190712484046164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,40116,0.0145443408869073,0.00390495030590699,0.00689063828732962,0.022198043486485,0.000196617392404625
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,40080,0.0209465198586996,0.00562772095337067,0.00991618679009313,0.0319768529273062,0.00019862685969498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,40451,0.0308915503540814,0.00830997670607063,0.014603996010183,0.0471791046979798,0.000202255492355563
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42663,0.00938303445778587,0.00252613442673415,0.00443181098138694,0.0143342579341848,0.000204521679869099
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,-0.0155357970036722,0.00418280075720733,-0.0237340864877986,-0.00733750751954588,0.000204675998768039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,0.0443754111912478,0.0119581129969654,0.0209375097171956,0.0678133126653,0.000207530217696361
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,42370,0.0123491550843824,0.0033287802680225,0.00582474575905831,0.0188735644097065,0.000208264171460784
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42573,0.02588559908084,0.00698134456236067,0.0122021637386131,0.0395690344230669,0.000209892033202941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.0408226269512242,0.0110099648515122,0.0192430958422604,0.0624021580601881,0.000209914773721873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,40449,0.0129136091422184,0.00348461618155578,0.00608376142636912,0.0197434568580678,0.000211658298242758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,0.0170640171122182,0.00460489878965868,0.00803841548448717,0.0260896187399492,0.000211879575909743
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0310272428158281,0.00838138980059992,0.0145997188066523,0.047454766825004,0.000214825656870651
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,0.0268205666759888,0.00725144213800801,0.0126077400854931,0.0410333932664845,0.00021763291013495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,40116,0.0203370110987271,0.0054992817348993,0.00955841889832448,0.0311156032991297,0.000218265583717982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,-0.00684805290726319,0.00185317034320176,-0.0104802667799386,-0.00321583903458773,0.000220647419470041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,0.0110188288738207,0.00298337038106026,0.0051714229269426,0.0168662348206988,0.000222305524442824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.020064635401087,0.00543661929376666,0.00940886158530434,0.0307204092168697,0.000224570955192072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.0401051633456896,0.0108661803720404,0.0188074498164904,0.0614028768748888,0.000224583449175952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,42448,0.0251215392549591,0.00680937099730292,0.0117751721002454,0.0384679064096729,0.000225807312891762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0246740223537492,0.00669091346176865,0.0115598319686826,0.0377882127388157,0.000227359834564498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0204713192770978,0.00555630260123381,0.00958096617867958,0.0313616723755161,0.000230402287090964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.0338612893236261,0.00920090799298351,0.0158275096573784,0.0518950689898738,0.000234153410643402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,40449,0.0163210480141936,0.00443726638931451,0.0076240058911372,0.0250180901372501,0.000236002280364883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,-0.00821013297731774,0.00223671982748248,-0.0125941038391834,-0.00382616211545208,0.000243105117048853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,42370,0.0298670742645233,0.00813816541193902,0.0139162700571228,0.0458178784719238,0.000243506890915802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,40527,0.0363221312043868,0.00990020364370785,0.0169177320627194,0.0557265303460542,0.00024478315199522
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.0264361851187158,0.0072121351523813,0.0123004002200485,0.0405719700173832,0.000247789427015325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,-0.0118297374817344,0.0032294719987922,-0.0181595025993672,-0.00549997236410174,0.000250384535979728
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,42475,-0.0120638537343906,0.00329539542328032,-0.01852282876402,-0.00560487870476114,0.000252383226722281
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,0.030931412696944,0.00846208268900804,0.0143457306264883,0.0475170947673998,0.000257858647296853
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42711,0.0104769822581746,0.00286631804177967,0.00485899889628646,0.0160949656200628,0.000257949472765716
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.0357863772008649,0.00980902053735518,0.0165606969476487,0.055012057454081,0.000265154401873439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42611,0.0241249846066668,0.00661427085296358,0.0111610137348582,0.0370889554784754,0.000265895970485867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLU,Clusterin,40539,-0.0116440226534501,0.00319456267377746,-0.017905365494054,-0.00538267981284632,0.000268638308639221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0140774056543182,0.00386621969319386,0.00649961505565819,0.0216551962529781,0.000272658899229096
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,-0.00939746082333593,0.00258190664686731,-0.0144579978511959,-0.00433692379547599,0.000273940236330214
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,0.0136057830150205,0.00373910945636931,0.00627712848053663,0.0209344375495043,0.000275204171797329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0167745486550866,0.00461667712449396,0.0077258614910784,0.0258232358190947,0.000280907318231781
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0270654059654365,0.00745872303002127,0.0124463088265948,0.0416845031042782,0.000286139617799941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,40182,0.0251017964769061,0.00694883830256362,0.0114820734038814,0.0387215195499308,0.000304761034617316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,40116,0.014652597129954,0.00405954920586554,0.00669588068645751,0.0226093135734504,0.000308261516774542
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,0.0106867166206957,0.00296632011909975,0.0048727291872602,0.0165007040541312,0.000316295085578293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0255151581238616,0.00708637503393159,0.0116258630573557,0.0394044531903676,0.000318849525841828
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,-0.00859517952954485,0.00238969458093102,-0.0132789809081696,-0.00391137815092006,0.000323352081566559
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,40449,0.0221303705023908,0.00615504563503419,0.0100664810577238,0.0341942599470578,0.000325174016222521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00731218939601777,0.00203713999272234,-0.0113049837817536,-0.00331939501028198,0.000332564110732411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0276485248548887,0.00770490550196297,0.0125469100710412,0.0427501396387361,0.000334105278605536
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42611,0.0266644328458416,0.00743184896264802,0.0120980088790514,0.0412308568126317,0.000334590336774066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,40539,-0.00835760140796581,0.00233194564273915,-0.0129282148677345,-0.00378698794819708,0.000339842513710255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,0.0163791011276063,0.00457300765464293,0.00741600612450614,0.0253421961307064,0.000342612419636528
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGN,Biglycan,42328,-0.0433774084601726,0.0121123599020267,-0.0671176338681449,-0.0196371830522002,0.000343187261832801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0203423102705215,0.00568589434509216,0.00919795735414086,0.0314866631869021,0.000348113531030325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42594,0.0146642800186039,0.00410309013245431,0.0066222233589935,0.0227063366782144,0.000352858018338529
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,40482,0.0105956772691716,0.00296521054308389,0.00478386460472722,0.0164074899336161,0.000353938795910236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.0121265684866077,0.00339567456084785,0.00547104634734596,0.0187820906258695,0.00035688809097875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,0.0146809299510894,0.00411974465650155,0.00660623042434632,0.0227556294778324,0.000367144098760058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.0423438496287895,0.0119290528414416,0.0189629060595639,0.065724793198015,0.000387071703254763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0200327705468966,0.00564484421151402,0.00896887589232913,0.0310966652014641,0.000388494029828123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,0.041284669052441,0.0116370332730686,0.0184760838372265,0.0640932542676554,0.000389938875070203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,0.0107923673186019,0.00304367505583836,0.0048267642091587,0.0167579704280451,0.000392706316029867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0173521714031974,0.00491790484994563,0.00771307789730394,0.0269912649090908,0.000419834104413236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0185222128143556,0.0052517298831204,0.0082288222434396,0.0288156033852716,0.000421925968191234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,42346,0.0205327736101048,0.00582478779909798,0.00911618952387273,0.0319493576963368,0.000424813358249178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,-0.0157495722447817,0.00446993553980857,-0.0245106459028065,-0.00698849858675687,0.000427703603872724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0225963784985942,0.00641409967281548,0.0100247431398758,0.0351680138573125,0.000428496017907165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,40449,0.021357378941209,0.00607616374312341,0.00944809800468712,0.0332666598777309,0.000441574823890712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPL,Periplakin,40199,0.0118230995741266,0.00337610798102532,0.00520592793131695,0.0184402712169362,0.000463626550355182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,0.022216659442292,0.00636580286603803,0.00973968582485744,0.0346936330597265,0.000484909455399442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,0.0073193583304495,0.00210006533654916,0.00320323027081315,0.0114354863900859,0.000493499921553654
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAT,Catalase,40361,0.0191611900292576,0.00549922763592427,0.00838270386284607,0.0299396761956692,0.000495240491677052
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.024198601545966,0.00694609682856888,0.010584251761971,0.037812951329961,0.00049633045168061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,0.0174167463229567,0.00501124930223802,0.00759469769057015,0.0272387949553432,0.000511806378514428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,40235,0.014640326674745,0.00421636152617788,0.00637625808343634,0.0229043952660536,0.000518061611773352
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0156605216889546,0.00452901140076814,-0.0245373840344602,-0.0067836593434491,0.000546566012540763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0195171051960232,0.00564482064222073,0.00845325673727056,0.0305809536547758,0.000546856121772757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0174808440337055,0.00505765996297108,0.00756783050628219,0.0273938575611288,0.000549691531136014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.0170095651753895,0.00496252153650542,-0.0267361073869401,-0.0072830229638389,0.000610752165527568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,0.0202301092442571,0.00590355693444319,0.0086591376527484,0.0318010808357657,0.0006129988379131
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,42311,0.0147645136502109,0.00431962187335242,0.00629805477844011,0.0232309725219816,0.000632723051353491
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42618,0.0126379263849717,0.00370204704946162,0.00538191416802693,0.0198939386019165,0.000642606704731013
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0252298796025328,0.00739397789572431,0.0107376829269131,0.0397220762781524,0.000646675077094863
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0148523074398728,0.00435533554297432,0.00631584977564311,0.0233887651041024,0.000651240758747068
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,0.0261552796028865,0.00767170518123572,0.0111187374476645,0.0411918217581085,0.00065360634043187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42794,0.0296400497943348,0.0087099292067769,0.0125685885490521,0.0467115110396175,0.000668379165148426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.0156177820743783,0.00458985024037495,-0.0246138885455132,-0.0066216756032434,0.000669606267830435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,0.0142837628443539,0.00420046996967926,0.00605084170378258,0.0225166839849253,0.00067456344302636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.0128025731347692,0.00376873503631191,0.0054158524635978,0.0201892938059405,0.000683559789793926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,0.0155853770029082,0.00459082707721604,0.00658735593156476,0.0245833980742516,0.000688540764761374
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.0407808176478213,0.0120366556412913,-0.0643726627047523,-0.0171889725908903,0.000705949920371856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,42346,0.0225547099143802,0.0066605027047049,0.00950012461315859,0.0356092952156018,0.000710395632285986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0160643588981191,0.00474544520488443,0.00676328629654561,0.0253654314996926,0.000713644509587465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,0.0125699074887593,0.00371427808428803,0.00528992244355474,0.0198498925339638,0.00071591676890841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42689,0.0153645625353061,0.00454041052779782,0.00646535790082243,0.0242637671697899,0.000716519991197603
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,0.00777942909385591,0.00229911635734477,0.00327316103346015,0.0122856971542517,0.00071769649780992
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,0.0204104950752795,0.00603351309306175,0.00858480941287843,0.0322361807376805,0.000719795084487324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42587,0.027671793349982,0.00819775454165411,0.01160419444834,0.0437393922516241,0.000738820538185481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,0.0228444350839055,0.00676882411332098,0.00957753982179634,0.0361113303460146,0.00074078123727277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.0402880076417387,0.0119489772091518,0.0168680123118011,0.0637080029716762,0.000749248732654895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,0.0253314764521721,0.00751464920864576,0.0106027640032264,0.0400601889011178,0.000751658647589342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.024060436464299,0.00713893313901939,-0.038052745416777,-0.010068127511821,0.000753353317332172
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,0.00996809656349132,0.00295913869288147,0.00416818472544363,0.015768008401539,0.000758136474376191
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0240160661629887,0.00715366036169842,-0.0380372404719176,-0.00999489185405978,0.000790042826775017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.0115785558929119,0.00344928145592655,-0.018339147546528,-0.00481796423929591,0.000791180679545086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0198484785235301,0.00591349675458616,0.00825802488454126,0.031438932162519,0.000791651892805166
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0206716152164209,0.00616130720306518,0.00859545309841313,0.0327477773344286,0.000795631544771615
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,40482,0.025788752547021,0.0076990166850079,0.0106986798444055,0.0408788252496365,0.000811886296379325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,0.0176938172885781,0.00530002027995831,0.00730577753985983,0.0280818570372964,0.000845282002757698
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0182638771867558,0.0054718280425717,0.00753909422331527,0.0289886601501963,0.000847169646047768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,-0.0197925448310777,0.00593417056448972,-0.0314235191374776,-0.00816157052467785,0.000854651001958506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42734,0.0230976064723133,0.00693613258172188,0.00950278661213841,0.0366924263324882,0.000870651632287802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42587,-0.0258875331439171,0.00778564033129199,-0.0411473881932494,-0.0106276780945848,0.000886446338255047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,0.0153784358286835,0.00462642179920138,0.00631064910224876,0.0244462225551182,0.000890137252847974
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42636,0.0101109108031399,0.00304699164675856,0.00413880717549308,0.0160830144307866,0.000907993573840254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,0.0188512891996096,0.00568480207550854,0.00770907713161291,0.0299935012676064,0.000915346913508355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.00973603181789428,0.0029437003348829,0.00396637916152379,0.0155056844742648,0.000944062734591903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRL,Prolactin,42711,0.0249155738356142,0.00753425713785608,0.0101484298454163,0.0396827178258121,0.000945564549495333
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0200149096716125,0.00606663965503374,0.0081242959477464,0.0319055233954786,0.000972748802117323
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00963275458398572,0.00292247210050618,0.00390470926699362,0.0153607999009778,0.000983411512550113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42689,0.0159237327735764,0.00483205280586071,0.00645290927408942,0.0253945562730634,0.000985216327116024
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0202682092710103,0.00615285600315211,0.00820861150483212,0.0323278070371884,0.000990447330867861
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.00975782588473404,0.00297078655870695,0.0039350842296684,0.0155805675397997,0.00102389498277342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42591,0.00821827365651888,0.00250458641719555,0.0033092842788156,0.0131272630342222,0.00103597731983982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,0.026530198100887,0.00809350734602924,0.0106669237026697,0.0423934724991043,0.001048878024156
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0166692228327081,0.005096001219722,0.00668106044205295,0.0266573852233632,0.00107429411753315
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42794,0.00647624473252501,0.00198085563016542,0.0025937676974008,0.0103587217676492,0.00108036826534207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.00998350199495954,0.00305473360201713,0.00399622413500597,0.0159707798549131,0.0010856310892535
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,40483,0.0173130913505801,0.00529783842036062,0.00692932804667326,0.0276968546544869,0.00108651839132103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,0.0103852937970231,0.00318190467148103,0.00414876064092031,0.0166218269531259,0.00110185807176295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,0.0128075253230895,0.0039277202947791,0.00510919354532247,0.0205058571008565,0.00111434785626792
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,40482,0.0206635345763008,0.00633963053723627,0.00823785872331767,0.0330892104292838,0.00111969785679383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,42357,0.0275228339424661,0.00845652418935587,0.0109480465313286,0.0440976213536036,0.00113827953844395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,0.0185002783386088,0.00568686691057865,0.00735401919387465,0.029646537483343,0.00114417281985889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,0.0109705002724652,0.00337782897902844,0.00434995547356951,0.017591045071361,0.00116591276843933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,0.0118228663837482,0.00364019576964292,0.00468808267524811,0.0189576500922483,0.00116625349614875
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,40511,0.0233905076153233,0.00720890409398784,0.00926105559110713,0.0375199596395395,0.00117928679603982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0115578770249006,0.00357627710637717,-0.0185673801533999,-0.0045483738964014,0.00123366530247259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,0.0157039195670652,0.00486567631946941,0.0061671939809051,0.0252406451532252,0.00125187542685385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0159143623105773,0.00493079049088973,0.00625001294843339,0.0255787116727211,0.00125213597097755
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,0.0321942082620118,0.00998577557076696,0.0126220881433085,0.051766328380715,0.00126769810265365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,0.0131756149123361,0.0040902811136262,0.0051586639296288,0.0211925658950435,0.00127965472677454
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0229677687842461,0.00714137882152867,0.00897066629404989,0.0369648712744423,0.00130294116109184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0203041095337816,0.00633188928053156,0.00789360654393979,0.0327146125236235,0.00134678007153471
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.0205794381773561,0.00642832520264369,-0.0331789555745377,-0.00797992078017444,0.00137165748502606
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,40451,0.0170122103927571,0.0053202380958136,0.00658454372496248,0.0274398770605518,0.00138940023524871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.0319481095234048,0.00999141787506468,0.012364930488278,0.0515312885585316,0.00138992305755245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0125135059319811,0.00391994143259163,0.0048304207241015,0.0201965911398607,0.00141557567360729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,40116,-0.0129874623818784,0.00406952504900757,-0.0209637314779333,-0.0050111932858236,0.00141988282646584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,40483,-0.0252421321358051,0.00791244134103323,-0.0407505171642302,-0.00973374710737992,0.00142571784182159
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0278742659799814,0.00874921573174242,0.0107258031457663,0.0450227288141966,0.00144699312324889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,40460,0.0296250049492172,0.0093003964342671,0.0113962279380537,0.0478537819603807,0.00144973699815982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,42357,0.0153024583260848,0.00480645991653294,0.00588179688968026,0.0247231197624894,0.00145730261790666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42543,-0.0160580337579571,0.00505155865366776,-0.025959088719146,-0.00615697879676832,0.00148209516884904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42721,0.0138044246907672,0.00434646342502386,0.0052853563777204,0.0223234930038139,0.00149649399406866
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,40199,0.013108461364,0.00413129256675779,0.00501112793315476,0.0212057947948453,0.00151303802298226
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,0.0209082048312543,0.0065919375230451,0.00798800728608592,0.0338284023764227,0.00151844432841084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,-0.0134921863112146,0.00426361825648443,-0.0218488780939241,-0.00513549452850516,0.00155766247649838
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,0.0159930668062637,0.00506746236367859,0.0060608405734537,0.0259252930390738,0.00160353653863432
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,0.0150754200810439,0.00480927186167836,0.00564924723215435,0.0245015929299335,0.00172495260405501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42666,-0.00876876898760302,0.00279839752289158,-0.0142536281324705,-0.00328390984273553,0.00173107452497856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),40324,-0.0577634934001755,0.0184401329327977,-0.0939061539484589,-0.0216208328518921,0.00173781103250724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0287901152027583,0.00919229612986503,0.0107732147882228,0.0468070156172937,0.0017408086303125
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,0.0227072126086184,0.00725965342634531,0.0084782918929816,0.0369361333242552,0.00176527989119825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0161113558093722,0.00515899349959557,0.00599972855016491,0.0262229830685795,0.0017941860020823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.0296652647905606,0.00950117526747413,0.0110429612663113,0.0482875683148099,0.00179915009279174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0180707560815027,0.00579341542039225,0.00671566185753389,0.0294258503054715,0.00181741562828899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,0.0177890519923152,0.00570393390447859,0.00660934153953721,0.0289687624450933,0.00182103814662003
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,0.0220271273642429,0.00706446872881812,0.00818076865575942,0.0358734860727265,0.00182538002131299
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42636,0.0127622033694345,0.00410453900250062,0.00471730692453334,0.0208070998143357,0.00187929168843874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,40451,0.0144676201376208,0.00465783929939657,0.00533825511080357,0.0235969851644381,0.00190056851254596
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42611,0.0281061176566742,0.00905920263246838,0.0103500804970362,0.0458621548163122,0.00192296200858404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42594,0.0121289549070431,0.00391582469202818,0.00445393851066786,0.0198039713034183,0.00195616311490909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,40136,0.0199422678693166,0.00645177916898381,0.00729678069810836,0.0325877550405249,0.0020000367249293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,0.0390608806058004,0.012637090315445,0.0142921835875283,0.0638295776240725,0.00200005121902538
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,40080,-0.0148350523292918,0.00481730198098075,-0.0242769642120141,-0.00539314044656956,0.00207840070910607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,-0.00816659268140016,0.00265410323974651,-0.0133686350313033,-0.00296455033149701,0.00209630883925917
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,-0.0105532496932453,0.00343057603518635,-0.0172771787222105,-0.00382932066428007,0.00210055413875217
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,0.0108417098434147,0.0035280682028235,0.00392669616588066,0.0177567235209488,0.00212360393875308
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,40511,0.00833444796879267,0.00271692079359055,0.00300928321335519,0.0136596127242302,0.00216289136792745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,40527,-0.0304488837954792,0.00993455836042506,-0.0499206181819123,-0.0109771494090461,0.00218221250523025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,42370,0.00912547067513822,0.00299096849325639,0.00326317242835569,0.0149877689219208,0.00228527574960999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.00770168098696576,0.00252572759247284,0.002751254905719,0.0126521070682125,0.00229829232382764
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,40532,-0.00776091724447911,0.00255077965630781,-0.0127604453708424,-0.00276138911811579,0.00235106491066839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0113832264776657,0.00375213058463112,0.00402905053178875,0.0187374024235427,0.00242055012564094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0269673187791889,0.00889763510593316,0.0095279539715599,0.0444066835868179,0.00244447269263638
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,0.0119528072247473,0.00395562724274667,0.00419977782896382,0.0197058366205308,0.00251904216318791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0144736306260504,0.00479017772394999,0.0050848822871084,0.0238623789649924,0.00252070275095976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,0.021373988401719,0.00707860437573698,0.00749992382527451,0.0352480529781635,0.0025374286825245
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0221171596369784,0.00732580748226234,0.00775857697174426,0.0364757423022126,0.00254035405394207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,42249,0.0314972719933602,0.0104347712901112,0.0110451202647422,0.0519494237219782,0.00254526509556329
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,0.0119803956650868,0.00397210724567504,0.00419506546356371,0.0197657258666099,0.00256611619550986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.0262639470884643,0.00870798790005405,0.00919629080435839,0.0433316033725703,0.0025664983213238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,40116,-0.0106799318774877,0.00354211282314401,-0.0176224730108499,-0.00373739074412542,0.0025745903321247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,40384,0.0135817447973464,0.00451385248047821,0.00473459393560908,0.0224288956590837,0.00262776279112753
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBN1,Drebrin,40199,0.0152104529803742,0.00505515386969519,0.00530235139577162,0.0251185545649768,0.00262788702913503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,0.0180648362858202,0.0060041774291574,0.00629664852467172,0.0298330240469687,0.00262846043862094
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,40375,0.0299584739529149,0.00995725344523289,0.0104422572002584,0.0494746907055714,0.00262944907728989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,40199,-0.00935412031213233,0.0031174490376702,-0.0154643204259659,-0.00324392019829875,0.00270079588890809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MB,Myoglobin,42794,0.0160002176915083,0.00535142941375866,0.00551141604054127,0.0264890193424752,0.00279571721953942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,-0.0084567891619936,0.0028312757371679,-0.0140060896068427,-0.00290748871714452,0.00282421280501586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,40136,-0.0127383513681008,0.00426629888142777,-0.0211002971756992,-0.00437640556050237,0.00283455632387301
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.00947343212477513,0.00317415904223043,-0.0156947838475468,-0.00325208040200348,0.00284605254665488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLG,Plasminogen,40285,0.00647641202293671,0.00217102961377793,0.00222119397993198,0.0107316300659414,0.00285959838619013
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,0.00974999837013464,0.00326907773636241,0.00334260600686432,0.016157390733405,0.00286419026145514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,0.0283174871060338,0.00950480602519441,0.00968806729665271,0.0469469069154148,0.00289551676200325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0117684133844696,0.00395511391239393,-0.0195204366527617,-0.00401639011617751,0.00293158520670011
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42495,0.00981067757611035,0.00329785661418458,0.00334687861230857,0.0162744765399121,0.00293644178782411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.0240945231674528,0.00812387650038079,0.00817172522670643,0.0400173211081991,0.00302440340786697
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0130096714627358,0.0043933390415126,0.00439872694137108,0.0216206159841005,0.00307056176387955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,0.0162240218772696,0.00548155742174335,0.00548016933065265,0.0269678744238866,0.00308548164853187
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,40283,0.0134443977140792,0.00454320495827756,0.00453971599585513,0.0223490794323032,0.00309058635974954
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0195617247700329,0.00661975036490455,0.00658701405481996,0.0325364354852458,0.00313283191859959
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0184118111555188,0.00623174920965717,0.00619758270459073,0.0306260396064468,0.00313826682329292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,0.0165768337503108,0.0056121706786757,0.00557697922010647,0.0275766882805152,0.00314513792401475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFB,Complement factor B,40344,0.00967113908376654,0.0032768253653363,0.0032485613677074,0.0160937167998257,0.00317021604843615
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,40199,0.012284625993983,0.00416337200764704,0.00412441685899477,0.0204448351289712,0.00317781103532817
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,0.0146053594944244,0.00496390776653881,0.00487610027200832,0.0243346187168404,0.00326340808035157
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42611,-0.0132402210083361,0.00450068592999329,-0.022061565431123,-0.00441887658554929,0.00326844272840384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,40284,-0.0091970000825342,0.00313866287042292,-0.0153487793085631,-0.00304522085650528,0.00339403229485559
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42597,0.0120932557682496,0.0041323660444848,0.0039938183210594,0.0201926932154398,0.00343405416029416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42611,-0.0148570047312267,0.00508100369228191,-0.0248157719680992,-0.00489823749435411,0.00346109813158999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,0.0117441861788364,0.00402119604571172,0.00386264192924141,0.0196257304284313,0.00349978082218597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0126604688809803,0.00433606815870832,0.004161775289912,0.0211591624720486,0.00350848507460584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,40199,0.0147818367704245,0.00506319050690741,0.00485798337688598,0.024705690163963,0.00351337132317398
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,40451,0.0115562125435442,0.0039642744438874,0.00378623463352491,0.0193261904535635,0.00356288151930288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0162552924477807,0.00558358911724533,0.00531145777797985,0.0271991271175815,0.00360677907537439
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,0.0365836005720589,0.0125736913185967,0.0119391655876093,0.0612280355565085,0.00362685675877012
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0122387670960605,0.00422649085484831,0.00395484502055781,0.0205226891715632,0.00378904948868261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.0307199813917535,0.0106207011130236,0.00990340721022722,0.0515365555732797,0.00382976892481885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,0.00743819139452256,0.00257218180170891,0.0023967150631731,0.012479667725872,0.00383671324169095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0113719794647521,0.00393414633354994,0.00366105265099423,0.01908290627851,0.00385279003886704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,0.0175949920579984,0.00611073171238418,0.00561795790172541,0.0295720262142714,0.00399258244183741
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,40451,-0.0162637550733898,0.00565197163185013,-0.0273416194718161,-0.00518589067496356,0.00401547177235493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGN,Cingulin,40182,0.0120217354277578,0.00417861734840634,0.00383164542488132,0.0202118254306342,0.00402293290519231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,40483,0.0112954412571873,0.0039269989487704,0.00359852331759733,0.0189923591967773,0.00403050853466455
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42646,0.0161508756674927,0.00562332962107507,0.00512914961018554,0.0271726017247998,0.00408365758906809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,-0.00718322202087681,0.00250558898993858,-0.0120941764411564,-0.0022722676005972,0.00415193585239475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0204900717315533,0.00715366442593918,0.00646888945671249,0.0345112540063941,0.00418733981393403
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0191498978764769,0.00668841553154835,0.00604060343464209,0.0322591923183116,0.00420122634578407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0143226724613515,0.00501634483490783,0.00449063658493211,0.0241547083377708,0.00430769052419577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,0.0101196023263816,0.00354686031613648,0.00316775610675407,0.0170714485460091,0.00433603809533468
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,0.0159137344278593,0.00557817656826731,0.00498050835405538,0.0268469605016632,0.00434072300633526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,0.0145918623896835,0.00512310989124735,0.00455056700283867,0.0246331577765283,0.00440294541076572
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,0.00997772995790385,0.0035089549070818,0.00310017834002351,0.0168552815757842,0.00446890057301865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.016469268246488,0.00579456098820807,0.00511192870960019,0.0278266077833758,0.00448714427248976
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,0.00621510742479084,0.00219036674943216,0.0019219885959038,0.0105082262536779,0.00455404447497081
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,0.0214416795781985,0.00756296563265417,0.00661826693819629,0.0362650922182006,0.0045895676949553
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.00810756394710124,0.00286352700526798,0.00249505101677599,0.0137200768774265,0.00464245875153975
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,0.00706848386280529,0.00250802734792528,0.00215275026087173,0.0119842174647388,0.00483575347030645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.0111485883009726,0.00395849247529523,0.00338994304939393,0.0189072335525512,0.00486564534408428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.0164225063220062,0.00583506469510987,0.00498577951959088,0.0278592331244216,0.00489321813016335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,40199,0.0141878908415161,0.00504098704853536,0.0043075562263868,0.0240682254566454,0.00489389236550651
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,40511,0.0181222118731403,0.00643989154084795,0.00550002445307833,0.0307443992932023,0.00490052015267435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0130155938008439,0.00463118252860211,0.00393847604478373,0.022092711556904,0.00495640783865674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,0.00966079159924617,0.00344479461186828,0.00290899415998434,0.016412589038508,0.00504742116801487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0112524593950874,0.00401418199277567,-0.0191202561009277,-0.00338466268924705,0.00506903659662933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,0.00802548875161156,0.00286352985479559,0.00241297023621221,0.0136380072670109,0.00507701136561338
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0208199524176021,0.00743261556593828,0.00625202590836306,0.0353878789268411,0.00509934713158055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0106819209011959,0.00381596438808917,0.00320263070054109,0.0181612111018506,0.00513052028329474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,0.0203488421826707,0.00727324983447697,0.00609327250709583,0.0346044118582455,0.00515301324005957
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42652,0.0107767863523793,0.00386195367334432,0.00320735715262445,0.0183462155521342,0.00527005783665324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,0.0278673871705821,0.00999623234763336,0.00827477176922068,0.0474600025719434,0.00531607437222105
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,0.0146696591453148,0.00527745202729093,0.00432585317182457,0.025013465118805,0.00544865188286635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,-0.0118538159735292,0.00426548258291679,-0.0202141618360461,-0.00349347011101231,0.00546004326733069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,42262,0.0129370813117361,0.00467149921647514,0.00378094284744487,0.0220932197760274,0.00562450770747494
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,-0.0111728209885825,0.00403556410150916,-0.0190825266275405,-0.00326311534962457,0.00563767528011755
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42681,0.0192746491341695,0.00697069873283409,0.00561207961781467,0.0329372186505243,0.00569834295122002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0225649455068929,0.00816394173250033,0.00656361971119226,0.0385662713025936,0.00571795881923408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,40383,-0.00842147825103333,0.00304911774928142,-0.0143977490396249,-0.00244520746244176,0.00575528941320559
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00812074639630948,0.0029428321130845,-0.0138886973379551,-0.00235279545466387,0.00579860853207061
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.0233920143936191,0.00848470284813387,0.00676199681127669,0.0400220319759615,0.00584213431068184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,40539,-0.00542238983539266,0.001967580609315,-0.00927884782965005,-0.00156593184113527,0.00586302934814735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42594,0.0164773830934652,0.00598442592830086,0.00474790827399548,0.0282068579129349,0.0059063310329847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0100841014422279,0.00366545713373339,-0.0172683974243453,-0.00289980546011042,0.00594727863776388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.0179443779577819,0.00652581522423026,-0.0307349757972732,-0.00515378011829058,0.00597381837566935
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.00917541777407833,0.00333895098889467,-0.0157197617123119,-0.00263107383584477,0.00600410308078531
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,0.0236284838288469,0.00862491766012928,0.00672364521499355,0.0405333224427003,0.00616025188078237
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42636,-0.0325068881789818,0.0119117924978321,-0.0558540014747327,-0.00915977488323098,0.00636156930077045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,40269,0.0112738120121578,0.00414386614172644,0.00315183437437398,0.0193957896499416,0.00652648279629032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0110762249950994,0.00408027166078637,0.00307889253995815,0.0190735574502407,0.00664632496489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,0.0211454673321647,0.0077951565822267,0.00586696043100034,0.036423974233329,0.00668527729231797
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42611,0.0326352967750232,0.0120639040393861,0.00899004485782648,0.0562805486922199,0.0068349066194892
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,42237,-0.0191423524732407,0.00708942888476699,-0.033037633087384,-0.00524707185909743,0.00694026074235328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,-0.0151767032916163,0.00562564244027059,-0.0262029624745467,-0.00415044410868595,0.00698925639533773
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0197101091295256,0.00730608052800776,0.00539019129463041,0.0340300269644208,0.00698942646684545
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,40116,0.0173090664901028,0.00642131412497332,0.00472329080515511,0.0298948421750505,0.00703770827394545
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0120077233492524,0.00446289504019534,0.00326044907046955,0.0207549976280353,0.00714371567186947
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIM,Vimentin,42357,0.0314648573918321,0.0117052447552324,0.00852257767157651,0.0544071371120876,0.00719504813053526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,0.0258449625686662,0.00962174790965915,0.00698633666573424,0.0447035884715981,0.00723807902152703
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,0.0146868150343189,0.00547978811546527,0.00394643032800694,0.0254271997406308,0.00736743964036097
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,40182,0.0141234803496265,0.00526981921184336,0.0037946346944135,0.0244523260048395,0.00737166908549291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,-0.00859144743588644,0.00320721298135523,-0.0148775848793427,-0.00230530999243019,0.00739988877237933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,0.0256317639719354,0.00957173475842275,0.00687116384542675,0.044392364098444,0.00742039676539207
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,-0.00827677393249056,0.00310318873591811,-0.0143590238548901,-0.00219452401009106,0.00765834620608346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,40223,-0.0145914109642589,0.005486418236823,-0.025344790708432,-0.0038380312200858,0.00783578898045476
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0175648954360761,0.00661798133217403,0.00459365202501505,0.0305361388471372,0.00796117886177386
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00557398529689921,0.00210668058326607,-0.0097030792401007,-0.00144489135369772,0.00815998887902564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42505,-0.0345628841067882,0.0130636892019028,-0.0601677149425176,-0.00895805327105885,0.00816126951912019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.0107165029633778,0.00405246446072213,0.00277367262036247,0.0186593333063932,0.00819418600987405
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.00844725040757839,0.00319531752012381,-0.0147100727470211,-0.00218442806813572,0.00821153521065895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.0200522125554747,0.00759404927942025,0.00516787596781096,0.0349365491431384,0.00828775376136759
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,42311,0.0183821743887632,0.00697489553423513,0.00471137914166234,0.0320529696358641,0.0084118036416935
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42495,-0.00899518155619557,0.00341401481549084,-0.0156866505945576,-0.00230371251783352,0.00842891436403215
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00728605770151939,0.00276741025137085,0.00186193360883252,0.0127101817942062,0.00847972279416777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.0127241142441222,0.00483819903737064,-0.0222069843573687,-0.00324124413087575,0.00855231470080518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,42303,0.0285489874406121,0.0108637382420295,0.00725606048623429,0.0498419143949898,0.00860099092303576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,0.0185952507469171,0.00709225627623239,0.00469442844550158,0.0324960730483326,0.00875600461627119
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,42311,-0.0140644926982773,0.00536561295621071,-0.0245810940924503,-0.00354789130410434,0.00877148383583346
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,40136,0.0117365261282795,0.00449127943020827,0.00293361844507132,0.0205394338114878,0.00898265026897837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,0.0161043063791501,0.00617235305802931,0.00400649438541262,0.0282021183728875,0.00909028393467182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,40527,-0.0139396712639128,0.0053430916654157,-0.0244121309281275,-0.00346721159969798,0.0090949117356258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00857438454981217,0.00329062145372911,0.00212476650050312,0.0150240025991212,0.00918060884353173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42721,0.00652763175211732,0.00250711722111732,0.00161368199872737,0.0114415815055073,0.00923402232738184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.0161631952736103,0.00621622656597209,0.00397939120430502,0.0283469993429156,0.00932828135356548
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,0.0194567142917093,0.00749563778786502,0.0047652642274939,0.0341481643559248,0.00944917881537043
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_DRA,,42549,0.00964624337867555,0.00371635434757072,0.00236218885743695,0.0169302978999142,0.00945237682529005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.00815696917252083,0.00315053563136048,0.00198191933505428,0.0143320190099874,0.00963611311873851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0154787774646152,0.00598684699060407,0.00374455736303122,0.0272129975661992,0.00973511720480296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,40116,0.015694500172326,0.00607718025740068,0.00378322686782066,0.0276057734768313,0.00982077412313978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,0.0126046057009166,0.00488409753254602,0.00303177453712637,0.0221774368647068,0.00986952579783263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42559,0.0188342236873044,0.0072999530662642,0.00452631567742652,0.0331421316971822,0.00988925339600824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0113233352098985,0.00439348647824516,-0.019934568707259,-0.00271210171253797,0.00997032914451856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.0146284063444961,0.00567763250947887,-0.0257565660630746,-0.00350024662591747,0.00999152192130131
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,0.00907799412556336,0.00353067422042082,0.00215787265353855,0.0159981155975882,0.0101481969065407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,40136,-0.0239300709844398,0.00931312713460461,-0.0421838001682649,-0.00567634180061479,0.0101976906366727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,-0.00922141585029485,0.00358913720285831,-0.0162561247678971,-0.00218670693269257,0.0102026345368326
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42626,-0.0171449358042281,0.00667951858493037,-0.0302367922306916,-0.00405307937776457,0.0102751449893983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,0.0208599389886493,0.00813295164919347,0.00491935375623007,0.0368005242210685,0.0103346754903985
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,0.0208046578564145,0.00812353089895471,0.00488253729446329,0.0367267784183657,0.0104471001126381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,0.0103480409220091,0.00405402762015566,0.00240214678650405,0.0182939350575142,0.0107077490047084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,42311,0.0156222468794583,0.00614800915079307,0.0035721489439039,0.0276723448150127,0.0110642104367492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,40449,0.0170540262407458,0.00671562789338944,0.00389139556970253,0.0302166569117891,0.0111159122494506
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,0.0269533872384427,0.0106349382877778,0.00610890819439817,0.0477978662824872,0.0112768005459872
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,-0.00653749510665884,0.00259553462712173,-0.0116247429758174,-0.00145024723750025,0.0117888480246729
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42734,0.00873929551665004,0.00347470085277968,0.00192888184520187,0.0155497091880982,0.0119106148279465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00659954134788712,0.00263288029673101,0.00143909596629435,0.0117599867294799,0.0122021060999839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRTN,Neurturin,42370,0.0124246477510574,0.00495813449392458,0.00270670414296525,0.0221425913591496,0.0122255659939763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42570,0.0167362374731336,0.00668194582378791,0.0036396236585093,0.0298328512877579,0.0122674959594198
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.0278907906081329,0.0111376377615417,0.00606102059551114,0.0497205606207547,0.0122851596471953
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.0131104921911492,0.0052355089265175,-0.0233720896871235,-0.00284889469517487,0.0122865230044328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0168577807422178,0.006732825238177,0.00366144327539092,0.0300541182090448,0.0122982375709601
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,42357,0.0134546266395546,0.00537976346834284,0.00291029024160259,0.0239989630375065,0.0123974232336583
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0103407378371265,0.00414432272802415,0.00221786529019912,0.0184636103840538,0.0126043109893186
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.018438248856677,0.00740562109083056,0.00392323151864909,0.0329532661947049,0.012797304616442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,-0.00993882416988295,0.00399425562586112,-0.0177675651965707,-0.00211008314319516,0.012848595999927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0153010296272837,0.00615120502706452,0.00324466777423723,0.0273573914803301,0.0128796524724541
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0219622538784455,0.00883875565682301,0.00463829279107243,0.0392862149658186,0.0129759328637408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.0074402184828039,0.00299643022793327,0.0015672152360547,0.0133132217295531,0.0130414817958964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42611,-0.0164929841716035,0.00665296870071896,-0.0295328028250127,-0.00345316551819437,0.0131857983016254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,0.00777343947163753,0.00313700602222705,0.00162490766807251,0.0139219712752026,0.0132252865957674
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,40384,0.00790440040151323,0.00319163309665901,0.00164879953206157,0.0141600012709649,0.0132786939614203
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42679,-0.00700258094315885,0.00283132259315301,-0.0125519732257388,-0.00145318866057895,0.013401109883921
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42711,-0.00581202395507951,0.00235678058428213,-0.0104313139002725,-0.00119273400988653,0.0136721676854859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0144848896606441,0.00587391953093876,0.00297200738000414,0.0259977719412841,0.0136770591337056
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,-0.0105455395030466,0.00427745527634733,-0.0189293518446873,-0.00216172716140578,0.0137022320090811
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0143900029809828,0.00584480624512634,0.00293418274053517,0.0258458232214304,0.013828582621865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42531,0.0113067223944781,0.00459717922475778,0.00229625111395287,0.0203171936750034,0.013926005014195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0064057497262776,0.00260971557759091,0.00129070719419941,0.0115207922583558,0.0141175985946206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42594,0.00772781735996884,0.0031496844139514,0.0015544359086241,0.0139011988113136,0.0141591626230897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,0.0120406601778049,0.00492072081044542,0.00239604738933183,0.0216852729662779,0.0144208455068149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00748349788432111,0.0030606202765332,-0.0134823136263262,-0.00148468214231603,0.0144971803410005
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,40283,-0.0134964088846584,0.00553675163805315,-0.0243484420952426,-0.00264437567407425,0.0148005578442039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0199103809652471,0.00818328463993606,0.00387114307097246,0.0359496188595218,0.0149850202329871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,0.0191248002473524,0.00786075754206905,0.00371771546489706,0.0345318850298078,0.0149895180777913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42611,0.0130599059237177,0.00539032401862018,0.00249487084722219,0.0236249410002133,0.0154127521575723
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',40116,0.0106336599593774,0.00439011369515577,0.00202903711687209,0.0192382828018827,0.0154437348539344
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,42154,0.0090982186647444,0.00375981384538056,0.0017289835277985,0.0164674538016903,0.0155401999594909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0246137016497595,0.0101792181707261,0.00466243403513628,0.0445649692643828,0.0156208479317757
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.0225828375006848,0.00935625090443128,0.00424458572799954,0.0409210892733701,0.0158063884501293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0203859714192679,0.00844703906877792,0.00382977484446314,0.0369421679940726,0.015821271952389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,0.00866047387467294,0.00358948592090349,0.0016250814697021,0.0156958662796438,0.0158469601850208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.00722677774433377,0.00299892186152989,0.00134889089573519,0.0131046645929323,0.0159751463997968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42794,0.0174109070871419,0.00724335047368309,0.00321394015872304,0.0316078740155607,0.0162429810629084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,42357,-0.0094362660869964,0.00392944816786307,-0.017137984496008,-0.00173454767798478,0.0163452366231931
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,0.0119199756221045,0.00496754783400794,0.00218358186744893,0.0216563693767601,0.0164278853397837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,40199,0.0299271552156822,0.0124722694347788,0.00548150712351584,0.0543728033078486,0.0164341995270822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.00622912260877199,0.00259793631184826,0.0011371674375494,0.0113210777799946,0.0165140145052016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,-0.00765348199515786,0.00319305273785618,-0.013911865361356,-0.00139509862895975,0.0165471903569889
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,0.00785925055702996,0.00328193326910975,0.00142666134957485,0.0142918397644851,0.0166500238819404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.0414712810281656,0.0173277899505545,-0.0754337493312525,-0.00750881272507879,0.0167096410933112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42587,-0.00671562003710393,0.00280608657280224,-0.0122155497197963,-0.00121569035441154,0.0167142975971384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0126442558872571,0.00528628826218246,0.0022831308933795,0.0230053808811347,0.0167778626660779
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0121018457674078,0.00506816252748871,0.0021682472135299,0.0220354443212856,0.0169651598612791
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,40199,0.0151049034994554,0.00633371309893719,0.00269082582553855,0.0275189811733723,0.0171032983606347
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42603,0.00968691449526072,0.00406916157932459,0.00171135779978451,0.0176624711907369,0.0172998714473184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,42381,0.0110548607627649,0.00465058386534689,0.00193971638668502,0.0201700051388448,0.0174639661128774
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,0.0123387828692849,0.00519560300919639,0.00215540097125999,0.0225221647673099,0.0175702945266336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,0.0123494722755679,0.00520199449877114,0.00215356305797644,0.0225453814931593,0.0176143123386431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.0237350643282913,0.0100123930527906,0.00411077394482173,0.0433593547117609,0.0177774496258666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,40482,0.011626390518825,0.00490496979721882,0.00201264971627617,0.0212401313213739,0.0177889845523372
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,0.0206358605496516,0.00870789013578209,0.00356839588351866,0.0377033252157844,0.0178122446907155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42770,0.0142033212668887,0.00600752705006818,0.00242856824875502,0.0259780742850223,0.0180804036559032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,40199,0.0106782501570672,0.0045238859903149,0.00181143361604994,0.0195450666980844,0.0182718261099473
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,40182,0.0145719974087162,0.00617486055139582,0.00246927072798042,0.026674724089452,0.0182976914119408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0106640375741688,0.00453411252378307,0.00177717702755403,0.0195508981207836,0.0186925914906414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRNN,Cornulin,42209,-0.0163631103969752,0.0069631209467587,-0.0300108274526222,-0.00271539334132815,0.0187898847313228
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,40482,0.0074970375064926,0.00319277788326859,0.00123919285528617,0.013754882157699,0.0188854154185281
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,0.0135987706737536,0.00579344861467241,0.00224361138899563,0.0249539299585115,0.0189289289882422
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,0.00834936328458385,0.00357578898421563,0.00134081687552122,0.0153579096936465,0.0195599030092113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.00890209515923229,0.00381449295329866,0.00142568897076693,0.0163785013476977,0.0196232257462328
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0152693364327419,0.00655968497027334,0.00241235389100613,0.0281263189744776,0.0199431374302078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42587,0.0172802192210305,0.00743104536662435,0.0027153703024468,0.0318450681396142,0.0200649644779863
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,40267,-0.0071330595170626,0.00306764416107511,-0.0131456420727698,-0.00112047696135539,0.020076225803025
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,40223,0.0274903844167483,0.0118405495416269,0.00428290731515955,0.050697861518337,0.0202663966378548
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.00889693603643335,0.00384701326663826,0.00135679003382236,0.0164370820390443,0.0207577696672048
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,40539,0.0119204596645132,0.00516314518880867,0.00180069509444821,0.0220402242345782,0.0209748236207326
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,40182,0.012374144520255,0.00536605520996265,0.00185667630872818,0.0228916127317818,0.021128934958047
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42754,-0.00919035897463379,0.00399460938853877,-0.0170197933761698,-0.0013609245730978,0.0214242448292866
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,-0.00656304280351659,0.00285356024744871,-0.0121560208885161,-0.00097006471851711,0.0214663116601943
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,-0.011776208718454,0.00514730111365031,-0.0218649189012086,-0.0016874985356994,0.0221651621160787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,40116,0.0165665354327985,0.00725530693240449,0.00234613384528572,0.0307869370203113,0.0224278190597498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.0232970231890587,0.0102823318230552,0.0031436528158706,0.0434503935622469,0.0234870090149095
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.0211207038079179,0.00935369465827566,0.0027874622776976,0.0394539453381382,0.023961195933592
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,0.0209769557493402,0.00929554667109678,0.00275768427399052,0.0391962272246899,0.0240452052496131
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42721,0.00678634659994754,0.00301124356814795,0.000884309206377552,0.0126883839935175,0.0242329344556754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,42370,0.0116796607011658,0.00518878647509132,0.00150963920998679,0.0218496821923447,0.0244055854431493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,42362,0.0135863339865206,0.00606894289159188,0.0016912059190005,0.0254814620540407,0.025194317861881
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,40199,-0.0127945118059162,0.00571836121743468,-0.0240024997920882,-0.0015865238197442,0.0252772839588924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0110892681835156,0.00495670742392754,0.00137412163261766,0.0208044147344136,0.0252879831992054
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,40532,-0.00507117212895019,0.00226691751030277,-0.00951433044914362,-0.000628013808756767,0.0253034587324292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00838189657009277,0.00375706623209872,0.00101804675517929,0.0157457463850063,0.0257032388861235
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00550098122802617,0.00246851703487903,0.00066268783966328,0.0103392746163891,0.0258702541493948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,40116,-0.0071832864732207,0.00322372061503766,-0.0135017788786945,-0.00086479406774688,0.0258834862611557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,0.0124932933569083,0.00561877389509101,0.00148049652252994,0.0235060901912867,0.0262029637385554
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,40182,0.012276541653004,0.00553315963081409,0.00143154877660841,0.0231215345293997,0.0265260151078426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,40136,-0.0107986817136117,0.0048743429985232,-0.0203523939907172,-0.00124496943650619,0.0267522553352516
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.0112672780606553,0.00508974478970519,-0.0212431778484775,-0.00129137827283315,0.0268682000491677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,40482,0.010196197918176,0.0046200519577313,0.00114089608102262,0.0192514997553293,0.0273379933502293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,-0.00621184486323555,0.00281789301603206,-0.0117349151746584,-0.000688774551812719,0.0275143919045408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,0.00968197818075887,0.00439553527060008,0.00106672905038272,0.018297227311135,0.027637370724036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42636,0.014867317067635,0.00676252221319185,0.00161277352977895,0.028121860605491,0.0279314013276862
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,-0.00679123110192675,0.00309955120416077,-0.0128663514620819,-0.000716110741771641,0.0284666037812116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,40182,0.014328185727323,0.00654243530305664,0.00150501253333199,0.027151358921314,0.0285423851264754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.0259301193154258,0.0118500523247611,0.00270401675889407,0.0491562218719575,0.0286731540956089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,-0.00577101583605185,0.00263769318640495,-0.0109408944814056,-0.000601137190698151,0.0286939167994983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,42017,0.0061908094497737,0.00283709086717106,0.000630111350118414,0.011751507549429,0.0291204106610819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0136191127499633,0.00624849045339632,-0.0258661540386201,-0.00137207146130654,0.0293095257057982
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.0260847292303938,0.0119880694309967,0.00258811314564013,0.0495813453151474,0.0295808438944645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0190379286816262,0.00875663698264896,0.00187492019563423,0.0362009371676182,0.0297176020081114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,40527,-0.0056175187565544,0.00258697012077975,-0.0106879801932827,-0.000547057319826091,0.0299166080007335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,0.0143442378676683,0.00662387712114978,0.00136143871021472,0.0273270370251219,0.0303683822624799
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0105085861081325,0.00486016319046463,-0.0200345059614432,-0.000982666254821836,0.0306253370680963
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42721,0.00471145249871692,0.00218443490227183,0.000429960090264125,0.00899294490716972,0.0310365541390013
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,0.0183789432419723,0.00852307215172283,0.00167372182459559,0.0350841646593491,0.0310724179510869
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,40154,0.0150572330609008,0.00698410489953808,0.0013683874578062,0.0287460786639955,0.0311109169051768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,40116,-0.00804821109372298,0.00373821469719775,-0.0153751119002306,-0.000721310287215391,0.0313439798014366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,-0.00548466301816161,0.00255224677661905,-0.0104870667003349,-0.000482259335988282,0.0316556753568287
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,40283,-0.0201776929845877,0.00939685067649461,-0.0385955203105172,-0.00175986565865831,0.0317924111895825
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,0.0089359529843968,0.00416229470456148,0.000777855363456304,0.0170940506053373,0.0318204805365651
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00687528572939538,0.00321007606793231,-0.0131670348225427,-0.000583536636248059,0.0322329769147683
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42721,-0.013043297957041,0.0061054245951198,-0.0250099301634758,-0.00107666575060621,0.0326691354995432
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.0128133734546102,0.00600535690600176,-0.0245838729903736,-0.00104287391884673,0.0328930210452296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,0.0126565649321152,0.00593811888269307,0.0010178519220368,0.0242952779421936,0.0330735148744261
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.00603573290683575,0.00283289077736731,0.000483266983195813,0.0115881988304757,0.0331413622256313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,42459,-0.0143020726724154,0.00673834579388681,-0.0275092304284335,-0.00109491491639721,0.033815071677759
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,0.0101401151926886,0.00480802817085415,0.000716379977814454,0.0195638504075627,0.0349668389177081
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,0.0216156283386286,0.0103084208698396,0.00141112343374303,0.0418201332435142,0.0360260466477353
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,40080,-0.0111683277307804,0.00533030551762026,-0.0216157265453161,-0.000720928916244654,0.0361717348274657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.0127933399236664,0.00611361368141211,-0.0247760227392341,-0.000810657108098647,0.0364037686679928
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,40136,0.018019916564073,0.00861352466008191,0.00113740823031248,0.0349024248978336,0.0364571119175428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0110854943822587,0.00531174745158331,0.000674469377155415,0.021496519387362,0.0369125410417394
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42711,0.00621061708634027,0.00298018510963609,0.000369454271453539,0.012051779901227,0.0371816084141153
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.00914225822943513,0.00439361912520958,0.00053076474402434,0.0177537517148459,0.0374744503200533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,0.00702339618813244,0.00337734836393181,0.000403793394826093,0.0136429989814388,0.0375890679605641
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0148771607449715,0.00717068348174539,0.000822621120750568,0.0289317003691925,0.0380354590668186
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERVV_1,,40116,-0.00915975057565379,0.00442581957125603,-0.0178343569353156,-0.000485144215991969,0.0385117007424993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42594,0.0138092789567955,0.0066770114752299,0.00072233646534489,0.0268962214482461,0.0386419975397778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,-0.0201973897017766,0.00982176646805748,-0.0394480519791693,-0.000946727424383949,0.0397640668934683
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,0.0136804914768959,0.00667206494547209,0.000603244183770623,0.0267577387700212,0.0403438466784564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,42311,0.01346466458565,0.00657449921871464,0.000578646116969256,0.0263506830543306,0.0405785224996965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,-0.00711670206353352,0.00348590193675878,-0.0139490698595807,-0.000284334267486302,0.0412137664075452
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.0128594083491977,0.00630220407195758,0.000507088368160807,0.0252117283302345,0.0413281428607036
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.00855126998855719,0.00419129146660009,0.000336338714021018,0.0167662012630934,0.0413490628842062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42794,-0.0061985767074629,0.00304242904876052,-0.0121617376430335,-0.000235415771892273,0.0416315374063436
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,0.00506196701695192,0.00248457791607175,0.0001921943014513,0.00993173973245254,0.0416339717358185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,40116,-0.0117762397759225,0.00578079538702677,-0.023106598734495,-0.000445880817350051,0.0416609354831107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.0244606554260557,0.0120103712388415,0.000920327797926383,0.048000983054185,0.0417069763216066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,0.0148803228413792,0.00733058054492541,0.000512384973325373,0.029248260709433,0.0423871067852462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42594,-0.0190093713550536,0.00937527135385738,-0.0373849032086141,-0.000633839501493132,0.0426200636542078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.0143634787298209,0.00708444790922042,-0.028248996631893,-0.000477960827748895,0.042638584780103
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.00961209409943665,0.00476515639618776,0.000272387562908647,0.0189518006359646,0.0437021965729369
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,40483,0.00624515684764895,0.0031021739033854,0.000164895997013565,0.0123254176982843,0.0441220194667004
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.00722986952850398,0.00359647947996669,0.000180769747769268,0.0142789693092387,0.0444277174513193
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,42370,0.00784670769142626,0.00390603543692361,0.000190878235055983,0.0155025371477965,0.0445715472644701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,40302,-0.0072031408996288,0.00359412098708299,-0.0142476180343115,-0.000158663764946138,0.0450787246958977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,40080,0.0124258524948645,0.00622228734820434,0.000230169292383994,0.024621535697345,0.0458510006753584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,40451,0.0107377081143694,0.00537965059677296,0.000193592944694456,0.0212818232840444,0.0459594789762828
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFP,Properdin,40539,-0.00447673567375048,0.00225605887953408,-0.00889861107763729,-5.48602698636734e-05,0.0472445819429607
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,40182,0.00628867582249688,0.00317175731765293,7.20314798971387e-05,0.0125053201650966,0.047424663982258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,0.00578417191548373,0.00292088695567831,5.92334823542482e-05,0.0115091103486132,0.047692728422308
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,-0.00544857969069262,0.0027522417575789,-0.0108429735355473,-5.41858458379752e-05,0.0477587379399646
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,-0.0137351308593037,0.00694028129393714,-0.0273380821954205,-0.000132179523186952,0.0478314993626915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,-0.00726525640276459,0.00368180883812749,-0.0144816017254945,-4.89110800347024e-05,0.0484834288468936
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0145114811548171,0.00735557860627583,9.4547086516494e-05,0.0289284152231177,0.0485331868041322
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42500,-0.0096199409038924,0.00487668665983047,-0.0191782467571601,-6.16350506246841e-05,0.0485574085005631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,-0.00969980884395957,0.00493687926562795,-0.0193760922045904,-2.35254833287953e-05,0.0494620469564581
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42590,0.0171525538685045,0.00873012948597423,4.15000759950261e-05,0.034263607661014,0.0494633925998789
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0148247605056601,0.00754527225056575,3.60268945512054e-05,0.0296134941167689,0.0494647398777798
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42794,-0.00805855803651252,0.004121470237282,-0.0161366397015852,1.95236285601974e-05,0.0505724933958678
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.0121047810483338,0.00619346958524274,-0.0242439814354096,3.44193387419763e-05,0.050670107216256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.015536842361264,0.0079566639643555,-0.0311319037314008,5.82190088727584e-05,0.0508826312735133
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,0.0114087527349193,0.00585752766749022,-7.20014933615603e-05,0.0228895069632001,0.0514747530451252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,0.00622686690029546,0.00319747137131438,-4.01769874807285e-05,0.0124939107880716,0.0515034270658462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0100707619524517,0.00519436738682375,-0.000110198125722823,0.0202517220306263,0.0525530872654021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.013538578000124,0.00698585630795016,-0.000153700363458362,0.0272308563637063,0.0526484485367896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,40182,0.00939426854849418,0.00485675953017721,-0.000124980130653145,0.0189135172276415,0.053105979917858
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.0105303056393124,0.00544416178143699,-0.000140251452304098,0.0212008627309289,0.0531094522416631
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.0177311098377576,0.00919065464602434,-0.0357447929439653,0.000282573268450121,0.0537249821388525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,-0.00613796815543797,0.00318181124783838,-0.0123743182012012,9.83818903252569e-05,0.0537466649287472
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42553,0.0115688449856915,0.00601577388369711,-0.000222071826354786,0.0233597617977379,0.0544905978072626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,40483,0.0187528455631085,0.00983921519489392,-0.000532016218883529,0.0380377073451006,0.0566847905417188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,0.00420011369280632,0.00220986071022962,-0.000131213299243747,0.00853144068485638,0.0573726235705236
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,-0.00917431788118918,0.00483765302236758,-0.0186561178050296,0.000307482042651283,0.0579282716073847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42638,0.00564979262593676,0.0029826989515881,-0.000196297319175911,0.0114958825710494,0.0582215006222917
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,-0.00858300547012712,0.00453641832629811,-0.0174743853896714,0.000308374449417169,0.0585135538164456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.010370809266278,0.00548237710326162,-0.000374649856114743,0.0211162683886708,0.0585618999629229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,42311,0.00742299458373997,0.00392765279173578,-0.000275204888062172,0.0151211940555421,0.0587891550808562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,-0.0153435821071236,0.00813519765142089,-0.0312885695039085,0.000601405289661355,0.0593116245992155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0103591572573409,0.00549801134320168,-0.000416944975334428,0.0211352594900162,0.0595643810445913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0111044429391638,0.00589349301596196,-0.000446803372121654,0.0226556892504492,0.0595663084840364
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.0114949410318005,0.00611768547025076,-0.000495722489891036,0.023485604553492,0.0602753412397461
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.0051226148818043,0.0027304148713973,-0.00022899826613441,0.010474228029743,0.0606640842178254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,0.0158715851532895,0.00846250323616352,-0.000714921189590975,0.03245809149617,0.0607470539925366
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,40080,0.013914322944056,0.00741975348886835,-0.000628393894125974,0.028457039782238,0.0607771121002577
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,0.0116459417532056,0.0062188463069054,-0.000542997008328962,0.0238348805147402,0.0611386433212488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,0.00517905072025825,0.00276825884198887,-0.000246736610039925,0.0106048380505564,0.0613889729504181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.00878415872447078,0.00473660923510452,-0.000499595376334074,0.0180679128252756,0.0636902652131059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.00533728162313651,0.00288304388944242,-0.000313484400170641,0.0109880476464437,0.064158042779727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42495,0.0167833337571009,0.00906895828684823,-0.000991824485121584,0.0345584919993235,0.0642442046697173
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00646701907188827,0.00349911281191417,-0.000391242039463507,0.01332528018324,0.0645969061353134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0144005669328231,0.00779680880973491,-0.00088117833425733,0.0296823121999035,0.0647721702697846
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0278224817447158,0.0150709099728825,-0.00171650180213389,0.0573614652915655,0.0648994823202083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0121644309089788,0.00660894308286933,-0.000789097533445084,0.0251179593514027,0.0657066263922271
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,42357,-0.00977033586907875,0.00533031596479905,-0.0202177551600849,0.000677083421927377,0.0668288626406397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,40511,0.00962048869345552,0.00525762460170076,-0.000684455525877974,0.019925432912789,0.0673036614623278
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.00657493888301044,0.00359542592509255,-0.000472095930170968,0.0136219736961918,0.0674672039487407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,40527,0.0171947964034979,0.0094069965460561,-0.00124291682677205,0.0356325096337679,0.0675948684917968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,-0.00961916235677735,0.00526511681361579,-0.0199387913114643,0.000700466597909599,0.0677283056808746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,0.0174893589949868,0.00958005215543684,-0.00128754322966935,0.036266261219643,0.0679367727335837
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,40116,0.00735867125442615,0.00403784296914591,-0.000555500965099829,0.0152728434739521,0.0684176560507313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00505714395648508,0.0027755619183519,-0.0104972453164548,0.000382957403484644,0.0684731036227433
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,0.00531502486212717,0.00292026928621934,-0.000408702938862746,0.0110387526631171,0.0687742068259109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,0.00636842768616038,0.00349911785463858,-0.000489843308931249,0.013226698681252,0.0687798313480844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,40199,0.00484485520212642,0.00266324099188662,-0.00037509714197135,0.0100648075462242,0.0689145451396874
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,40136,-0.00648237076651967,0.00356726826672357,-0.0134742165692979,0.000509475036258525,0.069216802484352
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NCLN,Nicalin,42370,0.00944809979983064,0.00522550858427388,-0.000793897025346163,0.0196900966250074,0.0706179664897594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,-0.00882705665790708,0.00488342728461459,-0.0183985741357517,0.000744460819937518,0.0707034531539065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,0.0438115057748569,0.0242592724320933,-0.00373666819204597,0.0913596797417598,0.0709497299242383
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.016121925177652,0.00892820655190497,-0.00137735966408178,0.0336212100193857,0.0709877227093696
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42794,-0.00438819607857796,0.00243022171039351,-0.00915143063094923,0.000375038473793316,0.0709908691517578
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,42370,-0.00892518690675187,0.00495597205152509,-0.018638892127741,0.000788518314237298,0.0717422371350435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,-0.0048805701780578,0.00271256901428799,-0.0101972054460623,0.000436065089946659,0.0720024463769568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42636,0.00474539668278686,0.00264645216920254,-0.000441649568850126,0.00993244293442384,0.0729767933469074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,-0.00496070246591416,0.00277767680788305,-0.0104049490093649,0.000483544077536631,0.0741350305377234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.0177177512231066,0.00992447322340596,-0.00173421629476909,0.0371697187409823,0.0742419907563921
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,-0.00285781961773713,0.00160800286696013,-0.00600950523697899,0.000293866001504739,0.0755498156038524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.00821987123580749,0.00463203043288331,-0.000858908412643794,0.0172986508842588,0.0759956138343252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,0.00569854931653815,0.00321789267031865,-0.00060852031728641,0.0120056189503627,0.0766051131776113
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,42276,0.0086925012454491,0.00491077931931465,-0.000932626220407613,0.0183176287113058,0.0767361190189234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,-0.00662376149379051,0.00374341914611968,-0.0139608630201851,0.000713340032604053,0.0768476436738241
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,-0.00609844742891751,0.00344729416464072,-0.0128551439916133,0.000658249133778302,0.0769077455577747
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,0.00587498312808398,0.00332712952433037,-0.000646190739603551,0.0123961569957715,0.0774553139934253
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,42370,-0.011150451466411,0.00631610374748076,-0.0235300148114732,0.00122911187865133,0.0775196713073303
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,0.0117923462361646,0.00668513355747401,-0.0013105155364844,0.0248952080088137,0.0777610636639801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,40449,0.0475319242483769,0.0269719126623231,-0.00533302456977642,0.10039687306653,0.0780500054840694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,0.00402265586352067,0.00228290094973691,-0.000451829997963673,0.00849714172500501,0.0780826952331561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.00708734432638858,0.00402568236216208,-0.000802993103449101,0.0149776817562263,0.0783403126996868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42654,-0.0146657961712672,0.00834022779517104,-0.0310126426498024,0.00168105030726805,0.07869527279708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42594,0.00974868832356299,0.00554804583350234,-0.00112548151010159,0.0206228581572276,0.0789169353192033
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.00595861469651821,0.00339407688289711,-0.000693775993960127,0.0126110053869966,0.0791852707920122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.0093439509407527,0.00534433502872086,-0.0198188475970456,0.00113094571554019,0.0804247796412088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0047677582930397,0.00272729873138219,-0.000577747220469385,0.0101132638065488,0.0804590093159255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42477,0.0122354190851506,0.00702212079048393,-0.00152793766419791,0.0259987758344991,0.0814597313507015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F2,Prothrombin,40539,-0.00261574050422217,0.0015055349878764,-0.00556658908045992,0.000335108072015582,0.0823409152107503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,40136,-0.00897923689464562,0.00518430270810246,-0.0191404702025264,0.0011819964132352,0.0833008992000956
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,40136,-0.0166707375575635,0.00962512045798829,-0.0355359736552206,0.00219449854009351,0.0833012091610179
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00893817051358466,0.00516241739062378,-0.0190565085992073,0.00118016757203794,0.0834100299531426
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42656,0.0055304211730562,0.00319935834979819,-0.000740321192548254,0.0118011635386606,0.0839030599929619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,0.00644706769563811,0.00373142459094323,-0.000866524502610619,0.0137606598938868,0.0840566641808954
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,-0.00858059347938307,0.00498065806614682,-0.0183426832890308,0.0011814963302647,0.0849513281911597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,42346,0.0138102119245376,0.00805277133835448,-0.0019732198986372,0.0295936437477124,0.0863754070376332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,0.0113860116792913,0.00664253805612919,-0.00163336291072192,0.0244053862693045,0.0865370610415789
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,0.0145214065689932,0.00848502411440916,-0.00210924069524873,0.0311520538332352,0.0870274876133032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,40419,-0.005908581348165,0.00345483349287098,-0.0126800549941921,0.000862892297862121,0.0872498357629809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,40199,0.00537199964080077,0.00314131605436765,-0.000784979825759831,0.0115289791073614,0.0872735067854086
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42706,0.010363380680331,0.00607944322091876,-0.0015523280326698,0.0222790893933317,0.0882809348581316
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,42445,0.00660216809695975,0.00387371358597253,-0.000990310531546415,0.0141946467254659,0.0883389527879431
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00475683200958102,0.00280146036137307,-0.000734030298710187,0.0102476943178722,0.0895346104073304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,40250,0.014699191395086,0.00865686532499409,-0.00226826464190239,0.0316666474320744,0.0895395198724188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00626737248726919,0.00369660476893078,-0.0135127178343735,0.000977972859835143,0.0900202685182353
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,40539,-0.00356418572138294,0.00210513083192476,-0.00769024215195547,0.000561870709189597,0.0904649094606768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,-0.00916318327834119,0.00541360921036206,-0.0197738573306508,0.00144749077396845,0.0905563404990151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42654,0.00550883206245887,0.00326075002203844,-0.000882237980736463,0.0118999021056542,0.0911588556676813
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,-0.0117370390905051,0.00696127294361236,-0.0253811340599853,0.0019070558789751,0.0918142467611011
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.00553163817390426,0.00329266876094879,-0.0119852689453639,0.000921992597555372,0.0929885415702851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,0.0124719945709034,0.00746400648436609,-0.00215745813845416,0.0271014472802609,0.0947550041281185
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.0051909569304854,0.00310899035985245,-0.0112845780357962,0.000902664174825402,0.0950153983043924
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,40116,-0.0101918187753951,0.00612551033515519,-0.0221978190322993,0.00181418148150908,0.0961747385927539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,40182,-0.00664218116546687,0.00399218272734866,-0.0144668593110702,0.00118249698013649,0.0961815434158518
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,-0.0244835046720189,0.0147645113307283,-0.0534219468802463,0.00445493753620844,0.0972912111222209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,0.0148834487223589,0.00899321189064999,-0.0027432465833151,0.0325101440280329,0.0979601622823012
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42711,0.0107068392994775,0.00647308446181247,-0.0019804062456749,0.02339408484463,0.0981395078794254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0140054577414639,0.0084756539966693,-0.0026068240920079,0.0306177395749357,0.0984748791465666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,40302,-0.00638030051169585,0.003869981719001,-0.0139654646809378,0.00120486365754611,0.0992447170071941
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,0.0062506523135065,0.00379908516439514,-0.00119555460870798,0.013696859235721,0.099930317173205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0110809899518673,0.00678090726431404,-0.00220958828618822,0.0243715681899228,0.102257097036851
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,0.00557127945383918,0.00341338310895371,-0.00111895143971009,0.0122615103473885,0.102668931684259
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.0121299156379122,0.00743916077437424,-0.0267106707556857,0.00245083947986132,0.1030143141491
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.00765585139265048,0.00470064335840504,-0.00155740958982339,0.0168691123751244,0.1034043884868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.00942816549800349,0.00581142350608702,-0.00196222457392706,0.020818555569934,0.104756712733252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00670836132572113,0.00413743947171644,-0.0148177426902853,0.00140102003884308,0.104964111580367
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.00862775180151901,0.00532299069892554,-0.00180530996837505,0.0190608135714131,0.105074065649788
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42636,0.0138774781887271,0.0085635452138463,-0.00290707043041166,0.0306620268078658,0.105142025165699
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.00572393127506804,0.00353814744602488,-0.00121083771914072,0.0126587002692768,0.105734404134083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0102908706084394,0.00638414409486337,-0.0022220518174928,0.0228037930343716,0.107002386511077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00652309574482682,0.00405000144218218,-0.00141490708185025,0.0144610985715039,0.107286857106942
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,0.00712771681397996,0.00443074777679809,-0.0015565488285443,0.0158119824565042,0.107706823274388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,40223,0.0119614122002206,0.00743538227930926,-0.00261193706722552,0.0265347614676668,0.107707260940633
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.00595505796731079,0.00370577766816309,-0.00130826626228887,0.0132183821969105,0.108090342439435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00680442137626865,0.00425180818730562,-0.0151379654233877,0.00152912267085036,0.109547736706208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,-0.00456542981296682,0.00285304854525339,-0.0101574049616635,0.00102654533572982,0.109584527662171
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,0.0101065240606914,0.00634626529786277,-0.00233215592311962,0.0225452040445025,0.111297063753984
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0139014040182437,0.0087352348048343,-0.00321965619923152,0.0310224642357189,0.111543821613894
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42578,0.0176328599084846,0.0110954748260497,-0.00411427075057276,0.0393799905675419,0.112040263544164
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,0.0102338194647651,0.00644315281284295,-0.0023947600484071,0.0228623989779373,0.112241458514298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,0.017381317707912,0.0109514008925016,-0.00408342804139122,0.0388460634572152,0.112506352954586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0181403152684193,0.011434284222707,-0.00427088180808635,0.0405515123449249,0.112657526063701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.00870313663918712,0.0055040805440992,-0.00208486122724732,0.0194911345056216,0.113856821772532
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42495,-0.00892090823964908,0.00565688454403358,-0.0200084019459549,0.00216658546665673,0.114819252957365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,40182,0.00648745649754001,0.00411474632299751,-0.0015774462955351,0.0145523592906151,0.114908130360205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,-0.00652849213178318,0.0041422153938914,-0.0146472343038103,0.00159025004024396,0.115029356770139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42754,0.0122727368970181,0.00779006362256168,-0.00299578780320278,0.027541261597239,0.115179458168834
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,40182,0.0108903916179085,0.00693104356436472,-0.0026944537682464,0.0244752370040633,0.116153737544221
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,0.010176300508993,0.00647668112380466,-0.00251799449366415,0.0228705955116501,0.116159960452859
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42754,0.00688568902225743,0.00438514592725416,-0.00170919699516072,0.0154805750396756,0.116384874146579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,0.00523614216437975,0.00333738308764847,-0.00130512868741125,0.0117774130161708,0.116686202304904
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,42332,0.00800187599829802,0.00510676720799833,-0.00200738772937871,0.0180111397259747,0.117158376494955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,40199,0.00475358335076086,0.00304169442572046,-0.00120813772365124,0.010715304425173,0.11812659537955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,0.0122107632796241,0.00781452908914924,-0.00310571373510846,0.0275272402943566,0.118182128864827
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.0197773451176703,0.0126790156922919,-0.00507352563922181,0.0446282158745625,0.11882369277557
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FN1,Fibronectin,40539,0.00420321585400719,0.0026951610186912,-0.00107929974262757,0.00948573145064194,0.118896128477211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,40116,-0.00774053195830368,0.00498050634544274,-0.0175023243953715,0.00202126047876409,0.120173879222123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,0.00727590687458018,0.0046873674344958,-0.00191133329703159,0.0164631470461919,0.120628850347208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,40136,-0.00782111314137576,0.00504558150174946,-0.0177104528848047,0.00206822660205319,0.121148469926528
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.0123595839203032,0.00799405441033262,-0.0280279305645552,0.00330876272394871,0.122109930435642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0106332759669259,0.00689226217421591,-0.00287555789453726,0.0241421098283891,0.122906493819488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,42353,0.0137947633205638,0.008961225421777,-0.00376923850611911,0.0313587651472467,0.123734723391988
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,0.014381947381635,0.00936177953484812,-0.00396714050666734,0.0327310352699373,0.124508307382617
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00504443841216224,0.00328844565460896,-0.00140091507087133,0.0114897918951958,0.125061349153906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,-0.00871394949471869,0.00568258888452175,-0.0198518237083813,0.00242392471894394,0.125189881461132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,0.0116110976747071,0.00758920005005849,-0.00326373442340754,0.0264859297728217,0.126057092586952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,0.00948118520327854,0.00621512169175972,-0.00270045331257051,0.0216628237191276,0.127162530239365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,-0.00921492028959581,0.00605263616655725,-0.021078087176048,0.0026482465968564,0.127916896566211
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PALLD,Palladin,40199,-0.00601828895982504,0.00395514229940661,-0.013770367866662,0.00173378994701192,0.128128912743895
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,40182,-0.0107446041036023,0.00708733749907051,-0.0246357856017805,0.00314657739457592,0.129540966704969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,0.00676577197556416,0.00446702183138042,-0.00198959081394146,0.0155211347650698,0.129901494532998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,-0.0173691126644511,0.0114683614727577,-0.0398471011510561,0.00510887582215391,0.129922596401481
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,0.00512059126496324,0.00338243044293265,-0.00150897240318475,0.0117501549331112,0.130085229496796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,0.0129890602683754,0.00859519242624139,-0.00385751688705769,0.0298356374238085,0.130765989936409
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,-0.00729269297790338,0.0048263018584194,-0.0167522446204054,0.00216685866459865,0.130804066856483
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,40182,-0.00916275632064164,0.0060642047978998,-0.0210485977245252,0.00272308508324196,0.130828010332441
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,40449,0.0171702167413225,0.011370268499951,-0.00511550951858151,0.0394559430012265,0.131046558856741
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42636,0.0114751292084536,0.00760059148978304,-0.00342203011152117,0.0263722885284283,0.131126157717087
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,0.00821131670761461,0.00544517809650506,-0.0024612323615353,0.0188838657767645,0.131583147396567
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,-0.00759899648235469,0.0050660952722065,-0.0175285432158794,0.00233055025117005,0.133650793907159
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.00611596240938125,0.00409525488691141,-0.00191073716896512,0.0141426619877276,0.135354451644135
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.00541685800521812,0.00363060530059447,-0.0125328443943833,0.00169912838394705,0.13572288921093
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,-0.00794370789451126,0.0053470123343373,-0.0184238520698124,0.00253643628078984,0.137404687945542
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,0.00855909583049997,0.0058090517296701,-0.00282664555965343,0.0199448372206534,0.140664889619132
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,40199,0.00911913411330876,0.00619078612845372,-0.00301480669846053,0.0212530749250781,0.140775011980722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,-0.0221785151753937,0.0150592307374063,-0.05169460742071,0.00733757706992255,0.140845829111022
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,0.00806572202117688,0.00550768042839136,-0.00272933161847018,0.0188607756608239,0.143099363581719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0081581846683426,0.00558080881881263,-0.00278020061653015,0.0190965699532154,0.143816844554888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,0.00894336578944724,0.00613726844773746,-0.00308568036811818,0.0209724119470127,0.1450781790888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0109750369997627,0.00753662602262776,-0.0037967500045877,0.0257468240041131,0.145353312832822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,42370,-0.0204490067088786,0.0140510979132908,-0.0479891586189286,0.0070911452011715,0.145601308128882
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,0.00767880604455388,0.00528537436375165,-0.00268052770839936,0.0180381397975071,0.146296594064067
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,-0.00385780319866308,0.00265694763641522,-0.00906542056603691,0.00134981416871074,0.146539295631195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,0.0162219702682093,0.0112182120898629,-0.00576572542792192,0.0382096659643405,0.148194573332256
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,40333,0.00916792751119632,0.00634317864913047,-0.00326470264109941,0.0216005576634921,0.148395952790915
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,40223,0.0102223010558399,0.0070786348160494,-0.00365182318361689,0.0240964252952968,0.148737484866327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,-0.00689372900810982,0.00477482539022138,-0.0162523867729437,0.00246492875672409,0.148828452183558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0111253734586312,0.00771104929635093,-0.00398828316221658,0.026239030079479,0.149110018260139
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,0.00954336260641678,0.00665221297125645,-0.00349497481724586,0.0225817000300794,0.151420653062128
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,0.00372094018743425,0.00259844794050044,-0.00137201777594662,0.00881389815081512,0.152176264058089
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42587,0.0276699884141151,0.0193661801791665,-0.0102877247370512,0.0656277015652814,0.153091130829433
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00627071722980638,0.00439244467084631,-0.0148799087846652,0.0023384743250524,0.153431468802088
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.00755650757614942,0.005308841489107,-0.0028488217425003,0.0179618368947991,0.154653633648779
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,-0.00880178819517942,0.00618724876550576,-0.0209287957755707,0.00332521938521188,0.154889646874421
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,0.00643318852300823,0.00453593620307968,-0.00245724643502795,0.0153236234810444,0.156139600934968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,-0.00629502951522989,0.00444495278667837,-0.0150071369771195,0.00241707794665972,0.156739719752048
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,40293,-0.00352114496353242,0.00249040868799353,-0.00840234599199973,0.0013600560649349,0.157424487704512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,40182,-0.00693200390664475,0.00492118475988502,-0.0165775260360194,0.00271351822272988,0.158980387758451
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,-0.010050274810016,0.00715189276431419,-0.0240679846280718,0.00396743500803982,0.159971695456867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAG,S-arrestin,40136,-0.00746728800374509,0.005314806831379,-0.0178843093932479,0.00294973338575776,0.160050539140589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,40479,0.00367525892872849,0.00262112262606713,-0.00146214141836309,0.00881265927582007,0.160892060125549
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,-0.00470201716399727,0.00336154274411608,-0.0112906409424648,0.00188660661447026,0.161906238094612
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,42311,-0.00468136331603164,0.00336769207629146,-0.0112820397855629,0.00191931315349963,0.164528001128644
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,40527,-0.0127062413779093,0.00914698108404325,-0.030634324302634,0.00522184154681548,0.164823988369039
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00664665189252316,0.00478930578876737,-0.00274038745346089,0.0160336912385072,0.165222660763543
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,-0.00627662254424826,0.0045238298005391,-0.0151433289533049,0.00259008386480836,0.165330071009074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0101232789391482,0.00730124591469671,-0.00418716305365739,0.0244337209319537,0.165617300929312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,40479,-0.00669171329778064,0.00483808221608013,-0.0161743544412977,0.00279092784573641,0.166651317130496
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.00813988979048901,0.00589822844185867,-0.00342063795555399,0.019700417536532,0.167592162786501
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00804718160391024,0.00583667508719393,-0.0194870647748103,0.00339270156698986,0.168007122284435
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42594,0.00766385127867982,0.00556020660287792,-0.0032341536629609,0.0185618562203205,0.168121566670138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,40182,0.0106042121476336,0.00769396545521711,-0.00447596014459198,0.0256843844398591,0.168154006383074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,-0.0116055299582925,0.00842717216143133,-0.028122787394698,0.00491172747811285,0.168491847336922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,40199,0.0121301471177573,0.00880951940066222,-0.00513651090754069,0.0293968051430552,0.168559948718411
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.0113288126118807,0.00822923363776346,-0.0274581105418971,0.0048004853181357,0.168646797387078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,40283,0.00564706848923279,0.00410271244583603,-0.00239424790460584,0.0136883848830714,0.168718448944769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0046587809502454,0.00339544996836179,-0.00199630098774371,0.0113138628882345,0.170070844826609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,0.00440122208301071,0.00321436638365095,-0.00189893602894514,0.0107013801949666,0.170953855560489
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,40482,-0.00493625859360747,0.00362072998359719,-0.012032889361458,0.00216037217424303,0.172804957258497
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,0.0141515011734606,0.0103865522507062,-0.00620614123792364,0.0345091435848448,0.17307315948002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,0.00505081419942684,0.00371362720427801,-0.00222789512095806,0.0123295235198117,0.173833199231104
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,-0.00590442085370382,0.00434424399234756,-0.014419139078705,0.0026102973712974,0.174131212508637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,40199,-0.00404019276637112,0.00297369826475257,-0.00986864136528615,0.00178825583254392,0.174287755806967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00458341342385216,0.00337392327336415,-0.0111963030396459,0.00202947619194158,0.174338853361933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00508022319181099,0.0037635735079238,-0.0124568272673416,0.00229638088371965,0.177095021294593
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00819593514170604,0.00607557243478608,-0.0201040571138868,0.00371218683047466,0.177365570529635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,40116,-0.00470313336744143,0.00349825993202864,-0.0115597228342176,0.0021534560993347,0.178840276989335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,40136,0.00623913851463571,0.00464102898384678,-0.00285727829370398,0.0153355553229754,0.178865109100978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,-0.00698061066521134,0.00521170673495731,-0.0171955558657277,0.00323433453530498,0.180465196885745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0101188785181143,0.00755497410068565,-0.0249266277554582,0.00468887071922954,0.180479289818387
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,0.0131400006353288,0.00981446387364396,-0.00609634855701334,0.032376349827671,0.180649679246269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00508136881746172,0.00380009047927995,-0.0125295461568504,0.00236680852192698,0.181190537751991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,40199,-0.0061194002650085,0.00457988548587639,-0.0150959758173262,0.00285717528730923,0.181528856471306
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,0.00633484006444665,0.00474373148820132,-0.00296287365242794,0.0156325537813212,0.18176386818463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,-0.00377354626414703,0.00283262821082993,-0.00932549755737369,0.00177840502907963,0.182826387884865
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,40302,0.00600892634323297,0.00451513376038972,-0.00284073582713089,0.0148585885135968,0.18326856175294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,0.00578333447745088,0.00436276061421096,-0.00276767632640261,0.0143343452813044,0.184990768412594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,40182,0.0115815548639631,0.00875258447620607,-0.00557351070940078,0.028736620437327,0.185791277890664
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,0.00539874189215627,0.00408035988753799,-0.0025987634874182,0.0133962472717307,0.185823743556224
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.00783580303307724,0.00593310810864388,-0.00379308885986475,0.0194646949260192,0.18663184810997
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00457944059122054,0.00347030148578625,-0.0113812315033616,0.00222235032092051,0.18698815907888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,40065,-0.00548475645957973,0.00418300384440512,-0.0136834439946138,0.00271393107545431,0.189817749670091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,-0.00712707089916807,0.00543558026363312,-0.017780808215889,0.00352666641755283,0.189821565777735
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,40449,-0.015082412886167,0.0115140532057135,-0.0376499571693655,0.00748513139703157,0.190251859501476
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.00687114581123912,0.00525693539126639,-0.003432447555643,0.0171747391781212,0.191214163112539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,-0.00387805202154873,0.00297450369185353,-0.00970807925758166,0.0019519752144842,0.192341195243474
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00402469456075818,0.00308923091660533,-0.00203019803578827,0.0100795871573046,0.192660772235107
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,-0.00283909729877377,0.00218242423604471,-0.00711664880142139,0.00143845420387385,0.193317998650981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,40199,0.002280906640961,0.00176165351590153,-0.00117193425020599,0.005733747532128,0.195432522791031
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,42370,0.00449244030743037,0.00346986019956663,-0.00230848568372022,0.011293366298581,0.195445203688983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,0.00559737384882404,0.00433372307431379,-0.00289672337683098,0.0140914710744791,0.196527249181578
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,0.00981749088930099,0.00760117311655502,-0.00508080841914684,0.0247157901977488,0.196531387071081
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,40516,-0.00289090539531048,0.00224590376522574,-0.00729287677515293,0.00151106598453196,0.198054303324696
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,40060,0.00577540367858763,0.00449389068562429,-0.00303262206523598,0.0145834294224113,0.19876103955352
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,0.00435384295917724,0.00338884876029368,-0.00228830061099837,0.0109959865293528,0.198904893268251
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0139766120784051,0.0108943251900632,-0.00737626529411868,0.035329489450929,0.199545093476719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,0.00843076554606033,0.00657883920510891,-0.00446375929595313,0.0213252903880738,0.200041106368592
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,-0.0093056397921784,0.00726905161681927,-0.0235529809611442,0.00494170137678737,0.200511672496731
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00626037125159308,0.00490740360857627,-0.00335813982121642,0.0158788823244026,0.202084354635045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,42370,-0.00400925235010496,0.0031451902772111,-0.0101738252934387,0.00215532059322879,0.202429110398593
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,0.00516754017576419,0.00408351433041029,-0.00283614791183998,0.0131712282633684,0.20573205840786
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.00633712856451278,0.00500784170335491,-0.00347824117406283,0.0161524983030884,0.205739380041985
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.0081593739308819,0.00646963225710435,-0.0208398531548064,0.00452110529304262,0.207270716844333
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,0.00530991679151052,0.0042111703622941,-0.00294397711858591,0.013563810701607,0.207362374729704
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,-0.00360772110433648,0.00286693052606194,-0.00922690493541788,0.00201146272674493,0.208272048215627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,-0.00171761667633564,0.0013660943319563,-0.00439516156696998,0.000959928214298702,0.208664461127292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42636,-0.0100628923726703,0.00800419066405715,-0.0257511060742223,0.00562532132888168,0.208701986740944
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,40080,-0.00437605181794699,0.00348255897342727,-0.0112018674058644,0.00244976376997047,0.208939187630051
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,42334,0.00743098131722747,0.00593112014535562,-0.00419401416766954,0.0190559768021245,0.210271706785547
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.00275482091816725,0.00220279702525063,-0.00707230308765849,0.00156266125132399,0.211102037522077
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.00917633354787529,0.00733911894250505,-0.00520833957943461,0.0235610066751852,0.211204297464262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42721,0.00800008153507753,0.00640688695943011,-0.00455741690540549,0.0205575799755605,0.211807750372946
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,0.011455053517363,0.00918891384375445,-0.0065552176163957,0.0294653246511217,0.212564011685461
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,40539,0.00326269252363641,0.00262136115590645,-0.00187517534194023,0.00840056038921305,0.21328398846656
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,-0.00432685771675387,0.00348613186294388,-0.0111596761681239,0.00250596073461614,0.214572165222268
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.010995352131863,0.00886780841327466,-0.00638555235815534,0.0283762566218813,0.21503170660722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.00481108899732172,0.00388692328312521,-0.00280728063760369,0.0124294586322471,0.21583056689556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,-0.00782029602839796,0.00634663588572709,-0.0202597023644231,0.00461911030762714,0.217897665478156
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,-0.00636598408663604,0.00516688142884445,-0.0164930716871712,0.00376110351389908,0.217947530887126
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42587,0.00353142013711903,0.00286682463148045,-0.00208755614058265,0.00915039641482072,0.21803688627876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,-0.00450127278633429,0.00365615856470687,-0.0116673435731598,0.00266479800049118,0.218293116722712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,40509,-0.00451926277262813,0.00367219251769171,-0.0117167601073039,0.00267823456204761,0.2184713236321
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,40182,0.00344336884803516,0.00280866150277713,-0.00206160769740802,0.00894834539347833,0.220231668722216
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,0.00425072781658634,0.00346885087242818,-0.00254821989337289,0.0110496755265456,0.220451279801824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,40199,0.00594227230993987,0.00485052756486429,-0.00356476171719414,0.0154493063370739,0.22057223150325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,40182,-0.00736108448655665,0.00601379586765818,-0.0191481243871667,0.00442595541405338,0.220966030400016
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0046971792474802,0.00384348339888526,-0.0122304067092953,0.00283604821433492,0.221690304582206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.00459310702302902,0.00377147054133017,-0.0119851892840362,0.00279897523797812,0.223304951362531
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.00455047841365134,0.00374110011797477,-0.0027820778175792,0.0118830346448819,0.223877841645079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,40511,0.0118829701783766,0.00977110456154781,-0.00726839476225712,0.0310343351190103,0.223959335114114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,40199,-0.004140019448325,0.00340931079218787,-0.0108222686010132,0.00254222970436322,0.22464878991544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,-0.00539724118695811,0.00445171127264006,-0.0141225952813326,0.00332811290741642,0.22538591492206
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,-0.00870800275839665,0.00718507458095167,-0.0227907489370619,0.00537474342026862,0.225549954984277
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00548217106306394,0.0045317565606439,-0.0034000717957981,0.014364413921926,0.22640682690903
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0111846867027052,0.00924901586992309,-0.00694338440234403,0.0293127578077545,0.226579685963502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,-0.00333414223227084,0.00276266260599855,-0.008748960940028,0.00208067647548631,0.227512865758464
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,0.00934310501050466,0.00774747671801316,-0.00584194935680113,0.0245281593778104,0.227860281223459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00354134565908901,0.0029382541627657,-0.00930032381810979,0.00221763249993177,0.228130532602907
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42608,0.00712158701443178,0.00592329704057036,-0.00448807518508612,0.0187312492139497,0.229268083364197
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,40302,-0.00721466440311092,0.00600506207319328,-0.0189845860665698,0.00455525726034791,0.229609886995591
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,-0.00480216802993409,0.00401246190673396,-0.0126665933671326,0.00306225730726446,0.23140503337807
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CFD,Complement factor D,40539,0.00253834143403155,0.00212529635622096,-0.00162723942416153,0.00670392229222463,0.232367209926462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42638,-0.00411358817188329,0.0034480163768043,-0.0108717002704197,0.00264452392665315,0.232878542525059
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,-0.00801296351872934,0.00676383917868587,-0.0212700883089536,0.00524416127149496,0.236166713345334
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.00309857672814955,0.0026234352106303,-0.00824050974098495,0.00204335628468585,0.23758305554325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,0.00589275712275451,0.00499684501646052,-0.0039010591095081,0.0156865733550171,0.238306040673918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCN,Decorin,42357,0.0028596638090831,0.00242949093587062,-0.00190213842522332,0.00762146604338952,0.239191658177861
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,40483,-0.00504381228614302,0.004289988955334,-0.0134521906385977,0.00336456606631162,0.239732838595569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,42357,-0.0125904958120476,0.0107438731331546,-0.0336484871530306,0.00846749552893542,0.241267727439844
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00432355137756706,0.00369141739891637,-0.00291162672430902,0.0115587294794431,0.241521796314337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,-0.00426514992777382,0.00364372028098568,-0.0114068416785058,0.00287654182295812,0.241801669841196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.00827759587626629,0.00709055165478767,-0.00561988536711754,0.0221750771196501,0.243069467720395
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,40182,0.00420601638590998,0.00360553890392949,-0.00286083986579182,0.0112728726376118,0.243420266743832
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.00512212716791405,0.00439368297777367,-0.00348949146852235,0.0137337458043505,0.243722710119098
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,0.00504882096922513,0.0043382237207926,-0.00345409752352835,0.0135517394619786,0.24453060292878
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,40080,0.00698874390126368,0.0060067474269697,-0.00478448105559693,0.0187619688581243,0.244659404261961
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,40116,-0.00480083346206286,0.00412959566628884,-0.012894840967989,0.00329317404386327,0.245040278325835
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.00566293356988288,0.00487906367874682,-0.00390003124046088,0.0152258983802266,0.245801388231809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,40136,-0.0110779241196061,0.00956054024881729,-0.0298165830072879,0.00766073476807583,0.246598398716567
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,0.0049000420821582,0.00425750536403472,-0.00344466843134984,0.0132447525956662,0.249790173885165
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00293977163161967,0.00256000801037149,-0.00795738733194779,0.00207784406870845,0.250851525571952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,-0.00683606737127665,0.00596038585600348,-0.0185184236490435,0.00484628890649017,0.251441167298115
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,0.00543591398528269,0.00474600879519024,-0.00386626325329017,0.0147380912238555,0.252082034979038
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,0.00631060605421502,0.00553157718342029,-0.00453128522528874,0.0171524973337188,0.253964000613174
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,-0.0045315698309099,0.00397233981343195,-0.0123173558652365,0.00325421620341671,0.253986077411768
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,-0.00565980600506773,0.00496821304760948,-0.0153975035783823,0.00407789156824686,0.254643055767389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,-0.0122715770786973,0.0107758617451825,-0.0333922660992551,0.00884911194186041,0.254809691188385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.00743170792603421,0.00653526474740638,-0.00537741097888229,0.0202408268309507,0.255491926172749
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00556662526830697,0.00490910600029051,-0.0151884730288764,0.00405522249226242,0.256845150736677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.00711192701843093,0.00632019874147836,-0.00527566251486666,0.0194995165517285,0.260499195153724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,0.00297431964910519,0.00264402290063671,-0.00220796523614276,0.00815660453435314,0.26064586800418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,42357,-0.00811413487183065,0.0072278828290099,-0.02228078521669,0.00605251547302875,0.261621212839189
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42587,0.00471802790091184,0.00422392353760393,-0.00356086223279186,0.0129969180346155,0.264023947938584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,0.00962795590737306,0.0086373004908795,-0.00730115305475076,0.0265570648694969,0.265001555599996
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,-0.00609170673884185,0.00546865416951368,-0.0168102689110887,0.00462685543340497,0.265333040445408
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00491494723404693,0.00441610878646261,-0.0135705204555136,0.00374062598741977,0.265750424407626
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,0.00678505218950899,0.00612101722295562,-0.00521214156748402,0.018782245946502,0.267676348655604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,40080,-0.0132258396363209,0.0119935695966927,-0.0367332360458386,0.0102815567731967,0.270162632249758
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,40302,-0.00627894659676046,0.00570577020488193,-0.017462256198329,0.00490436300480813,0.271157525060243
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,40136,-0.00609212405446245,0.00554262336586604,-0.0169556658515599,0.004771417742635,0.271730793770492
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42782,-0.00505205162841406,0.00459963893671562,-0.0140673439443767,0.00396324068754855,0.272067522848134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,42483,0.011377992401542,0.0103612362714765,-0.00893003069055198,0.0316860154936359,0.272167285195697
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0111625657627991,0.010165992135745,-0.00876277882326118,0.0310879103488594,0.272211212396079
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,-0.00513803533209774,0.00467970089621504,-0.0143102490886792,0.00403417842448374,0.272254288415562
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,42346,-0.00871301222753779,0.00793994325305173,-0.0242753010035192,0.0068492765484436,0.272502155727414
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,0.00244835612607364,0.00223380240382508,-0.00192989658542351,0.00682660883757079,0.273081465816552
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,-0.00747936087753151,0.00683060012355781,-0.0208673371197048,0.0059086153646418,0.273550017926592
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.00863608735117874,0.00788967091424945,-0.00682766764075019,0.0240998423431077,0.273713157911062
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00279358956819803,0.00255822533809022,-0.0022205320944588,0.00780771123085485,0.274855026260382
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,42346,-0.00926541693281734,0.00850367589658342,-0.0259326216901208,0.00740178782448616,0.275919106067304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00442046903672181,0.00407234880473652,-0.00356133462056176,0.0124022726940054,0.277731170431296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42721,-0.00485760027528541,0.00449359712450668,-0.0136650506393185,0.00394985008874769,0.279714228923661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,40080,-0.00866167008004881,0.00804932952094846,-0.0244383559411078,0.00711501578101018,0.281918239624123
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00308533575192856,0.00286728176913802,-0.00870520801943908,0.00253453651558196,0.281924536750746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,0.00310963422668142,0.00290645942819898,-0.00258702625258858,0.00880629470595142,0.28468573067487
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42673,0.00407726306897248,0.00381972794801875,-0.00340940370914427,0.0115639298470892,0.28580026744134
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.00640052204830186,0.00599711499611457,-0.0053538233440827,0.0181548674406864,0.285875019229181
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENG,Endoglin,42794,-0.00187076130322977,0.00175350537310523,-0.00530763183451601,0.00156610922805647,0.286049732427273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,0.00430733225362539,0.00404031831904774,-0.00361169165170817,0.012226356158959,0.286407722433584
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,40302,0.00895428814402618,0.00842562171208152,-0.00755993041165359,0.025468506699706,0.287920668033627
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0154571532418512,0.0145483514523768,-0.0130576156048074,0.0439719220885098,0.288046990812986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,-0.00227971892554935,0.00216262749875084,-0.00651846882310099,0.0019590309720023,0.291836320075227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,40182,-0.00523251989708187,0.00497600447999237,-0.0149854886778669,0.00452044888370318,0.293028962655136
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,40182,0.00645272180605309,0.00615461098693611,-0.00561031572834169,0.0185157593404479,0.294460379490363
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,0.00527991570168795,0.00504390989920683,-0.00460614770075744,0.0151659791041333,0.295219493177556
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,40482,0.00721100803452952,0.0069026473946161,-0.00631818085891803,0.0207401969279771,0.296196587192288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,40511,-0.00319104669350284,0.00305791019276507,-0.00918455067132238,0.00280245728431669,0.296721298308595
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00564136450416937,0.00542940415033974,-0.0162829966388353,0.00500026763049653,0.29880909317399
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,42370,-0.00458527032909678,0.00441542654627742,-0.0132395063598005,0.00406896570160697,0.299072214206521
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42611,-0.0025745108778778,0.00248260065926275,-0.00744040817003279,0.0022913864142772,0.299744410249478
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,42247,-0.00697814628564808,0.0067384521841245,-0.0201855125665321,0.00622921999523595,0.300421468515736
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,42322,0.00896629569370233,0.00866417810187261,-0.00801549338596797,0.0259480847733726,0.300748812804305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,-0.00950841043713788,0.00921459679854075,-0.0275690201622778,0.008552199288002,0.302148484233871
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,42370,0.00333613335659546,0.00323394187481555,-0.00300239271804301,0.00967465943123394,0.302278632026359
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,0.00477701189942314,0.00463129830906622,-0.00430033278634665,0.0138543565851929,0.302342404338879
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NENF,Neudesin,40451,0.0115114266743417,0.011163669853387,-0.0103693662382968,0.0333922195869801,0.302492279786621
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,-0.00889557463024443,0.00864133500844271,-0.0258325912467921,0.00804144198630328,0.303300657955927
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42679,-0.00386046542911926,0.00375169526393237,-0.0112137881464267,0.00349285728818819,0.30350176264145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,40116,-0.00768371590006356,0.00746792359923381,-0.0223208461545618,0.0069534143544347,0.303551384270594
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,40116,-0.00619139035565842,0.00603217936255595,-0.0180144619062681,0.00563168119495124,0.304728819190163
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,40080,0.00551852380079142,0.00538609021308285,-0.00503821301685098,0.0160752606184338,0.305580360598611
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,-0.00809803354195322,0.00790385978444291,-0.0235895987194613,0.00739353163555489,0.305590213713785
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,40199,-0.00581599772727147,0.00567894925626199,-0.016946738269545,0.00531474281500203,0.305795104255419
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.00583484747419512,0.00569961628492661,-0.00533640044426103,0.0170060953926513,0.305983436950385
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00481976398223748,0.00471968803340948,-0.0140703525277201,0.00443082456324511,0.30717977871524
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42594,0.00633596899666923,0.00621184940012357,-0.00583925582757296,0.0185111938209114,0.307755837742911
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,42346,0.00766550745620278,0.00753095016189029,-0.00709515486110219,0.0224261697735078,0.308759775417229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,42370,-0.00478214602564152,0.00470952660511396,-0.0140128181716649,0.00444852612038184,0.30992445817751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.00465285558267906,0.00459128859503773,-0.00434607006359489,0.013651781228953,0.310887116063184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.00580344413528996,0.00582018559484124,-0.0172110079011788,0.00560411963059887,0.318722886861713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.00411402639449191,0.00416288302644163,-0.0122732771263175,0.00404522433733369,0.323045385827254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42721,0.00323105333037282,0.0032760836983653,-0.00319007071842318,0.00965217737916882,0.324025725572111
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.00473312177414339,0.00481293193789196,-0.00470022482412486,0.0141664683724116,0.325420062311712
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,40116,0.00459690159604777,0.0046795515750344,-0.00457501949101965,0.0137688226831152,0.325955091472571
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,0.00920135388209101,0.00937146344740109,-0.00916671447481513,0.0275694222389972,0.326192363850124
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,0.0048241016411936,0.0049329464108261,-0.00484447332402556,0.0144926766064128,0.328128063623017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00551203717520587,0.00563731546458284,-0.00553710113537649,0.0165611754857882,0.328206376791158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.00391202373484374,0.0040071477600852,-0.0117660333446107,0.00394198587492325,0.328955774460922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,42346,0.0137584717152045,0.0140945903822261,-0.0138669254339587,0.0413838688643677,0.32900677885738
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42636,0.0039911911724172,0.0040942926260291,-0.00403362237459984,0.0120160047194342,0.329667964748968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,-0.00848445235854914,0.00870366037160912,-0.025543626686903,0.00857472196980472,0.329670024235568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,42370,0.00409585438942886,0.0042433110202791,-0.00422103521031817,0.0124127439891759,0.334437509829635
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,0.00439194821262119,0.00455023024676227,-0.00452650307103285,0.0133103994962752,0.334458756278959
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,40198,0.00678453784427486,0.00706553083901286,-0.00706390260019034,0.0206329782887401,0.3369603437021
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,40116,0.00824824680421472,0.00859497928836306,-0.00859791260097688,0.0250944062094063,0.337248249660746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0117463373494998,0.0122428527837702,-0.0122496541066898,0.0357423288056895,0.337356082970572
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00366387826586989,0.00383059413216346,-0.00384408623317049,0.0111718427649103,0.338851743890778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEO1,Neogenin,40482,0.00215264137630203,0.00225114087320868,-0.00225959473518697,0.00656487748779104,0.338969134027158
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,-0.00406801679450908,0.00426263468426841,-0.0124227807756752,0.004286747186657,0.339930897549298
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.00637949127369846,0.00668476644561686,-0.00672265095971059,0.0194816335071075,0.339935748006202
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,0.00263179026932324,0.0027636539127144,-0.00278497139959698,0.00804855193824347,0.340972098490146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.00395308090910057,0.00415130230600137,-0.00418347161066211,0.0120896334288632,0.340987306779254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,0.00327168661223425,0.00344243882253054,-0.00347549347992561,0.0100188667043941,0.341931142551765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,0.00429201354516851,0.00451647546512901,-0.00456027836648435,0.0131443054568214,0.341979463300314
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,42332,0.00713511649757084,0.00752013874020013,-0.00760435543322142,0.0218745884283631,0.342739194359958
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00712340273758547,0.00751220866278245,-0.0218473317166391,0.00760052624146814,0.343026155278995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00635271022226143,0.00670016064461662,-0.01948502508571,0.00677960464118715,0.343077721536371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,40136,-0.00739660827089654,0.00781076763154175,-0.0227057128287184,0.0079124962869253,0.343672000133484
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,0.00269507747041309,0.0028609942798844,-0.00291247131816034,0.00830262625898652,0.346209584915082
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,40199,0.00339010430909318,0.00360909403954032,-0.00368372000840585,0.0104639286265922,0.347585652904503
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00258951687888289,0.00276437048204183,-0.00282864926591909,0.00800768302368488,0.348905138423509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,40080,-0.00387033781665708,0.00415670814203302,-0.0120174857750418,0.00427681014172765,0.351819143695502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.00318878218974246,0.00342888399283865,-0.0035318304362213,0.00990939481570622,0.352403038357294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIT,Vitrin,40511,-0.00362873916778452,0.00390246780072308,-0.0112775760572018,0.00402009772163271,0.352464675219425
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,-0.00517364342624368,0.00557741900861521,-0.0161053846831295,0.00575809783064214,0.353632235802612
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.00272303503076843,0.00293649871796403,-0.00303250245644107,0.00847857251797792,0.353787858292711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,40223,0.00170716464558466,0.00184502824802494,-0.00190909072054422,0.00532342001171354,0.354841395362292
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42495,-0.00111711474435774,0.00120849281533222,-0.00348576066240888,0.0012515311736934,0.355301760852196
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,-0.00643698339358516,0.00700737228654482,-0.020171433075213,0.00729746628804269,0.358324347214918
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,0.0058629234354206,0.00640995398309329,-0.00670058637144225,0.0184264332422834,0.360390823952834
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,42370,0.00559415230483778,0.00611769825128575,-0.00639653626768229,0.0175848408773579,0.360512357070258
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,40302,-0.00259830872840733,0.00285095184090312,-0.00818617433657745,0.00298955687976279,0.362113442838255
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,0.00789138507201344,0.00868268892412249,-0.00912668521926664,0.0249094553632935,0.363441833715227
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,42311,0.00507458426064097,0.00558912370151225,-0.00588009819432304,0.016029266715605,0.363927048249906
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,-0.00654435538725479,0.0072615774656649,-0.020777047219958,0.00768833644544841,0.367485627891091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,-0.00364712478165118,0.00405094265329732,-0.0115869723821139,0.00429272281881157,0.367972113056007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,42346,0.00957115417459975,0.010669457206642,-0.0113409819504186,0.0304832902996181,0.36970277659432
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,40080,-0.00287971393008104,0.00322380540376113,-0.00919837252145286,0.00343894466129078,0.371734791009866
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,0.00514449139447873,0.00577677272707806,-0.00617798315059427,0.0164669659395517,0.373191360844495
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,40483,-0.0093130156897162,0.0104827645986575,-0.0298592343030849,0.0112332029236525,0.374338007666106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,F3,Tissue factor,42636,-0.00243108525526562,0.00274958228416374,-0.00782026653222654,0.00295809602169531,0.376622798832402
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42538,0.00517781403023637,0.00590840031127023,-0.00640265057985327,0.016758278640326,0.380856723714273
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,0.00209898387079756,0.002405012027265,-0.00261483970264184,0.00681280744423697,0.382815740694782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.00465741053690641,0.00534344120548406,-0.00581573422584234,0.0151305552996552,0.38343572206019
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42636,0.0033972365247087,0.0039089253972854,-0.00426425725397069,0.0110587303033881,0.384809428532029
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00319494051998979,0.00367735115048413,-0.0104025487749387,0.00401266773495911,0.384967019316746
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0238516092921484,0.0274663246788473,-0.0299823870783923,0.077685605662689,0.385197220331209
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,-0.00426023533392998,0.00491914898127473,-0.0139017673372285,0.00538129666936849,0.386477539736568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTTG1,Securin,40302,0.00357839395272345,0.00415517745989635,-0.0045657538686734,0.0117225417741203,0.389152435928804
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00589250619590523,0.00685588747712019,-0.0193300456510608,0.00754503325925034,0.390093967438225
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,40302,-0.0030481002740414,0.00357057503080275,-0.0100464273344148,0.00395022678633198,0.393305107013076
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,42346,-0.0143360564116487,0.0168418004394861,-0.0473459852730415,0.018673872449744,0.394663343617724
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00730917877326855,0.0085868259575586,-0.0241393576500834,0.0095210001035463,0.39467229553126
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,-0.004999878838436,0.00587891271368464,-0.0165225477572579,0.0065227900803859,0.39507876204401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,-0.00317654537801676,0.00374675806359524,-0.0105201911826634,0.00416710042662991,0.396560767953625
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,-0.00302912627077534,0.00358168833801855,-0.0100492354132917,0.00399098287174102,0.397724108882343
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,0.0121400276152309,0.0143729928471615,-0.0160310383652057,0.0403110935956675,0.398328807168412
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,0.00753709309032507,0.00894100456623844,-0.00998727585950228,0.0250614620401524,0.39925783379876
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.00446415843642145,0.00532042024700164,-0.0148921821205447,0.00596386524770177,0.401452632324229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00436237223532239,0.00521032185257508,-0.0145746030663695,0.00584985859572477,0.402467079435391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42699,0.0129966866146452,0.0155579546117822,-0.017496904424448,0.0434902776537383,0.403522816467719
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,40116,-0.0043922759789439,0.00528580308891929,-0.0147524500332257,0.00596789807533791,0.40601598943528
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,-0.00265182422484045,0.00319761456432284,-0.00891914877091321,0.00361550032123232,0.406942196214597
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.00271948312586469,0.00329396686123411,-0.00917565817388355,0.00373669192215417,0.409051809122184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,-0.00632372175731321,0.00766984496983109,-0.0213566178981821,0.00870917438355572,0.409678332514569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,-0.00339689340053218,0.00413226673099079,-0.0114961361932741,0.00470234939220977,0.411068404690384
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42651,-0.00290915258405356,0.00354188600248705,-0.00985124914892817,0.00403294398082105,0.411457544174983
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,-0.00340663484688134,0.00414916430433203,-0.0115389968833721,0.00472572718960943,0.411637191223583
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42710,-0.00368381984592116,0.00448878448129107,-0.0124818374292517,0.00511419773740935,0.411847583584252
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00407220049502622,0.00497048979148381,-0.0138143604863345,0.00566995949628206,0.412647184625065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,0.00519917831937072,0.00635177396021241,-0.00725029864264559,0.017648655281387,0.413063667813964
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00181756474876852,0.00224895995061876,-0.00259039675444424,0.00622552625198128,0.419001226664514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00462127332111896,0.00572496813364962,-0.00659966422083429,0.0158422108630722,0.4195608905034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,0.00394487499053447,0.00489736800340537,-0.00565396629614005,0.013543716277209,0.420543434371708
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,40080,0.00346224981403188,0.00432198702781856,-0.00500884476049249,0.0119333443885563,0.423103829140566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,0.0071080204398867,0.00889373565169447,-0.0103237014374345,0.0245397423172079,0.424182124306389
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,42370,0.00468950712323792,0.00587648524369059,-0.00682840395439562,0.0162074182008715,0.424877771967632
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42594,0.0050704961194251,0.00636714079481658,-0.00740909983841539,0.0175500920772656,0.425840590315778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,0.00161569001157943,0.00203427691702348,-0.00237149274578659,0.00560287276894546,0.427076451875568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.00302942499460349,0.00382154077459153,-0.0105196449128029,0.00446079492359591,0.427955622390002
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.00414658543916043,0.00527160129101762,-0.014478923969555,0.00618575309123409,0.43153936116655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,40532,-0.00392591375893777,0.00499191743017033,-0.0137100719220716,0.00585824440419607,0.431617956388491
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,0.00353776960672238,0.00452415097651244,-0.005329566307242,0.0124051055206868,0.434246622038091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,0.00266892104405285,0.00343602250637328,-0.00406568306843878,0.00940352515654449,0.437321625092909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPHS2,Podocin,40199,-0.00827627018471889,0.0106606547345474,-0.0291711534644318,0.012618613094994,0.437566192056231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,-0.0033364899888748,0.0043090767710197,-0.0117822804600734,0.0051093004823238,0.438773900551254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,-0.0022500384704088,0.00295506712194342,-0.00804197002941789,0.0035418930886003,0.446424351699083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,-0.00748957975214506,0.00988980426794143,-0.0268735961173103,0.0118944366130201,0.448884581784679
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,-0.00311577312014633,0.00412104982901739,-0.0111930307850204,0.00496148454472775,0.449627726345796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,0.00589336877923977,0.00780618515198908,-0.00940675411865882,0.0211934916771384,0.450288451852917
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.00662530588998598,0.00878896605327822,-0.0106010675744393,0.0238516793544113,0.45097310445305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,-0.000624466672896253,0.0008284729047436,-0.00224827356619371,0.000999340220401203,0.451011508263321
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.00300511043954234,0.0039922401258584,-0.00481968020714013,0.0108299010862248,0.451620904205295
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,0.00662731726614111,0.00880739774836831,-0.0106351823206608,0.023889816852943,0.45178340728833
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,0.00418313964896472,0.00556367730481259,-0.00672166786846795,0.0150879471663974,0.452147742221796
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0073390370375752,0.00980125238477446,-0.0118714176365827,0.0265494917117331,0.454002061204762
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.00429974776281444,0.00577746543386383,-0.00702408448755867,0.0156235800131876,0.45675492902673
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00462159875981708,0.00621668903151352,-0.0168063092615836,0.00756311174194943,0.457244617999184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,0.00329811746215443,0.00444530829399516,-0.00541468679407608,0.0120109217183849,0.458141539570312
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,40116,0.00839738729481425,0.0113500636397017,-0.0138487374390011,0.0306435120286296,0.45940463454628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,-0.00536923216368873,0.00727338505091125,-0.0196250668634748,0.00888660253609732,0.460407074598071
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00334616650196395,0.00455422601196999,-0.0122724494854251,0.00558011648149723,0.462513897566244
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.00624885453094938,0.00852474897402012,-0.0104596534581301,0.0229573625200288,0.463558789244285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.00389450303577565,0.0053324790958281,-0.00655715599204743,0.0143461620635987,0.465200049161845
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,40451,0.0031968957023655,0.0044144101078862,-0.00545534810909146,0.0118491395138225,0.468960803243213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.00480377442682031,0.00663612822625258,-0.00820303689663474,0.0178105857502754,0.469150608715091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42594,0.00369015986729346,0.0051091804706738,-0.00632383385522719,0.0137041535898141,0.470146861743824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.00267048249183055,0.00369926656980026,-0.00458007998497796,0.00992104496863906,0.470373875433561
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.0033726193845525,0.00467465780244405,-0.0125349486773428,0.00578970990823784,0.470636529694576
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,40539,0.00526312469252198,0.00736386784480699,-0.00917005628329973,0.0196963056683437,0.47479501485986
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.00429017074938457,0.00600471666218261,-0.00747907390849334,0.0160594154072625,0.474953842506514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,40199,0.00398678773293543,0.00561331890329803,-0.0070153173175287,0.0149888927833996,0.47757212400883
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EPGN,Epigen,40451,0.0032745367293425,0.00461614281003688,-0.00577310317832978,0.0123221766370148,0.478111808094968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,0.00141367838026274,0.002004201629809,-0.00251455681416289,0.00534191357468837,0.480602351115969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,42370,-0.00359301879484801,0.00509463965723592,-0.0135785125230304,0.00639247493333439,0.480664184714782
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,40302,-0.00389162728983164,0.00552132831696995,-0.0147134307910927,0.00693017621142946,0.480927494359284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,0.00437891788590718,0.00622384415472256,-0.00781981665734903,0.0165776524291634,0.481714560260873
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,0.00410410227552863,0.0058724045225745,-0.00740581058871738,0.0156140151397746,0.484639822572707
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,-0.00296999778074495,0.00426083517101227,-0.011321234715929,0.00538123915443911,0.485788801960965
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,0.00726911938449441,0.0104353913493361,-0.0131842476602044,0.0277224864291932,0.486078342637208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,40482,-0.0025653268197711,0.00368293896541716,-0.00978388719198875,0.00465323355244654,0.486102931858979
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00278177428733486,0.00399852049882927,-0.00505532589037052,0.0106188744650402,0.486630967542324
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,40182,0.00294826805550771,0.00424333368645717,-0.00536866596994834,0.0112652020809638,0.487195367316301
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,0.0026693852299469,0.00386721520176763,-0.00491035656551766,0.0102491270254115,0.490044913387989
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,0.00195291958317914,0.00283303700800021,-0.00359983295250126,0.00750567211885955,0.490624810006599
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00334333691775876,0.00489110478253725,-0.0129299022915318,0.00624322845601424,0.494270994860824
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,0.00443929413496322,0.00651224297600393,-0.00832470209800448,0.0172032903679309,0.495452909151194
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,40302,-0.00281852136838764,0.00415551791430156,-0.0109633364804187,0.00532629374364341,0.497621016751637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.00288572561772336,0.00425494443582304,-0.0054539654764898,0.0112254167119365,0.497655510148999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,40199,0.00672589794265737,0.00992684900888956,-0.0127307261147662,0.0261825220000809,0.498073767316285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,40136,0.00330012023745111,0.00488219205124458,-0.00626897618298826,0.0128692166578905,0.499086348957151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,40199,0.00224145890785833,0.00331877118488505,-0.00426333261451637,0.00874625043023303,0.499443348602838
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.00575508830902972,0.00852685570315162,-0.0109575488691475,0.0224677254872069,0.499730149341934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,-0.00281219399380441,0.00416969422970158,-0.0109847946840195,0.00536040669641069,0.500048009057722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NRN1,Neuritin,40482,0.00248578780490784,0.00368608570827807,-0.00473894018331717,0.00971051579313285,0.500089543896146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,40116,-0.0034398602749618,0.00511178550984125,-0.0134589598742507,0.00657923932432706,0.501007748741069
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,-0.00245408577120689,0.00364914198194205,-0.00960640405581331,0.00469823251339953,0.501272615446017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,-0.00409458131033269,0.00612660761707549,-0.0161027322398006,0.00791356961913527,0.503938560673502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42674,0.0040936827953374,0.00615966781385557,-0.00797926611981952,0.0161666317104943,0.506321106447952
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00302016226876842,0.00455144426654975,-0.0119409930312059,0.00590066849366909,0.50698276491744
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.00521201654007322,0.00785847744148257,-0.0101905992452326,0.0206146323253791,0.507191733897502
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,-0.00431022357472931,0.00649964177636355,-0.0170495214564019,0.00842907430694324,0.507247458139288
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,0.00241804137041248,0.00366866414089427,-0.00477254034574029,0.00960862308656525,0.509838520352902
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,40080,-0.00634159828401194,0.00962163084436859,-0.0251999947389744,0.0125167981709505,0.509846738432864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,0.00253065883268768,0.00384816540076473,-0.0050117453528112,0.0100730630181865,0.510791446224404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,40182,0.00432072181235303,0.0065711418229559,-0.00855871616064053,0.0172001597853466,0.510854065524148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00315424323051228,0.00480282434181537,-0.00625929247944584,0.0125677789404704,0.511356844984331
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,42346,0.00257391450978697,0.00393995027327857,-0.00514838802583903,0.010296217045413,0.51358331089106
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,40136,-0.00412638371654531,0.00632757032543014,-0.0165284215543884,0.00827565412129775,0.514332511058839
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,40065,0.00236535789797096,0.00362763056283051,-0.00474479800517683,0.00947551380111876,0.514389569008356
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.00176342639314911,0.00271299339574369,-0.00355404066250851,0.00708089344880674,0.515710284849304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00273122307244967,0.00423164684138969,-0.0110252508815735,0.00556280473667413,0.518663362691234
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,40182,-0.00225622717883347,0.00350673647749447,-0.00912943067472264,0.00461697631705569,0.519979318519628
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.00200682636881101,0.0031216964335506,-0.0081253513785702,0.00411169864094817,0.520325866937453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,40302,0.00267630418845112,0.00416649232747774,-0.00549002077340526,0.0108426291503075,0.520665781214776
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ESPL1,Separin,40080,-0.00373239035222063,0.00583995358357121,-0.0151786993760202,0.00771391867157894,0.522762859794142
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,0.00315518542080754,0.00494934838216459,-0.00654553740823506,0.0128559082498501,0.523815286981296
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00219796114782227,0.00347071251754481,-0.00460463538656556,0.0090005576822101,0.526558312957691
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,-0.00340366317014253,0.00539399772904803,-0.0139758987190767,0.0071685723787916,0.528047395558672
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,40483,-0.00166540260178511,0.00264433751331026,-0.00684830412787323,0.00351749892430301,0.52883847978801
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00605759405507931,0.00970190825680574,-0.0250733342384186,0.0129581461282599,0.532396743593588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,40199,0.00297584134916382,0.00480435131711406,-0.00644068723237973,0.0123923699307074,0.535662119882083
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,0.00307359328614796,0.00497151425838573,-0.00667057466028807,0.012817761232584,0.536427029410977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00438568919470987,0.00711771784117728,-0.0095650377739976,0.0183364161634173,0.537798389380809
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,-0.00233752596951129,0.00383394120696738,-0.00985205073516736,0.00517699879614479,0.54207760848416
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,-0.00291851027683312,0.00479558689347894,-0.0123178605880518,0.0064808400343856,0.542813837785568
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.00225921718664701,0.00373690636037733,-0.00506511927969256,0.00958355365298657,0.545475918546765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0016715254099634,0.00276885083202713,-0.00375542222080977,0.00709847304073656,0.546062446196939
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,40080,0.00444855321423686,0.00737296129183496,-0.0100024509177597,0.0188995573462334,0.546281500015533
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.00245161197653942,0.00407088939903087,-0.00552733124556108,0.0104305551986399,0.547033137087879
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,42311,0.0027220739239431,0.00453510998791771,-0.00616674165237562,0.0116108895002618,0.548368495797748
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0025841126585277,0.00431035700575018,-0.0110324123897981,0.00586418707274266,0.548843691996959
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00406516927892127,0.00680012426886727,-0.00926307428805858,0.0173934128459011,0.549980181150745
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,-0.00431409126661485,0.00723350575966943,-0.0184917625555669,0.00986358002233723,0.550917701573345
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,-0.00222537885039728,0.00373895137614015,-0.00955372354763198,0.00510296584683741,0.551730092915149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,0.00472248790294172,0.00793654058939043,-0.0108331316522635,0.020278107458147,0.551835035654778
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.00287001159733554,0.0048715410254513,-0.0124182320072201,0.00667820881254901,0.555780660010666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.00511184820622044,0.00868436722683996,-0.0119095115583859,0.0221332079708268,0.556122133311318
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,0.00373390236489295,0.00634992680805209,-0.00871195417888914,0.016179758908675,0.556529121249593
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TTN,Titin,40116,0.00390668126689798,0.00665709563134943,-0.00914122617054691,0.0169545887043429,0.557320144171968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,0.00295931201811112,0.00506056294695575,-0.00695939135792215,0.0128780153941444,0.55870819006122
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,0.00221355097221516,0.00378885137572824,-0.0052125977242122,0.00963969966864251,0.55907900376076
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.00166259361814908,0.00286369771881188,-0.00395025391072221,0.00727544114702037,0.561538242514305
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.00262113678706523,0.00452710562880035,-0.00625199024538345,0.0114942638195139,0.562609574201525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,-0.00295004220039973,0.00512884218045565,-0.0130025728740928,0.00710248847329335,0.565176762428888
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,-0.00464963744729189,0.00808654454004286,-0.0204992647457759,0.0111999898511921,0.56531139942313
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,0.00348544212370871,0.00608212210121104,-0.00843551719466493,0.0154064014420824,0.56661350343092
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,40199,0.0032201688896743,0.0056255202797097,-0.00780585085855672,0.0142461886379053,0.567048130863057
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,-0.00422698606885381,0.00738701123202879,-0.0187055280836302,0.0102515559459226,0.567185566390055
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,42460,0.00325761175266661,0.00571927704658971,-0.00795217125864922,0.0144673947639824,0.568969164884116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,42357,-0.00353307567737148,0.00623428667396785,-0.0157522775583485,0.00868612620360552,0.570916193281645
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,0.00271380646499109,0.00479194482602959,-0.00667840539402691,0.0121060183240091,0.57118135293184
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.00248182010613618,0.00439509165627943,-0.00613255954017149,0.0110961997524439,0.572302988093247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,0.0020581643613095,0.00367207509865573,-0.00513910283205573,0.00925543155467473,0.575156131092763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,0.0033230626839391,0.00593135928331619,-0.00830240151136063,0.0149485268792388,0.575318252747697
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,0.00718177457327635,0.0128322435415868,-0.0179694227682337,0.0323329719147864,0.575716330030588
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.00403706635897122,0.00722076300023813,-0.0101156291214955,0.0181897618394379,0.576108644468751
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,0.00622358965834416,0.0111425274640111,-0.0156157641711175,0.0280629434878059,0.576484149101604
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,-0.0027743657971182,0.00497654530654178,-0.0125283945979401,0.00697966300370369,0.577203361873619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,40269,-0.00210538649306823,0.00378615383648283,-0.00952624801257458,0.00531547502643813,0.57817063827639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,40483,0.00456857582100659,0.00826838997032043,-0.0116374685208214,0.0207746201628346,0.580592720774713
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,0.00145672449304312,0.00264564139676597,-0.00372873264461818,0.00664218163070442,0.581909904300376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.00166333396283595,0.00303757410102572,-0.00429031127517447,0.00761697920084636,0.583985315497787
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.00639414779705959,0.0116781844617046,-0.0164950937478815,0.0292833893420007,0.584025993359477
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,-0.00360302102148646,0.00658818359916023,-0.0165158608758405,0.0093098188328676,0.584462598744769
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,40527,-0.00180400050338659,0.0033050801591834,-0.00828195761538605,0.00467395660861288,0.585195913946418
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,-0.00184823938723696,0.00339500456086269,-0.00850244832652784,0.00480596955205392,0.586177514889116
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,40080,-0.00366570480213075,0.00673990515115733,-0.0168759188983991,0.00954450929413762,0.586534661075459
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00192755034875134,0.00358126349155367,-0.00509172609469385,0.00894682679219653,0.590425869440341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,40421,-0.00391796735453656,0.00729209036044497,-0.0182104644610087,0.0103745297519356,0.591077948287479
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,-0.00162807535392217,0.00304170941631525,-0.00758982580990006,0.00433367510205573,0.592487409731101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,40429,0.00285157273678644,0.0054150152957988,-0.00776185724297921,0.0134650027165521,0.598478493741701
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,-0.00469160333085028,0.00890990435939573,-0.0221550158752659,0.0127718092135653,0.598509581862463
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42584,0.003782643549796,0.00719192615790705,-0.0103135317197018,0.0178788188192938,0.598926828647073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42711,0.00157365837972468,0.00300221143319635,-0.00431067602934017,0.00745799278878952,0.600171398345695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.0033692552064819,0.006456341737269,-0.00928517459856535,0.0160236850115291,0.601783747462247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,40461,-0.00125047123126247,0.00242504244861503,-0.00600355443054794,0.003502611968023,0.606109549102488
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00352436806372735,0.00684576299010137,-0.00989332739687133,0.016942063524326,0.606685859963114
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,-0.00236695021862196,0.0046054601049006,-0.0113936520242271,0.00665975158698322,0.607299553661456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,40199,0.00307195240956356,0.00599866836303137,-0.00868543758197793,0.014829342401105,0.608587294619589
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.00495248869998668,0.00977463265344187,-0.0241107687007328,0.0142057913007594,0.612398398953916
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,40451,0.00395148921743489,0.00786572817845119,-0.0114653380123295,0.0193683164471992,0.615418592871913
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,-0.00285562903887271,0.00569999803507632,-0.0140276251876223,0.00831636710987688,0.616389840541841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,42201,-0.00137710221584134,0.00275086711939731,-0.00676880176986006,0.00401459733817739,0.616656491927109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,0.00372859879386865,0.00747105296057712,-0.0109146650088625,0.0183718625965998,0.61773812412257
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,40136,-0.0033112323369688,0.00665690570923054,-0.0163587675270606,0.00973630285312305,0.618907739939933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,0.00190627140557978,0.00384337804461021,-0.00562674956185624,0.0094392923730158,0.619912487611555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00214458039806869,0.00434262429445986,-0.00636696321907263,0.01065612401521,0.621425992096569
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00303217160989699,0.00614229791313805,-0.00900673229985359,0.0150710755196476,0.621560272668262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,40080,0.00224583620825987,0.00455402631188942,-0.00668005536304339,0.0111717277795631,0.621913738405637
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,40283,0.001800567790977,0.003661673421196,-0.00537631211456716,0.00897744769652116,0.62291742737995
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NEB,Nebulin,40116,0.00191153142604466,0.00389495400410249,-0.00572257842199623,0.00954564127408554,0.623598109781371
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,0.00291975896993231,0.00599419218690451,-0.00882885771640053,0.0146683756562651,0.626198348624565
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,40116,0.00327225883165491,0.00673102339153494,-0.00992054701575356,0.0164650646790634,0.62687354127265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,0.00182593598911597,0.00376784694006098,-0.00555904401340354,0.00921091599163548,0.627962796514847
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,-0.00232278467995917,0.00482622776993785,-0.0117821911090373,0.00713662174911901,0.630324533499112
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,0.00266073689796555,0.00554919892470294,-0.00821569299445222,0.0135371667903833,0.631606340758671
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,40434,0.0028987581861381,0.00605191560917376,-0.00896299640784247,0.0147605127801187,0.631960805367498
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,-0.00139661971335519,0.00293910980186055,-0.00715727492500187,0.0043640354982915,0.634663312880285
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,40116,0.00162075309095497,0.00341934550538567,-0.00508116409960094,0.00832267028151088,0.635512860529188
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00313598690416248,0.00662904624012719,-0.00985694372648681,0.0161289175348118,0.63617283296991
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42794,-0.00148454910295032,0.00315058555223566,-0.00765969678533221,0.00469059857943157,0.637507019982396
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,40302,-0.00168009132962623,0.00357210138048076,-0.00868141003536851,0.00532122737611606,0.638123524529066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,40199,0.00201552828808537,0.00428726912431533,-0.00638751919557268,0.0104185757717434,0.638279047058423
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00194873285885481,0.00415748592421864,-0.0100974052703234,0.00619993955261372,0.639272888117109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.00184131873791232,0.00394128868027262,-0.00956624455124665,0.00588360707542201,0.640375431138109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,40286,0.00472465326748627,0.0101148227540313,-0.0151003993304151,0.0245497058653876,0.640436125877401
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,-0.00521414679946967,0.0111811165894788,-0.0271291353148481,0.0167008417159088,0.640984979445675
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.00396650984295596,0.00850879102865388,-0.0127107205732056,0.0206437402591176,0.641104360777977
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00179079431430084,0.00385868369294016,-0.00577222572386186,0.00935381435246355,0.642589159495885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,40136,0.00519378592070138,0.0111931990335951,-0.016744884185145,0.0271324560265477,0.642647914902945
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.00189091937484949,0.00408141630792389,-0.00989049533838031,0.00610865658868133,0.643157078206779
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00325431558041732,0.00705513611900421,-0.0170823823736656,0.0105737512128309,0.644614808683428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,40080,0.00192063542647715,0.00418849761950802,-0.00628881990775856,0.0101300907607129,0.64656653015582
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,0.00132784588799051,0.00289747505244213,-0.00435120521479606,0.00700689699077707,0.646762300327023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.00192456386280159,0.00421104523128723,-0.00632908479052139,0.0101782125161246,0.647658721564955
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,-0.00263624903277845,0.00585511598074125,-0.0141122763550313,0.00883977828947441,0.652541238909761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,40136,-0.00260076392128347,0.00578364923903147,-0.0139367164297852,0.00873518858721821,0.65295352679149
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,40080,0.00189599113813924,0.00429255970719566,-0.00651742588796426,0.0103094081642427,0.658720559913178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,40182,0.00103766729132066,0.00235011600275975,-0.00356856007408845,0.00564389465672978,0.658831700495263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00243080549919637,0.00552641975054343,-0.0132625882102615,0.00840097721186874,0.660053044285558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,40283,0.00154964037109506,0.00353815562311217,-0.0053851446502048,0.00848442539239492,0.661409523268938
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,40483,-0.000990701820110266,0.00229045636936874,-0.005479996304073,0.00349859266385247,0.665361112306504
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42488,0.00225127074607302,0.00521060934792578,-0.00796152357586151,0.0124640650680075,0.665708318057666
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,40482,-0.00699010602284709,0.0162049878782385,-0.0387518822641945,0.0247716702185003,0.666218346302265
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,40199,-0.00204409447010144,0.0047522931904083,-0.0113585891233017,0.00727040018309882,0.667110939325899
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.000985820295533724,0.00229450489026192,-0.00548304988044709,0.00351140928937964,0.667461420137446
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,-0.00220203275033545,0.00513254060540685,-0.0122618123369329,0.00785774683626197,0.667907209257808
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,42311,0.00322174944786125,0.00752553698895077,-0.0115283030504822,0.0179718019462047,0.668578857970284
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,42357,0.00208244415891848,0.00492014343072421,-0.00756103696530097,0.0117259252831379,0.672120755902469
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,40116,0.00163834530876638,0.00389706211064749,-0.0059998964281027,0.00927658704563546,0.674197715844864
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00134068879545899,0.00320249866167567,-0.00761758617234329,0.00493620858142532,0.675488707504325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.000996349848027695,0.00239134201692522,-0.00568338020120113,0.00369068050514574,0.676943397383539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,40182,0.00379681239484454,0.00922623216898828,-0.0142866026563725,0.0218802274460616,0.680696656926018
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,-0.00135856016351455,0.00332411594355737,-0.00787382741288699,0.0051567070858579,0.682768885830642
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42569,-0.00117009529920805,0.00288324495478046,-0.00682125541057776,0.00448106481216165,0.68487706452934
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,-0.00257667469897848,0.00635255234574822,-0.015027677296645,0.00987432789868804,0.685035203996309
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,-0.000871169133748795,0.00214901101232634,-0.00508323071790843,0.00334089245041084,0.685203642126505
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.00210596994725558,0.00519669105320519,-0.00807954451702659,0.0122914844115378,0.685299863521391
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00119352868609125,0.00295219882832248,-0.00459278101742081,0.00697983838960332,0.686011264326023
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00231414063571505,0.00572749129416368,-0.0135400235722759,0.00891174230084577,0.686189213899068
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.00175186356500528,0.00440611510015365,-0.0103878491613064,0.00688412203129587,0.690934135592485
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSC1,Hamartin,40199,0.00296169319712391,0.00744904673783748,-0.0116384384090376,0.0175618248032854,0.690937501423065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.00127584905821948,0.00321209518284935,-0.0075715556166042,0.00501985750016524,0.691225313982146
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42721,-0.00180608298223897,0.00464370210252037,-0.0109077391031789,0.00729557313870095,0.697332788641199
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00108488064161732,0.0027938802716481,-0.00439112469081295,0.0065608859740476,0.69779567818465
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,0.00308262778357396,0.00795194707822028,-0.0125031884897378,0.0186684440568857,0.698277336900268
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,40136,-0.00197507482841814,0.00510478674985851,-0.0119804568581408,0.00803030720130454,0.698833003329162
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,-0.00326873127877365,0.00852665441353989,-0.0199809739293118,0.0134435113717645,0.701464387667615
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,0.0024555112654681,0.00642932715409118,-0.0101459699565506,0.0150569924874868,0.702525398958819
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,0.00236345739936188,0.00624279587155703,-0.00987242250888989,0.0145993373076137,0.704999972176072
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,40136,0.00237129248096062,0.00627990234484119,-0.0099373161149281,0.0146799010768493,0.705734928106896
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,40516,0.000562096058416615,0.00148978958912578,-0.00235789153626992,0.00348208365310315,0.705958518797727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,40482,0.00146051975657137,0.00389126446459617,-0.00616635859403712,0.00908739810717987,0.707419918668919
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,40199,-0.00215375539340195,0.00584277297087696,-0.0136055904163208,0.00929807962951689,0.712419043690437
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,0.00213387750345439,0.00582842803307428,-0.00928984144137121,0.01355759644828,0.714286050029663
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,0.00301393927604519,0.00823271588706956,-0.0131221838626111,0.0191500624147015,0.714302596054441
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.000691629875112259,0.0018989261353753,-0.00303026535022333,0.00441352510044784,0.715699342254269
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,0.00272642910932547,0.00754409082672738,-0.0120599889110602,0.0175128471297111,0.717807952399657
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.00179345751437503,0.00497883285939853,-0.00796505489004609,0.0115519699187961,0.718692236848024
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42689,-0.00109420825973152,0.00304818446899853,-0.00706864981896863,0.00488023329950559,0.719622784557722
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,-0.00130622275994955,0.0036797354300685,-0.00851850420288381,0.00590605868298471,0.722613366958897
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,0.00140169826971182,0.00395793310581853,-0.00635585061769249,0.00915924715711613,0.723234039760967
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00173413284471142,0.0049331123975182,-0.0114030331438471,0.00793476745442425,0.725198183118475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,40527,-0.00153442286434065,0.00438624600788228,-0.0101314650397899,0.00706261931110863,0.726475791179692
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.00327595345532282,0.00938079069466544,-0.0151103963062214,0.0216623032168671,0.726931408844229
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.00375654113009331,0.0107859181464111,-0.0173838584368724,0.024896940697059,0.727635233972856
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,0.00162389993858975,0.00466721107546751,-0.00752383376932656,0.0107716336465061,0.727892338550711
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00110528998294289,0.00321586633329429,-0.00740838799619969,0.00519780803031392,0.731079253515486
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,0.00144967390098649,0.00423125544798401,-0.00684358677706217,0.00974293457903516,0.731897875482145
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,40080,0.00253546253025403,0.00758341836044504,-0.0123280374562182,0.0173989625167263,0.738127218374587
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00133598536620745,0.00400426235898993,-0.00651236885741282,0.00918433958982772,0.738656840199736
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,42370,0.00157271030918339,0.00475124465098989,-0.0077397292067568,0.0108851498251236,0.740642065865381
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,-0.00185644159440248,0.00564060549928129,-0.0129120283729938,0.00919914518418884,0.742070580616332
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,42370,0.00249283327559481,0.00761841019807112,-0.0124392507126246,0.0174249172638142,0.743512938239387
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.00129031192748381,0.0039576613717684,-0.00646670436118225,0.00904732821614987,0.744407594228138
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,-0.00217456276483014,0.00667562275667574,-0.0152587833679146,0.0109096578382543,0.744622066770525
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,40199,0.00105847757003537,0.00325717704567844,-0.00532558943949438,0.00744254457956513,0.745211639889213
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,0.00196889965227256,0.00607392178472569,-0.0099359870457898,0.0138737863503349,0.745824846736034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.00085712417024566,0.00265448512194324,-0.0043456666687631,0.00605991500925442,0.746779767265151
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,0.00159129465878539,0.00493042069101257,-0.00807232989559925,0.01125491921317,0.746889592861611
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,42311,-0.00171781559691788,0.00537631780341421,-0.0122553984916097,0.00881976729777398,0.74934090768108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.00199485536180236,0.00627116474807606,-0.0142863382680314,0.0102966275444267,0.750415413598619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.00162617073163164,0.00512924903338474,-0.00842715737380244,0.0116794988370657,0.75121924081514
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,-0.00106773505100842,0.00337103127522586,-0.0076749563504511,0.00553948624843426,0.751447951399507
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00157277498526818,0.00496978630057333,-0.00816800616385555,0.0113135561343919,0.751653823498933
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.00103229660145633,0.00327123284335944,-0.00744391297444083,0.00537931977152817,0.752335404720648
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,0.00142055965081585,0.00450482865848324,-0.0074089045198113,0.010250023821443,0.752508354496231
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00227084398313848,0.00722960906813396,-0.0118991897904041,0.016440877756681,0.753448555001822
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,0.00237726836968608,0.00761172831684144,-0.0125417191313231,0.0172962558706953,0.754805861691109
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.00234216596241132,0.00751853306549782,-0.017078490770787,0.0123941588459644,0.755412029861622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.00240065329163919,0.00780214681972624,-0.0128915544750242,0.0176928610583026,0.758322067656999
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLPS,Colipase,42590,0.00225440531033234,0.00733750030911075,-0.0121270952955247,0.0166359059161894,0.758662187528777
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.00224122453388169,0.00730579407190754,-0.0120781318470571,0.0165605809148205,0.75902138495293
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,0.000721510818530443,0.00236676295742513,-0.00391734457802282,0.00536036621508371,0.760484127725042
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,0.00305674673032108,0.0101377183892216,-0.0168131813125533,0.0229266747731954,0.763022096151558
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,-0.000805211892347801,0.00268866471756592,-0.006074994738777,0.0044645709540814,0.764576555641893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,-0.00128583590480086,0.00432995209172767,-0.0097725420045871,0.00720087019498538,0.766500362830993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,-0.00227873962259531,0.00777291439600843,-0.0175136518387718,0.0129561725935812,0.769402110426573
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00105797075270275,0.00361628281305982,-0.0060299435608945,0.0081458850663,0.769864912927993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,0.00128784956666168,0.0044526597015753,-0.00743936344842591,0.0100150625817493,0.772409604678341
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00229425997722114,0.00797009115553889,-0.0133271186876351,0.0179156386420774,0.773460340697015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00150239210611053,0.00523268966371569,-0.0117584638469933,0.00875367963477222,0.77402847282254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00125041640079169,0.00438638148093171,-0.00984772410341785,0.00734689130183447,0.775597544824127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.000940384425652397,0.0033037502565453,-0.00553496607717639,0.00741573492848119,0.775924210620015
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.0020900409112785,0.00735413214189972,-0.016504139909402,0.012324058086845,0.776261824300283
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.00251961648640964,0.00890440669600637,-0.0149330206377628,0.0199722536105821,0.777209650027863
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,40223,-0.00245348245136577,0.00869109346098216,-0.0194880256348908,0.0145810607321593,0.777719950094257
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.00289592653629279,0.0103076174285764,-0.0230988566963024,0.0173070036237169,0.778753808646006
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.0049374336088142,0.0177527365061674,-0.0298579299432739,0.0397327971609023,0.780923513239938
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,0.0013931703463353,0.00504518224729048,-0.00849538685835404,0.0112817275510246,0.782446747018282
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42629,0.0050676001591977,0.0187192208605511,-0.0316220727274825,0.0417572730458779,0.786613317796032
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCIN,Adseverin,40136,0.0019994323840836,0.00739698754955239,-0.0124986632130391,0.0164975279812063,0.786931791786639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.000819716257108792,0.00305081148710603,-0.00515987425761902,0.0067993067718366,0.788174876576034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0017190336968237,0.00646378001523372,-0.0109499751330344,0.0143880425266818,0.790283611755442
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,40451,0.000703037959060664,0.00267933567998641,-0.0045484599737127,0.00595453589183402,0.793023548806304
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,40116,-0.001367945909564,0.00523427241823133,-0.0116271198492974,0.00889122803016942,0.793832133645407
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,-0.00154438494127306,0.00592170439029411,-0.0131509255462495,0.0100621556637034,0.794250146115058
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,0.00136008118334178,0.00525445654952597,-0.00893865365372912,0.0116588160204127,0.795760950425014
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00145227122443325,0.00567525223418777,-0.0125757656034413,0.00967122315457478,0.798036358156811
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,42311,-0.00148057159222646,0.00588218770793315,-0.0130096594997754,0.0100485163153225,0.801273621943041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,40080,-0.00121530063134173,0.00485385658508563,-0.0107288595381096,0.00829825827542611,0.802299491130579
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,42346,-0.00218336560564468,0.00888112248719865,-0.019590365680554,0.0152236344692647,0.805807273258855
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.000663027575614453,0.00275372578564542,-0.00606033011547948,0.00473427496425058,0.809734090754926
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42611,0.000805373547070817,0.00338860780295444,-0.00583629774671989,0.00744704484086153,0.81213996600195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,40302,-0.00413301127544477,0.0175233272478507,-0.038478732681232,0.0302127101303425,0.813547458174705
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.00301066141224136,0.0128087323103934,-0.0220944539161297,0.0281157767406124,0.814175470578155
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41779,0.00118109016607915,0.00504388167944739,-0.00870491792563773,0.011067098257796,0.814862293415041
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,42357,-0.000649213026035399,0.00278951337153143,-0.006116659234237,0.0048182331821662,0.815972023922108
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,-0.00148795579027498,0.00642948252449847,-0.014089741538292,0.011113829957742,0.8169874485388
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,0.00101807378686482,0.00440560225795541,-0.00761690663872778,0.00965305421245743,0.817252109113763
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,42357,-0.000766928192940457,0.00335425079518056,-0.00734125975149436,0.00580740336561345,0.819149436032453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,40080,0.00143099034518999,0.00627378059290792,-0.0108656196169095,0.0137276003072895,0.819580095831404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,0.000826175673862724,0.00362749382617697,-0.00628371222544413,0.00793606357316958,0.819841863896382
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.00074330128139753,0.00332057527133989,-0.00725162881322371,0.00576502625042865,0.822879662566619
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,-0.000657738350313614,0.00299944997364365,-0.00653666029865517,0.00522118359802794,0.826430413429877
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLSPN,Claspin,42292,-0.000765554375251846,0.00353813572010093,-0.00770030038664967,0.00616919163614598,0.828700967306397
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42652,-0.000996218908661507,0.0046161835280288,-0.010043938623598,0.00805150080627494,0.829139066027639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,42370,-0.00103095135733006,0.00478632391087769,-0.0104121462226503,0.00835024350799022,0.829462519635148
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.00125161536992772,0.00581265900880856,-0.0126444270271925,0.0101411962873371,0.829517347320254
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,-0.000848177909159178,0.00399946787001242,-0.00868713493438352,0.00699077911606516,0.83205414461247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,-0.000636090114649212,0.00300110372124731,-0.00651825340829394,0.00524607317899552,0.83214836057868
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.00161403295477903,0.00764624660175321,-0.0166006762942153,0.0133726103846573,0.832822204934695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,0.00168195959601671,0.00810553575264262,-0.0142048904791628,0.0175688096711962,0.83561732683074
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000784589779776801,0.00382752450846056,-0.00828653781635951,0.0067173582568059,0.837586711381677
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.000412796112181248,0.00201867431639655,-0.00354380554795599,0.00436939777231848,0.837974718923176
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,40451,0.000740088370709356,0.00363080514528906,-0.00637628971405721,0.00785646645547592,0.838485435946091
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,0.00145939098859886,0.00720597931139403,-0.0126643284617334,0.0155831104389311,0.839510056877766
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-0.000599598698760298,0.00296469699288217,-0.00641040480480936,0.00521120740728876,0.839727483320453
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,42293,0.00115230514694319,0.005724426520329,-0.0100675708329016,0.012372181126788,0.84047012094065
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,0.00126658965643022,0.00631272684999379,-0.0111063549695576,0.013639534282418,0.840982662324045
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.000959164249035591,0.00479588628115103,-0.0103591013600916,0.00844077286202043,0.841485710877802
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,0.000957046413035935,0.00487610396367251,-0.00860011735576219,0.0105142101818341,0.844399708715996
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,0.00138488237311589,0.00718076339345181,-0.0126894138780496,0.0154591786242814,0.847072100460084
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,42370,0.000636365921019388,0.00330025103318417,-0.00583212610402159,0.00710485794606037,0.847100178494327
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,40080,-0.00130470773613356,0.0067681681847613,-0.0145703173782657,0.0119609019059986,0.84714177481475
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.00238028121463535,0.012395180897816,-0.0266748357743547,0.021914273345084,0.847719482572968
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.00102196819454537,0.00534201046873649,-0.0114923087132689,0.00944837232417815,0.848287414666609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.00100724935034141,0.00552900541793306,-0.00982960126880739,0.0118440999694902,0.855448356652429
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C5,Complement C5,40539,0.00027645807131096,0.00152512477952587,-0.00271278649655974,0.00326570263918166,0.856159558351182
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,0.000470714581937011,0.00260016258353197,-0.00462560408178564,0.00556703324565966,0.856345129903294
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,40009,-0.000715406098296414,0.00397647437047081,-0.00850929586441921,0.00707848366782638,0.857226872575127
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42588,0.00140235535987276,0.00792546731654947,-0.0141315605805642,0.0169362713003097,0.859555897578376
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,-0.00159401768528611,0.00908021493343747,-0.0193912389548236,0.0162032035842513,0.860651354292336
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,40080,0.000555834811353005,0.00317276613779953,-0.00566278681873407,0.00677445644144008,0.860934117042335
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,42370,-0.00163864473419828,0.00944180417558111,-0.0201445809183372,0.0168672914499407,0.862220162661195
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.000418771127300045,0.00243839577874575,-0.00519802685364171,0.00436048459904162,0.863644193494509
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,40116,-0.000769642884936018,0.00459959719476639,-0.00978485338667815,0.00824556761680612,0.867114817598179
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,40199,-0.000692078986605232,0.00420926144278323,-0.00894223141446036,0.0075580734412499,0.869404994602891
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,40199,-0.000484297874310105,0.00295305162672065,-0.00627227906268258,0.00530368331406237,0.869734846619639
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,0.000648128857214266,0.00405462808706524,-0.00729894219343359,0.00859519990786213,0.873002832211818
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0005443467473811,0.00342173547204198,-0.00616225477782119,0.00725094827258339,0.873604290229066
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.000641912840471167,0.00413760822164111,-0.00875162495488773,0.0074677992739454,0.876712995846885
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.000900167429728668,0.00588699065995698,-0.0124386691232443,0.010638334263787,0.878473718575653
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.000769601827593503,0.00506572180368288,-0.00915921290762494,0.0106984165628119,0.879250129910071
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.000738546398879267,0.00493221877486542,-0.0104056951976155,0.00892860239985695,0.880973159686052
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,0.000299316817025056,0.00200689933025969,-0.00363420587028393,0.00423283950433404,0.88144273224512
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.000434400501297942,0.00294864095244738,-0.00621373676809481,0.00534493576549893,0.882879913487458
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.000423453410882937,0.00288586328881558,-0.00607974545696147,0.00523283863519559,0.88334490200049
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,-0.000424411554221173,0.00289811238157119,-0.0061047118221007,0.00525588871365835,0.883573012796456
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.000821147552941497,0.00564237523778862,-0.0118802030190072,0.0102379079131242,0.884293315983001
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.000920361882058958,0.00635016800016594,-0.0133666911623842,0.0115259673982663,0.884764826429239
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00103242201010635,0.00722265412319506,-0.0151888240915687,0.013123980071356,0.886338468554727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,-0.000707475729128171,0.00510238303273958,-0.0107081464732978,0.00929319501504141,0.889724585982754
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.000861858635741684,0.00638408950697849,-0.0116509567979361,0.0133746740694195,0.892613508886969
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.0006294821727512,0.00469049194718003,-0.00856388204372165,0.00982284638922405,0.893243399106765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.000702062173294224,0.00528346916144803,-0.0110576617297324,0.00965353738314391,0.894291523417342
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.000659691996704656,0.00502545025934357,-0.010509574505018,0.00919019051160873,0.89556396108867
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,40302,-0.000712817762830555,0.00551956278507273,-0.0115311608215731,0.010105525295912,0.897246138376291
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,40080,0.000495470507128267,0.00385969252667252,-0.00706952684514987,0.00806046785940641,0.897858178134902
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.000408230008700422,0.00321629328313151,-0.00589570482623733,0.00671216484363818,0.899001211686355
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.000692780468017967,0.00546257204425356,-0.0113994216747549,0.010013860738719,0.899082721162404
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,0.00043793982797808,0.00352114940388051,-0.00646351300362772,0.00733939265958388,0.901021359149283
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.000503206750750966,0.00411068378705149,-0.00755373347186995,0.00856014697337188,0.902573075944923
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,40036,-0.000423995947189749,0.00354934711658357,-0.00738071629569355,0.00653272440131406,0.904915163735544
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.000621323391623447,0.00522907679688711,-0.00962766713027528,0.0108703139135222,0.905419475857734
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,-0.000545052366543297,0.00464832334904907,-0.00965576613067948,0.00856566139759289,0.906657476399238
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,40451,0.000405680972496923,0.0034608221037081,-0.00637753035077095,0.0071888922957648,0.906687029939622
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.00102001371327705,0.00892438967107245,-0.0185118174685791,0.0164717900420249,0.909005993901909
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,40302,-0.000818898153873482,0.00718641920338047,-0.0149042797924992,0.0132664834847522,0.909278861615765
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.000641436905381708,0.00571426612448588,-0.011841398509374,0.0105585246986106,0.910625405282841
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.000504688416945091,0.00450182740884908,-0.00831889330439911,0.00932827013828929,0.910740204736017
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.000360550691980446,0.00345516883443604,-0.00713268160747508,0.00641158022351418,0.916892297636493
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,-0.000360568131369098,0.00348835795417562,-0.00719774972155332,0.00647661345881512,0.91767655049693
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,-0.000434799427949973,0.00447336024731644,-0.0092025855126902,0.00833298665679025,0.922571320334428
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42654,0.00105767755601072,0.0110523657273874,-0.0206049592696686,0.02272031438169,0.923762697609739
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42587,-0.000185578129085499,0.00195265411233952,-0.00401278018927096,0.00364162393109996,0.924285338555636
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,0.000574591017264932,0.00616963026860352,-0.011517884309198,0.0126670663437278,0.92579998277434
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,40199,0.000353793644386149,0.00379958619183538,-0.0070933952916112,0.0078009825803835,0.925814904509613
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,0.000758428399982828,0.00817404251389627,-0.0152626949272539,0.0167795517272195,0.926076054240866
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,0.000344926758827542,0.00376096899962786,-0.00702657248044306,0.00771642599809814,0.926928327708526
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.000573552720996993,0.00649901072447087,-0.0121645082989659,0.0133116137409599,0.929677763996706
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.00100117530353303,0.011486453736405,-0.0215122740198207,0.0235146246268868,0.930544551282101
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.000801175027823489,0.00927260066496774,-0.0173731222755133,0.0189754723311602,0.931148065090932
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ARTN,Artemin,42370,0.000382606421182838,0.00450657099702132,-0.00845027273297894,0.00921548557534462,0.93234243861586
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.000350460131774293,0.00415213472829963,-0.00848864419924156,0.00778772393569298,0.932736081886034
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.000591001498545337,0.00700645297070988,-0.0143236493211367,0.013141646324046,0.932778874788539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.000447645031444519,0.00556809862049182,-0.0113611183276085,0.0104658282647194,0.935924896131528
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,40451,-0.000308348115871673,0.00387828367499111,-0.00790978411885425,0.0072930878871109,0.93663130728262
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,-0.000716918579677005,0.00923466578207002,-0.0188168635125343,0.0173830263531802,0.938121086019823
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.000208666489453028,0.00282157459747702,-0.00532161972160194,0.005738952700508,0.941048361902415
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.000353783897267013,0.00484255613081332,-0.00984519391366111,0.00913762611912709,0.941761892068555
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,40136,-0.000271868207262973,0.00377449759324927,-0.00766988349003155,0.00712614707550561,0.942581216599564
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.00056563838799173,0.00819639342687388,-0.0166305695046645,0.0154992927286811,0.944982416359297
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BSND,Barttin,40080,-0.000231427696180749,0.00346617811734847,-0.00702513680618374,0.00656228141382225,0.946768103700695
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42595,0.000844926702375173,0.0132768987163419,-0.0251777947816549,0.0268676481864052,0.949258737564365
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,-0.000430419117467178,0.0070862439915448,-0.014319457340895,0.0134586191059606,0.951567093699358
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.000321573524214175,0.00531654605715654,-0.010742003796241,0.0100988567478126,0.951770133956178
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,0.000678865255699132,0.0113619355544541,-0.021590528431031,0.0229482589424293,0.95235656832993
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00010324343720354,0.00176702524121584,-0.00356661290998659,0.00336012603557951,0.953408721948247
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000198303140036155,0.00351184664806546,-0.00708152257024446,0.00668491629017215,0.95497088916539
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,42311,-0.000257787592978726,0.00479122861058922,-0.00964859566973359,0.00913302048377614,0.957092087296566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,40527,0.000228942614824254,0.00485215281691765,-0.00928127690633434,0.00973916213598285,0.962367634853694
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.000267090553899515,0.00571638537983602,-0.0109370247905791,0.0114712058983781,0.962734167471893
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.000361039721631754,0.00773107574086664,-0.0147918687304669,0.0155139481737304,0.962753332105737
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,0.000316596529066028,0.00732308500380028,-0.0140366500783825,0.0146698431365146,0.965516705745655
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,-0.000132608159014744,0.00310269483516923,-0.00621389003594644,0.00594867371791695,0.965909823094443
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.000166385351657557,0.0039573106517287,-0.00792271422904581,0.0075899435257307,0.96646341668948
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,42346,0.000211493322661487,0.00544834356442641,-0.0104672600636143,0.0108902467089373,0.969036152820661
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,40337,-0.000133507752453468,0.00347257794306312,-0.00693976052085719,0.00667274501595025,0.969332539719078
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.000145970988434785,0.00383453395934329,-0.00736971557187806,0.00766165754874763,0.969634587159605
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.000149099903850259,0.00404277181809452,-0.007774732859615,0.00807293266731552,0.970580849719462
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-9.92202706076854e-05,0.00273677940469309,-0.00546330790380613,0.00526486736259076,0.971080154963998
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.000113391720047607,0.00322628602137716,-0.00621012888185163,0.00643691232194685,0.971963674350914
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,40302,7.80306140842134e-05,0.00237554729597246,-0.0045780420860218,0.00473410331419023,0.973796848263007
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,-9.71110630307713e-05,0.00305050520261768,-0.00607610126016141,0.00588187913409987,0.97460456757392
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,40080,-0.000141708397911203,0.00468987097304303,-0.00933385550507554,0.00905043870925313,0.975895468531609
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39926,-0.000199893272805929,0.00709156535382,-0.0140993613662931,0.0136995748206813,0.977513156302761
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,5.37401095402511e-05,0.00209104138613831,-0.00404470100729084,0.00415218122637134,0.979496872274644
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,40482,0.000122237677658006,0.0048554572220637,-0.00939445847758685,0.00963893383290286,0.979915569428208
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42611,-5.06627105084993e-05,0.00203522701932186,-0.00403970766837934,0.00393838224736235,0.980140757582922
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,40116,0.00010644217439284,0.00480088553180152,-0.00930329346793814,0.00951617781672382,0.98231166624662
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,5.10084332867875e-05,0.00292281663615223,-0.00567771217357158,0.00577972904014515,0.986076437271566
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-5.34329409765531e-05,0.00327873437927548,-0.00647975232435649,0.00637288644240338,0.986997842413073
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,8.51113042119335e-05,0.00564223489912865,-0.0109736690980802,0.0111438917065041,0.987964891060325
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,42370,-4.1711125688223e-05,0.00288785094410834,-0.00570189897614058,0.00561847672476413,0.988476249227248
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-5.34567733551862e-05,0.00373739221127192,-0.00737874550744816,0.00727183196073778,0.988588321104286
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.00012418930329167,0.00887185905292967,-0.0172646544404505,0.0175130330470338,0.988831693403832
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,40302,-7.44465348198196e-05,0.00625035249727123,-0.0123251374294714,0.0121762443598318,0.99049701606861
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.000188121895147867,0.0185015889004973,-0.0360749923498268,0.0364512361401226,0.99188749870794
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,-5.5662237591781e-05,0.00675225181577443,-0.0132900757965097,0.0131787513213261,0.993422832600981
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-2.56721428998626e-05,0.00342127557990068,-0.0067313722795052,0.00668002799370547,0.994013100843373
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,-1.53682507826566e-05,0.00379722786832629,-0.00745793487270219,0.00742719837113688,0.996770847338263
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,-1.65459981145737e-05,0.00547967274736287,-0.0107567045829458,0.0107236125867166,0.997590827891205
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,1.24602373180706e-05,0.00524232678102293,-0.0102625002534869,0.010287420728123,0.998103592415727
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,40199,6.28906843484477e-06,0.00269846284221095,-0.00528269810229861,0.0052952762391683,0.998140485022337
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,HLA_A,,40482,7.60952936328567e-06,0.003361483444843,-0.006580898022529,0.00659611708125557,0.998193837202978
NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,42311,-1.86774850049799e-06,0.00387182135505501,-0.00759063760440831,0.00758690210740731,0.999615111572864
